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ABSTRACT 
 
Cytotoxicological Response to Engineered Nanomaterials: A Pathway-Driven Process. 
(May 2012) 
Amelia Antonia Romoser, B.S., Texas A&M University  
Co-Chairs of Advisory Committee:  Dr. Christie M. Sayes 
                                                                  Dr. Michael F. Criscitiello 
Nanoparticles, while included in a growing number of consumer products, may 
pose risks to human health due to heavy metal leaching and/or the production of reactive 
oxygen species following exposures. Subcellular mechanisms of action triggered as a 
result of exposure to various nanoparticles are still largely unexplored. In this work, an 
effort to elucidate such toxicological parameters was accomplished by evaluating 
oxidative stress generation, changes in gene and protein expression, and cell cycle status 
after low-dose exposures to a variety of metal and carbon-based nanomaterials in 
primary human dermal cells. Additionally, mitigation of nanoparticle toxicity via 
microencapsulation was investigated to assess the feasibility of utilizing nanomaterials 
in dermally implantable biosensor applications.   
Cellular immune and inflammatory processes were measured via qPCR and 
immunoblotting, which revealed gene and protein expression modulation along the NF-
κB pathway after a variety of nanoparticle exposures. The role of immunoregulatory 
transcription factor NF-κB was examined in an oxidative stress context in cells exposed 
to a panel of nanoparticles, whereby glutathione conversion and modulation of oxidative 
 iv 
stress proteins in normal and NF-κB knockdown human dermal fibroblasts were 
monitored. Results revealed decreased antioxidant response and corresponding increased 
levels of oxidative stress and cell death in exposed normal cells, compared to NF-κB 
incompetent cells. However, reactive oxygen species production was not an absolute 
precursor to DNA damage, which was measured by the comet assay, γ-H2AX 
expression, and flow cytometry. Protein analysis revealed that map kinase p38, rather 
than p53, was involved in the halting of the cell cycle in S-phase after ZnO exposures, 
which caused DNA double strand breaks.  
Microencapsulation of fluorescent quantum dot nanoparticles, specifically, was 
utilized as a method to improve system functionality and surrounding cellular viability 
for the purpose of a dermal analyte detection assay. In vitro results indicated a functional 
localization of nanoparticles, as well as cessation of cellular uptake. Subsequently, 
cellular metabolism was unaffected over the range of time and concentrations tested in 
comparison to unencapsulated quantum dot treatments, indicating the usefulness of this 
technique in developing nanoparticle-driven biomedical applications.  
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CHAPTER I 
INTRODUCTION 
 
Nanomaterials are defined as materials that have at least one dimension between 
1-100 nm (1 nm = 10
-9
 m) and typically exhibit physicochemical properties not shared 
by coarser particles of the same chemical composition (Académie des Sciences and 
Académie des Technologies, 2004; Hansen et al., 2007; Nanoscale Science Engineering 
and Technology Subcommittee, 2004; The Royal Society and The Royal Academy of 
Engineering, 2004). The actual size threshold whereby these new properties can be seen 
is still a matter of debate and a new study has reported that 30 nm and less for metal and 
metal-oxide particles is nearer to the point at which this phenomenon actually occurs 
(Auffan et al., 2009a). At this scale, the much larger particle surface-to-volume ratio 
plays a significant role in interaction at the biological interface. Due to the 'non-bulk' 
properties of nanoparticles, including their atypical surface structure and surface 
reactivity, processes such as dissolution, redox reactions or the generation of reactive 
oxygen species may be enhanced. Such properties may elicit biological responses that 
would not be produced by larger particles of the same chemical composition.  
  
1.1. Nanoparticle uses and dermal exposure 
Nanotechnology is among the fastest growing areas of scientific research and has 
important applications in a wide variety of fields. The nanotechnology industry is  
___________  
This dissertation follows the style of Molecular Immunology. 
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expected to generate revenues between $2.6 trillion and $3.1 trillion by the years 2014 
and 2015, respectively (Dai, 2010; Schmidt, 2009). Since 2005, the number of consumer 
products containing nanomaterials has increased dramatically each year, and 
approximately half of these products are of dermal relevance, such as cosmetic, 
sunscreen, and personal care products (Figure 1.1) (Woodrow Wilson International 
Center for Scholars, 2011). Applications include incorporation into commercially 
available products such as cosmetics and sunscreens, pharmaceuticals, stain resistant and 
insect resistant clothing, wound care strategies, sports equipment, dental bonding, and 
cleaning products. Additionally, there are many current and possible future applications 
for nanotechnologies as drug delivery systems, nanomedicine components, 
environmental remediators, and cellular imaging agents. 
Nanomaterials afford many unique advantages over larger sized materials, such 
as antioxidative and antibacterial properties, increased variation in material color, and 
improved light scattering ability. However, while these novel applications continue to 
expand in breadth, there is increasing concern regarding the safety of these materials. It 
has been estimated that $2.6 trillion in manufactured goods will contain nanomaterials 
by 2014, as 3 to 4 emerging nanotechnology-based consumer products are entering the 
market per week (National Institute of Standards and Technology (NIST), 2009). That 
said, the overall safety of acute or chronic exposures to nanoparticles arising from 
widespread use of nanoparticles and products containing nanoparticles remains relatively 
unknown. It is known that heavy metals are known to be detrimental to human and 
environmental health. Many of these new products contain nanoparticles comprised of  
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Fig. 1.1  Nanoparticle incorporation into consumer products. The trend in commercially 
available consumer products containing nanomaterials since the year 2005 is represented. 
Approximately half of these products in any given year are used in dermal applications. 
(Adapted from Nanotechnology Consumer Products Inventory, Woodrow Wilson International 
Center for Scholars, 2011). 
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bioavailable metals such as silver, zinc, iron, and cadmium, to name a few. 
Within the emerging discipline of Nanotoxicology, there exists a gap between 
materials safety evaluation and the technology developments that are swiftly producing 
new materials, synthesis techniques, applications, and products ready for the market. The 
2004 Royal Society & the Royal Academy of Engineering report stated that 
nanoparticles should be treated as new chemicals from a risk perspective because they 
can overcome the body‘s normal protective barriers due to their very small size 
(Nasterlack et al., 2008; National Institute of Occupational Safety and Health (NIOSH), 
2007; Schulte et al., 2008; The Royal Society and The Royal Academy of Engineering, 
2004). The fact that nanoparticles are a thousand times smaller than most microscale 
materials tested to date raises concern regarding human exposure (Kielhorn et al., 2006). 
Nanoparticles are capable of breaching biological barriers via inhalation, dermal 
absorption, and the digestive tract (Alvarez-Roma et al., 2004; Baroli et al., 2007; Chen 
and Schluesener, 2008; Hillyer and Albrecht, 2001; Jani et al., 1990; Oberdorster et al., 
1994; Peters et al., 1997; Ryman-Rasmussen et al., 2006), as well as by voluntary 
injection, absorption, or implantation for pharmaceutical delivery systems (Bianco et al., 
2005; Guterres et al., 2006; Klumpp et al., 2006; Lademann et al., 1999). With regard to 
dermal exposures, humans are likely to encounter nanoparticles by one of the following 
three ways: occupational exposure, consumer product exposure, or biomedical 
application exposure. The skin is the largest organ of the body, accounting for more than 
10% of body mass. It possesses the crucial role of protective barrier to the external 
environment, as well as other functions such as homeostasis maintenance and 
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metabolism. Depending on the physicochemical properties of the material in contact 
with skin, multiple pathways of penetration across the skin barrier have been identified, 
including intercellularly, transcellularly, and via hair follicles and sweat glands 
(Scheuplein, 1967). A variety of factors, including skin barrier integrity, anatomical 
location, and presence of skin diseases such as atopic eczema, contact dermatitis, and 
psoriasis can influence extent of the dermal uptake at the site of exposure (Crosera et al., 
2009). Injury, such as that from UV exposure and wounds are also factors to consider, as 
well as age and hydration state. Moreover, flexing of the skin, detergents, and chemicals 
can increase skin absorption (Filon et al., 2006; Nielsen et al., 2007). 
A handful of studies in the literature exist that have investigated the ability of 
nanoparticles to penetrate skin (Baroli et al., 2007; Chen and Schluesener, 2008; EPA, 
2007; Filon et al., 2006; Gopee et al., 2009; Isakovic et al., 2006; Kielhorn et al., 2006; 
Mortensen et al., 2008; Oberdorster et al., 2005; Rouse et al., 2007; Samberg et al., 
2010; Senzui et al., 2010; Xia et al., 2010; Zhang and Monteiro-Riviere, 2008), but 
many fewer have been able to quantify the amount of nanomaterial that was capable of 
breaching the stratum corneum (Gopee et al., 2009; Wu et al., 2009). Discrepancies in 
published results are common, however, and seem to be related to differences in 
techniques and methods utilized, absence of standardized protocols, and varying 
laboratory conditions. The skin is often considered less permeable and the risk 
perception by this route is less than that of respiratory exposures (Donaldson et al., 2006; 
Limbach et al., 2007; Nel et al., 2006; Oberdorster et al., 2005; Shimada et al., 2006). 
However, in the literature there are studies which suggest that the skin is an important 
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route of entry for nanoparticles both in occupational and consumer settings (Gopee et al., 
2009; Mortensen et al., 2008; Ryman-Rasmussen et al., 2006; Sonavane et al., 2008; 
Vogt et al., 2006) and it has been specifically shown that certain particles are more prone 
to dermal penetration based upon their physicochemical properties or the nature of the 
vehicle they are suspended in (Xia et al., 2010).  
Human skin consists of the epidermis, dermis, and subdermis. The epidermis, or 
outermost layer of dermal tissue, consists of the stratum corneum and underlying tissue, 
mainly comprised of keratinocytes. Upon topical application of a foreign substance, 
penetration through the stratum corneum depends upon many factors, regarding both the 
dermal tissue and the substance. Factors that affect flux of solute include molecular size 
(MW), octanol–water partition coefficient (Kow) and melting point (Mpt) of the solute 
(Roberts and Sloan, 2000). It has also been reported that in damaged skin (abraded, tape 
stripped, burned or UV exposed, etc), the SC hydrophilic–lipophilic gradient may also 
influence the penetration of particulate formulations applied topically (Nielsen, 2005; 
Nielsen et al., 2007). Additionally, the type of formulation in which agents are dispersed, 
and the application method will likely affect the absorption outcomes for any skin 
condition. 
Results of dermal nanoparticle penetration studies differ widely, depending on the 
nanomaterial tested, host species, and condition of skin, among other factors. While 
some have concluded that the stratum corneum resists penetration, others have found 
nanoparticles capable of breaching this barrier. For example, it has been concluded that 
quantum dots can penetrate through the epidermis into the dermis, especially with 
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flexing of the skin or by way of hair follicles (Mortensen et al., 2008; Zhang and 
Monteiro-Riviere, 2008), whereby microscopy from these publications revealed that a 
considerable portion of the dose penetrated to the dermis. Silver is currently being 
utilized as an antimicrobial agent in many dermal applications and has been found to 
penetrate both intact and damaged skin (Larese et al., 2009; Samberg et al., 2010). 
Titanium dioxide, a common ingredient in sunscreens and cosmetics, is generally 
recognized as safe for dermal exposure. However, while most titanium dioxide studies 
involving healthy skin report an absence of penetration, this may not necessarily be the 
case with damaged skin (Senzui et al., 2010). Hydroxylated fullerenes are currently 
included in many cosmetic preparations with the intention of preventing oxidative 
damage to the skin due to aging and sun exposure.  Unfortunately, there have also been 
reports of toxicity associated with exposure to fullerol and other similar carbon-based 
nanomaterials. For example, Xia et al. (2010) have recently reported that, depending on 
the vehicle composition, pristine fullerene nanoparticles can penetrate deeply into the 
stratum cornea in healthy skin, as tested both in vitro and in vivo (Xia et al., 2010). In 
another study, fullerol caused delayed cell death characteristic of apoptosis, including 
DNA damage in rodent and human glioma cells, which was determined to be caused in 
the absence of ROS (Isakovic et al., 2006). The dermal permeation capability or toxicity 
of fullerol, specifically, has not been assessed, although fullerene-based peptides were 
shown to penetrate intact skin, which was exaggerated with mechanical stress leading to 
infiltration into the dermis (Rouse et al., 2007). 
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1.2. Reactive oxygen species generation by nanoparticles 
ROS is a collective term used for a group of highly reactive molecules which 
contain oxygen (e.g. H2O2, O2•-, HO•, ROO•). A large number of publications have 
arisen due to findings of ROS generation resulting from exposure to a variety of 
nanoparticle types (Brown et al., 1999; Hussain et al., 2006; Lipovsky et al., 2011; Nel et 
al., 2006; Rancan et al., 2002; Sayes et al., 2004; Wilson et al., 2002). It has also been 
established that this occurrence of ROS production may be as a result of nanoparticles 
interacting with cellular material and/or simply originating from the nanoparticles 
themselves (Kaewamatawong et al., 2005; Lin et al., 2006; Stone et al., 1998). However, 
the ability of a nanoparticle to induce such a biological response is dependent upon the 
type of nanoparticle, as results have shown that some types are more apt to generate 
ROS than others in the same system (Rallo et al., 2011; Xia et al., 2006). Several 
hypotheses have been proposed to explain the mechanism of action leading to the 
cellular state of oxidative stress caused by ROS generation. Relating to nanoparticle 
exposures, increased surface area, crystal structure, chemical composition, and altered 
surface chemistry are thought to play a large role (Berg et al., 2009; Jiang et al., 2008; 
Schins, 2002). Additionally, it is thought that reactions involving nanoparticles or 
dissolved nanoparticle components may also increase cellular oxidative stress due to 
inflammatory mediator recruitment, which act to produce ROS (Brunner et al., 2006; Xia 
et al., 2008). ROS generation within the cell can cause a shift in glutathione oxidation 
state, which is commonly utilized as a means to assess overall cellular redox status 
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(Pastore et al., 2003). Glutathione is an antioxidant that prevents damage to cellular 
components in the presence of ROS (Pompella et al., 2003). 
This work is an effort to elucidate the inflammatory and immunological response 
mechanism potential in a dermal model exposed to both metal containing and carbon-
based nanomaterials, while considering the influence of physicochemical characteristics 
of the nanoparticles. Changes in gene and protein expression are measured, as well as 
metabolic activity, ROS generation, and resulting DNA damage. Additionally, the role 
of the immune and inflammatory response pathway regulator, NF-κB, is investigated. 
These studies examining the toxicological effects stemming from nanoparticle exposure 
are examined utilizing an in vitro system to model human health effects. 
 
1.3. Cellular signaling pathway modulation 
As the toxicological response to nanoparticles on the cellular level is beginning 
to be investigated, knowledge of regulatory cellular signaling pathways involved after 
exposures are of particular interest. A careful review of the current literature reveals 
publications that focus on nanoparticle-invoked pathways whose main function falls into 
one or more of the following categories: inflammatory response, immune response, 
oxidative stress/anti-oxidative protection, DNA damage, apoptosis, and autophagy (refer 
to Table 1.1). Previous reports with nanoparticle exposures (and other treatments) 
suggest that not all of these responses are present in a given cell at one particular time or 
dosing concentration. For example, the cell may mount an antioxidant response to deal 
with the ―insult‖ of the nanoparticle exposure by activating Nrf-2, a key transcription 
 10 
factor involved in upregulating antioxidant genes, or the exposure may trigger more of 
an inflammatory response, in which NF-κB plays a role. A disturbance of the cellular 
redox equilibrium and subsequent oxidative stress has been shown to trigger multiple 
stress pathways and transcription factors of redox-sensitive nature, such as nuclear 
factor-erythroid 2-p45–related factor 2 (Nrf2), which activates expression of antioxidant 
genes, as well as nuclear translocalization of nuclear factor kappa B (NF-κB) and 
activator protein-1 (AP-1), which act to promote inflammatory mediator genes (Cho et 
al., 2006; Rahman et al., 2006).  
It has also been shown that, following perturbation of one of these transcription 
factors or other important regulatory proteins, a DNA damage response pathway may be 
initiated, whereby p53 is a likely player. In other words, the type of exposure exerts 
influence over pathway selection. Figure 1.2 highlights these potential pathways that 
could be activated on the cellular level following nanoparticle exposure. 
 
1.3.1. NF-κB (inflammatory response) 
NF-κB has been implicated previously in nanoparticle exposures. NF-κB is a 
major transcription factor responsible for regulating genes of both the innate and 
adaptive immune response (Livolsi et al., 2001). NF-κB becomes activated through 
distinct signaling components: inactivated, cytosolic NF-κB is complexed with the 
inhibitory IκBα (NFKBIA) protein. A variety of intra- and extracellular signals, such as 
ROS, cytokines, UV irradiation, and growth factors, are recognized via integral  
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Table 1.1  Pathway-driven responses in biological systems exposed to nanoparticles.  
 
Pathway 
Identified 
 Particle-Type Genes or Proteins 
Modulated 
System and Doses Citation 
 NF-κB (p65) ZnO, 24-70 nm NF-κB, IL-8, p-p65, p-
IκB 
BEAS-2B cells, 2-8 
μg/mL 
(Wu et al., 
2009) 
MAPKs 
(ERK1/2) 
CdSe/ZnS QD, 10.5 
nm avg 
TNF-α, CXCL8, 
p47phox, p-p38 
PBMC, THP-1 cells 
(0.2-25 nM) and 
BALB/c mice (2 
nmol/mouse) 
 
(Lee et al., 
2009) 
NF-κB, AP-1, 
NRF-2 (all 
postulated)  
6 combustion-derived 
NPs (UfCP, SootL, 
SootH, Ptx90, DEP, 
PtxG), 800-43 m
2
/g 
SA   
 
CSF2, CXCL1/5, IL-6, 
MT1/2, CYP1A1, 
NQO1, OGG1 
BALB/cJ mice BAL 
and PMN  (0.5-50 
μg/μL) 
(Stoeger et 
al., 2009) 
MAPK (ERK), 
Nrf-2 
 Si, porous (5-15 nm) 
and fumed (7 nm), 
349.71 and 644.44 
m
3
/g SA 
 
 SOD, HO-1  BEAS-2B cells, 
1mg/L 
(Eom and 
Choi, 
2009b) 
ERK, p-38, 
Nrf-2, JNK 
CeO2,  (15, 30, and 45 
nm)  
Nrf-2, HO-1, p-38, 
JNK, SOD  
BEAS-2B cells, 
1mg/L 
(Eom and 
Choi, 
2009a) 
HIF-1α   Tungsten carbide 
cobalt, 62 nm 
SOX2, ID2, FOXO4 
and others related to 
hypoxia response, 
carbohydrate 
metabolism, endocrine 
pathways, and targets 
of several transcription 
factors 
 
HaCaT keratinocytes, 
33 μg/mL 
(Busch et 
al., 2010) 
NF-κB ZnO (<100 nm), CdS 
(10 nm) 
NF- κB IP15 (glomerular 
mesangial) and HK-2 
(epithelial proximal) 
cell lines, 5 μg/cm2 
 
(Pujalté et 
al., 2011) 
NF- κB TiO2, P25, 170 nm 
aggregated size 
NF- κB, TLR4 NIH/3T3, 10 ng/mL (Chen et 
al., 2011) 
p53 Nickel ferrite p53, survivin, bax/bcl-
2 and casapase 
 
A549, 25-100 μg/mL (Ahamed 
et al., 
2011) 
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Table 1.1  Cont. 
Pathway 
Identified 
Particle-Type Genes or Proteins 
Modulated 
System and 
Doses 
Citation 
Akt, ERK1/2 NPCB, 14 nm 
(Printex 90) 
Akt, ERK1/2, GSK-3 fusion 
protein 
RLE-6TN rat 
lung epithelial 
cells, 1-10 
μg/cm2 
 
(Unfried et al., 
2008) 
EGF-R, MAPK ufCB, 14 nm 
(Printex 90) 
ERK1/2, JNK1/2, casp3, 
Phosphotyrosine 
RLE-6TN rat 
lung epithelial 
cells, 1-10 
μg/cm2 
 
(Sydlik et al., 
2006) 
Cell cycle, 
MAPK, Nrf-2, 
PI3K/AKT, 
glycolysis, and 
others 
TiO2, P25  SOD2, YWHA2, PRDX6, 
YWHAB,YWHAE,YWHA2, 
AMPK2 and GSK-3 /β, and 
others 
BEAS-2B, 10 
μg/mL 
(Ge et al., 
2011) 
NF- κB Poly(acrylic 
acid)-coated 
gold, 5, 10, and 
20 nm in the 
presence of 
fibrinogen 
 
Mac-1 integrin receptor, NF- 
κB 
THP-1, 10 
μg/mL 
(Deng et al., 
2011) 
NF- κB CdSe/ZnS-
COOH QD, 15 
nm 
 
NF- κB , TNF-α, IL-1B and 
IL-10, HMOX-1, IL-6  
HDF, 30 and 60 
nM 
(Romoser et 
al., 2011b) 
NF- κB, 
cAMP/PKA, 
HIF-1α, JNK, 
PKC/Ca
++
, 
TGF-β/SMAD, 
ERK, cell cycle, 
C-myc, p53 
Ag, Au, Pt, 
Al2O3, Fe3O4, 
SiO2, and ZnO 
with 
respective 
primary 
diameters of 13, 
12, 13, 12, 8, 
19, and 20 nm 
 
NF- κB, CRE, HIF-1α, AP-1, 
NFAT, SMAD, SRF, E2F,  
MyC, p53 
RAW 264.7 
macrophages, 
0.375-100 
μg/mL 
(Rallo et al., 
2011) 
P53, JNK Ag (2 different 
sources 
compared), 
polydisperse 
particles 20 nm 
or less 
Cyt c, Bax, Bcl-2, JNK, 
PARP, p53 
NIH3T3 mouse 
fibroblasts, A10 
rat vascular 
smooth muscle 
cells, and 
HCT116 human 
colon cancer 
cells, 50 and 100 
μg/mL 
(Hsina et al., 
2008) 
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membrane receptors, which can lead to the activation of the enzyme IκB kinase (IKK or 
IKBKB).  
The role of IKK is to phosphorylate the NF-κB-associated IκBα protein, resulting 
in ubiquitination and dissociation of IκBα from NF-κB.  IκBα is degraded by the 
proteosome and the liberated NF-κB is then translocated into the nucleus where it binds 
to specific DNA motifs in promoters, termed response elements. It is capable of 
upregulating genes involved in immune cell development and maturation, as well as 
those dedicated to survival, inflammation, and lymphoproliferation (Zandi, 1997). 
Improper activation of NF-κB can lead to inflammatory diseases, whereas persistent 
suppression is known to cause depressed immune cell function and cell growth. 
Wu et al. showed that, in human bronchial epithelial cells exposed to ZnO NPs, 
NF-κB is actually required for the upregulation of inflammatory marker IL-8. NF-κB 
was also found to be activated in response to CdSe/ZnS quantum dots (Romoser et al., 
2011b), titanium dioxide (Chen et al., 2011), gold (Deng et al., 2011), combustion 
products (Stoeger et al., 2009), iron oxide, aluminum oxide, and silica dioxide (Pujalté et 
al., 2011), and ZnO  in other works. ZnO, however, has been found to also downregulate 
NF-κB in macrophages (Rallo et al., 2011). This discrepancy may be partially explained 
by the time point levels that were checked, as the renal cell study probed for response at 
an earlier time point (1 hr).  
 
1.3.2. Nrf2 (oxidative stress) 
 Nrf2, a basic leucine zipper-type transcription factor, is a member of the ‗‗cap ‗n‘  
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Fig. 1.2  Nanoparticle-induced pathway schematic. Several cell signaling pathways known to 
be triggered after exposure to ROS-generating nanoparticles are represented. Responding 
mechanisms may be inflammatory, genoprotective, or antioxidant in nature. The type and extent 
of reaction is system and nanomaterial-dependent. 
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collar‘‘ family consisting of six members. Nrf2 is typically retained in an inactive 
cytosolic state via interaction with actin-binding Keap1, a protein that also mediates its 
degradation via the ubiquitin–proteasome pathway (Cullinan et al., 2004; Kobayashi, 
2004). Nrf2 plays an important role in the cellular detoxification process by 
transactivating reporter genes linked to antioxidant response elements associated with 
phase II detoxifying genes (Kwong et al., 1999; Venugopal and Jaiswal, 1996; 
Venugopal and Jaiswal, 1998). Nrf2 also mediates the induction of detoxifying genes, 
NAD(P)H quinine oxidoreductase 1 and glutathione S-transferases (GSTs), by way of 
the antioxidant butylated hydoxyanisole (Itoh et al., 1997). Nrf2 regulates the expression 
of other detoxifying genes such as heme oxygenase 1 (HMOX1), superoxide dismutase 1 
(SOD1), catalase, UDP-glucuronosyltransferase (UGT), and g-glutamylcysteine 
synthetasen (GCS) (Alam et al., 1999). This has been determined due to published data 
reporting lower expression of these genes in the Nrf2 knockout mice (Chan and Kan, 
1999). Pro-oxidants activate Nrf2, which is likely due to oxidation of Keap1 and/or Nrf2 
phosphorylation by kinases such as protein kinase C (PKC), Akt or PKR-like 
endoplasmic reticulum kinase (PERK) (Nguyen et al., 2004). The importance of Nrf2 in 
the cellular stress response is apparent in Nrf2 knockout mice, which develop severe 
autoimmune disease resembling systemic lupus erythematosus (Li et al., 2004). 
Furthermore, even young Nrf2-incompetent animals are highly susceptible to oxidative 
stress exerted by various chemicals, leading to pathological disorder susceptibility, 
including cancer (Itoh et al., 2004). While this work does not assess activation of Nrf2 
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directly, genes and proteins downstream of Nrf2, such as HMOX1 and SOD1 are 
investigated after nanoparticle exposures.  
The published literature has recently begun to elucidate the importance of Nrf2 
involvement with regard to nanoparticle exposures. Stoeger, et al. examined the effects 
of six different combustion-derived nanoparticles in mice and correlated their findings in 
a cell-free ascorbate in vitro system as a means to predict toxicity (Stoeger et al., 2009). 
They found that by utilizing surface area as a measure of exposure, their simple 
quantitative model based on oxidative potential, coupled with Cyp1a1 induction 
capacity, was an appropriate indicator of inflammatory potential in vivo. Eom, et al. 
found in two different studies using human bronchial epithelial cells that Nrf2 
translocated to the nucleus for activation of antioxidant genes, such as HMOX1 and 
Cu/Zn SOD. MAP kinase member, ERK, was involved in silica exposures, whereas 
phosphorylation of p38 occurred in CeO2 exposures (Eom and Choi, 2009a; Eom and 
Choi, 2009b). Another recent study also found upregulation of catalase, SOD, and 
MAPK/ERK with exposures to 10 µM and 100 µM P25 TiO2, also in bronchial 
epithelial cells (Ge et al., 2011). 
 
1.3.3. DNA damage response 
Many proteins are involved in maintaining the cellular genomic integrity. 
Although maintaining this integrity is essential to avoid cancer initiation, but limited 
DNA damage may be tolerated by the cell through a system of repair mechanisms. 
Should repair pathways fail, replication of damaged DNA may induce changes in the 
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genetic sequence inherited by the daughter cells. Inability to maintain the genomic 
material may lead to accumulation of DNA damage. Loss of genome integrity further 
leads to changes in gene expression, resulting from deletions or duplications. Several 
different repair pathways, equipped with precisely-tuned sensing mechanisms, are 
present in eukaryotic cells and specific to the type of damage that is present (Elvers, 
2011). 
Induction of DNA damage or replicative stress triggers a complex network of 
proteins known collectively as the DNA damage response (DDR). DNA damage is 
recognized by sensor proteins that recruit and activate transducer and effector or 
mediator proteins, inducing those which control cell cycle progression (Petrini and 
Stracker, 2003). This signaling cascade may induce cell cycle arrest to allow time for 
DNA repair or cell death via apoptotic mechanisms.  
Upon DNA strand damage, ataxia telangiectasia and Rad3 related (ATR) is a 
protein kinase which recognizes ssDNA regions present after uncoupling of the 
replication fork formed by resection of DNA ends (Adams et al., 2006; Jazayeri et al., 
2006; Zou and Elledge, 2003). Although ATR is typically associated with single strand 
breaks, ATM can activate ATR via phosphorylation of TopBP1 in response to DSBs as 
well (Elvers, 2011). ATM is recruited and activated by MRE11-RAD50-NBS1 (MRN) 
sensory complex (Lee and Paull, 2005), then acetylated by TIP60, stimulating its 
disassociation into active monomers (Bakkenist and Kastan, 2003; Sun et al., 2005). The 
checkpoint kinases CHK1 and CHK2 also play major roles in the signaling that occurs 
after DNA damage. CHK2 is constitutively expressed throughout the cell cycle and 
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activated as needed in response to DNA damage, whereas CHK1 is preferentially 
expressed during S and G2 phases, but is amplified in response to the presence of DNA 
damage (Kaneko et al., 1999; Lukas et al., 2001). ATM is known to primarily signal 
through CHK2 and ATR through CHK1 (Gatei et al., 2000). 
ATM activation can lead to phosphorylation of H2AX as part of the DNA 
damage response, which serves to activate proteins involved in the cell cycle checkpoint 
control and halt cell cycle progression until the damage is repaired (Hanasoge and 
Ljungman, 2007). The phosphorylation signal on histone H2AX works as a platform for 
the recruitment of repair factors to the site of the break, as it is necessary for the 
recruitment of other factors to the sites of DNA damage (Paull et al., 2000). The 
presence of γ-H2AX, the active form of the histone, at the chromatin region nearest the 
site of the DSB, along with other proteins summoned by γ-H2AX, facilitates the 
activation of cell cycle checkpoints (Paull et al., 2000). The technique of analyzing 
differences in γ-H2AX levels after exposure to potential DNA damaging compounds is a 
well established procedure and is prevalent in the literature (Fernandez-Capetillo et al., 
2002; Podhorecka et al., 2010; Stewart et al., 2003). Furthermore, others have reported 
activation of this histone variant after nanoparticle exposures, indicating the importance 
of the technique for assessing nanomaterial-driven genotoxicity (Bhabra et al., 2009; 
Mroz et al., 2008; Trouiller et al., 2009). 
Both ATM and ATR may phosphorylate p53 (Cortez et al., 1999; Siliciano et al., 
1997), thereby promoting nucleotide excision repair (NER) (Ford and Hanawalt, 1997). 
Additionally, p38-activated MK2 may directly phosphorylate CDC25B and C, inducing 
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cell cycle arrest (Manke et al., 2005; Reinhardt et al., 2007). However, p38 kinase may 
or may not phosphorylate p53 after exposure in response to UV stimulation (Bulavin et 
al., 1999; Reinhardt et al., 2007), which is likely dependent upon the cell type analyzed.  
 
1.3.4. P38 and DNA damage 
The p38 MAPK subfamily plays important roles in cytokine production and the 
stress response. Recent reports have also demonstrated additional functions for p38 
MAPKs, for example, in the inhibition of cell cycle progression (Ambrosino and 
Nebreda, 2001; Reinhardt and Yaffe, 2009). p38 is activated by stimuli such as 
environmental or genotoxic stressors, transforming growth factor-β, and the 
inflammatory cytokines tumor necrosis factor and interleukin-1 (Wagner and Nebreda, 
2009). Activation of p38 MAPK through environmental stress can mediate cell death 
(Wood et al., 2009). Activated p38 phosphorylates transcription factors important in the 
regulating cell growth and apoptosis, including cAMP response element-binding 
proteinhomologous protein/growth arrest DNA damage 153 (CHOP/GADD153) (Wang 
and Ron, 1996), and NF-kB (Korus et al., 2002; Ridley et al., 1997).  p38 lies 
downstream of mitogen-activated protein kinase (MAPK)/ERK-kinases (MEKs): MAPK 
kinases-3, -6, and SAPK/ ERK-kinase-1. Using a quantitative microinjection approach, 
Molnar et al showed in 3T3-NIH fibroblasts that a GTPase, Cdc42H, can inhibit cell 
cycle progression at G1/S through a mechanism requiring activation of p38 (Molnar et 
al., 1997). In response to DNA damage stimuli that induce DSBs, activation of p38 
MAPK can also lead to the induction of a G2/M cell cycle checkpoint through p53-
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dependent and independent mechanisms (Bulavin et al., 2001; Mikhailov et al., 2005; 
She et al., 2001).  
Trouiller et al reported that mice given TiO2 nanoparticles in drinking water gave 
rise to γ-H2AX-positive cells at doses of 50-500 ppm, whereas micronuclei formed at 
the 500 ppm concentration (Trouiller et al., 2009). Another study using TiO2 and ZnO in 
a dermal context found that their particles could catalyze oxidative DNA damage in 
cultured human fibroblasts (Dunford et al., 1997). Sharma et al also reported significant 
DNA damage utilizing the comet assay in primary human keratinocytes with 14 ppm 
ZnO (Sharma et al., 2011). Auffan et al found that, in human dermal fibroblasts, a 
concentration as low as 6 ppm could induce significant SSBs and cause formation of 
binucleate cells (Auffan et al., 2009b). Additionally, it has been shown recently that 
some nanoparticles can cause cell cycle arrest in response to DNA damage. For example, 
G1 arrest was observed in mouse lung epithelial cells exposed to C60 and SWCNT 
(Jacobsen et al., 2008), and carbon black coated with benzo(a)pyrene gave rise to S-
phase arrest in human lung epithelial cells (Mroz et al., 2007). Additionally, AshaRani et 
al. reported that starch-coated silver NPs induced concentration-dependent G2/M phase 
arrest and DNA damage in human glioblastoma cells and fibroblasts (AshaRani et al., 
2009). Silver NPs were also found to induce S and G2/M phase arrest in Jurkat T cells 
(Eom and Choi, 2010), but G1 arrest in RAW264.7 macrophages (Park et al., 2010) 
using similar concentrations of nanomaterials. Additionally, SiO2 NPs induced G2/M 
arrest in human embryonic embryo cells (Wang et al., 2009).  The goal of this research, 
as it relates to DNA damage, was to elucidate the DDR mechanism potential in a dermal 
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model exposed to three metal oxide nanomaterials, while considering the influence of 
physicochemical characteristics of the nanoparticles. 
Lastly, nanoparticles may be amended to either improve functionality, to control 
location, or to protect the nanoparticle or surrounding biological system from potential 
damage (Gaihre et al., 2011; McShane and Ritter, 2010; McShane, 2002; McShane, 
2006; Romoser et al., 2011a). Chapter 5 discusses the mitigation of quantum dot-induced 
toxicity in human dermal cells via quantum dot microencapsulation in an effort to 
accomplish these tasks.  
 
1.4. Summary 
Nanoparticles are currently in many commercially available products for dermal 
use. Since it has been shown that some nanoparticles are capable of penetrating dermal 
tissue, depending on a variety of factors, including, but not limited to the nanoparticle 
characteristics and condition of the skin, investigation into subsequent toxicity and 
methods to protect biological surroundings is warranted. Analysis of oxidant generation 
is important in nanoparticle exposure scenarios and when assessing the outcome of the 
cell, as production of ROS leads to oxidative stress, thereby initiating subsequent 
cellular pathways. Several major pathways have been implicated in nanoparticle 
exposure studies, including the Nrf2 antioxidant pathway, NF-κB inflammatory and 
immune response pathway, and DDR pathway. It has been reported that NF-κB is 
important, if not critical, in initiating inflammatory mediators and determining cell 
survival in response to the presence of nanoparticles. If DNA damage occurs with 
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nanoparticle exposures, it is typically concentration-dependent, but tends to be 
exacerbated by the decreased size of nanoparticles, compared to their larger-sized 
counterparts of identical composition. Therefore, very low concentrations of 
nanomaterials may cause damage. Deciphering cellular pathway-driven toxicity, while 
considering nanoparticle physicochemical characteristics and the impending oxidative 
stress potential, will assist in further defining the risks associated with nanoparticle 
usage.  
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CHAPTER II 
QUANTUM DOTS TRIGGER IMMUNOMODULATION OF THE 
NF-κB PATHWAY IN HUMAN SKIN CELLS* 
 
2.1 Introduction 
 
Quantum dots (QDs) are crystalline semiconductors approximately 1-20 nm in diameter. 
QD nanocrystals composed of CdSe cores and ZnS shells have received attention due to 
their unique electronic and optoelectronic properties at nanoscale levels and their 
widespread applications (Azzazy et al., 2007; Delehanty et al., 2008; Hild et al., 2008; 
Jamieson et al., 2007; Li et al., 2007; Medintz et al., 2008; Michalet et al., 2005; Walling 
et al., 2009). Because of their unique characteristics, QDs are used at increasing rates for 
a wide variety of industrial and consumer-based applications, including biomedical 
imaging agents, inks, and solar panels (Alivisatos et al., 2005; Gao et al., 2004; Michalet 
et al., 2005; Roco, 2003). QDs may also pose risks to human health, where unintended 
exposure to nanomaterials may occur at the workplace or during end product use via 
inhalation, dermal absorption, or gastrointestinal tract absorption (Rzigalinski and 
Strobl, 2009). Dermal exposures to QD particles have shown toxicities due to heavy 
metal exposure and/or the production of reactive oxygen intermediates (ROIs) (Derfus et 
al., 2004; Kirchner et al., 2005b; Ryman-Rasmussen et al., 2007). 
__________  
*Reprinted with permission from ―Quantum dots trigger immunomodulation of the NFκB 
pathway in human skin cells‖ by Romoser, et al., 2011. Molecular Immunology, 48, 1349-1359, 
Copyright [2011] by Elsevier Ltd. 
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Due to the growing number of potential uses that are offered by QD materials, 
consumer handling and manufacturer exposure to QDs is likely to increase. Nanoscale 
materials are thought to impose increased adverse effects on organisms than microscale 
materials because of their finer sizes and corresponding larger specific surface areas per 
unit mass (Maynard and Kuempel, 2005; Monteiller et al., 2007; Oberdorster et al., 
2005). However, it is largely unknown which specific pathways or subcellular 
mechanisms of action are triggered as a result of QD exposure. Many investigators have 
shown that QDs can be internalized into cells and others have speculated the route of 
entry for particular QDs (Duan and Nie, 2007; Jaiswal et al., 2003; Zhang and Monteiro-
Riviere, 2009), but what are the mechanisms of injury and key participants on the 
molecular level in the cell and how do those processes develop?  We hypothesized that 
immune mediators of inflammation may be initiated in the exposed cell layers. 
In an attempt to fill this gap, human epithelial keratinocytes (HEK), found in the 
epidermis, and human dermal fibroblasts (HDF), located in the dermis, were utilized to 
query the molecular interactions with QDs. Dermal cells were chosen because contact 
with the skin is one of the routes of exposure to QDs. Zhang et al. (2008) and Mortensen 
et al. (2008) both concluded that QDs of similar or identical structure and composition to 
those used in this study could penetrate through the epidermis into the dermis, especially 
with flexing of the skin or by way of hair follicles (Mortensen et al., 2008; Zhang and 
Monteiro-Riviere, 2008). Microscopy from their publications revealed that a 
considerable portion of the dose penetrated to the dermis. These studies used 
concentrations which ranged from 1-2 µM. However, this manuscript focuses on the 
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nanomolar concentration range, yielding cellular viability between 15% and 100% in 
both HEK and HDF cells. A recent development in the nanotoxicology literature noted 
the importance of conducting in vitro experiments with a concentration range of 
nanoparticles that would not fully overwhelm the culture, as this would likely be 
inconsistent with equivalently-dosed in vivo studies (Oberdorster, 2010).  Similarly, 
Zhang et al. (2006) found genetic perturbation in dermal cells exposed to 8 and 80 nM 
concentrations of silica-coated QDs (Zhang et al., 2006).  From this range, we selected 
the lowest observable adverse effect level (LOAEL) concentrations of 30 and 60 nM to 
further investigate the mechanisms of cellular pathway stimulation by probing for 
adverse or protective responses in the fibroblasts. The human dermal fibroblast cell line 
was of interest partially due to its proximity to the vascular system and its importance in 
maintaining the structural framework of the tissue (Figure 2.1). Also, fibroblasts possess 
an elaborate cytokine response system, which allows these sentinels to initiate the 
process of inflammation (Le et al., 1987).  
In an effort to increase current knowledge regarding pathways of the human 
cellular response to QDs, we have quantitatively investigated effects of an engineered 
QD on the expression of 50 unique genes in HDF cell cultures. In this study, we 
compared the dose-response and time-course effects of CdSe/ZnS-COOH QD 
nanoparticles in cells that induce or suppress one or more of the following effects: 
inflammation, immunoregulation, apoptosis, and cellular stress. Specifically, we found  
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Fig. 2.1  Schematic representation of the experimental design. Infiltration through the stratum 
corneum allows penetration of the nanoparticles into the epidermis, which consists partially of 
keratinocytes. Further movement of QDs (green) into the dermis could occur, which houses 
dermal fibroblasts and increased vasculature (left). A porcine skin section is shown (right) as a 
representative comparison image, where 10 µm thick sections of skin removed from a 6 month 
old Yucatan Miniature Swine were H&E stained and imaged at 40X on a Zeiss AxioImager.Z1. 
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that many mRNA perturbations occurred in genes of the NF-κB pathway, which is 
involved in each of these processes. NF-κB is a major transcription factor responsible for 
regulating genes of both the innate and adaptive immune response (Livolsi et al., 2001). 
NF-κB becomes activated through distinct signaling components: Inactivated, cytosolic 
NF-κB is complexed with the inhibitory IκBα (NFKBIA) protein. A variety of 
extracellular signals can be stimulated via integral membrane receptors, which can then 
activate the enzyme IκB kinase (IKK or IKBKB). The role of IKK is to phosphorylate 
the NF-κB-associated IκBα protein, resulting in ubiquination and dissociation of IκBα 
from NF-κB.  IκBα is degraded by the proteosome and the liberated NF-κB is then 
translocated into the nucleus where it binds to specific DNA motifs in promoters, termed 
response elements. Here, it can upregulate genes involved in immune cell development, 
maturation, and proliferation, as well as those dedicated to survival, inflammation, and 
lymphoproliferation (Zandi, 1997). Conversely, a suppression of nuclear NF-κB can 
result in TNFα-induced apoptosis (Antwerp et al., 1996; Beg and Baltimore, 1996; Liu et 
al., 1996; Wang et al., 1996). This decrease in nuclear translocation is due to increased 
levels of IκBα, which we found to be upregulated in our study. 
Quantitative-PCR revealed both time and concentration dependent patterns of 
gene regulation. From our analyses of these data, we deduced that the particles used in 
this study influenced regulation of genes and proteins along the NF-κB pathway, as 
evidenced by deviations of relevant gene expression (NFκB, IL-1B, IRAK1/2, CASP1). 
Results from western blotting also revealed increased induction of inflammatory proteins 
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(HMOX-1, IL-1B, TNF-α) caused by stress, which is thought to arise from ROI and/or 
metal-induced toxicity in response to QD exposure.  
To our knowledge, this work is the first to examine immune and inflammatory 
responses arising from QD exposure in dermal cells. Very few studies exist that have 
analyzed this type of cellular response to QDs. Hoshino et al. (2009) found that direct 
injections of QD/nucleotide complexes into the peritoneal cavity of mice resulted in 
inflammation with the infiltration of inflammatory cells (Hoshino et al., 2009). They also 
found that the same complex induced the production of both proinflammatory cytokines 
and chemokines. Rehberg et al. (2010) recently found that, depending on surface 
modification, QDs can modulate leukocyte adhesion and migration (Rehberg et al., 
2010). Since such findings of cellular perturbation have been presented in the literature, 
further inquiry of the mechanisms of gene induction or suppression is necessary.  
 
2.2 Methods 
2.2.1. Quantum dot nanocrystal characterization 
CdSe/ZnS-COOH crystalline quantum dots were purchased from Ocean 
Nanotech, LLC (Springdale, Arkansas). Characterization data is summarized in Table 
2.1. Particle size and zeta potential were characterized in-house via Malvern ZetaSizer 
Nano ZS (Malvern Corp., Worchestershire, UK).  Particle characterization was 
performed on the particles while in Milli-Q ultrapure water. Chemical composition was 
determined via inductively couple plasma-mass spectroscopy (Elan DRC II, Perkin 
Elmer SCIEX); no metal impurities were detected. Particle surface area was calculated  
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Table 2.1  Quantum dot particle characterization. 
 
Property CdSe/ZnS-COOH 
Size (nm) 14.83 ± 0.07 
Zeta potential (mV) -54.00 ± 4.08 
Surface area (nm2) 690.93 
Cd2+ ions/QD 562 
Morphology Crystalline 
Ex/Em (nm) 380/545 
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using the formula SA=πd2 and total cadmium content was calculated from the formula 
utilizing the measured particle size, as follows: 
#cadmium ions/QD  
          
                  
    
 
 
   
             
    = 561.05 
The QD samples were diluted into cell culture media, resulting in 1.25 µM stock 
solution, immediately prior to cell culture inoculation. A final 60 nM concentration 
contained 6.4×10
16
 QDs/mL. Suspensions were mixed thoroughly and added to cell 
cultures as described below.  
 
2.2.2. Cell culture and experimental dosing 
Human epidermal keratinocytes (CRL-2404, ATCC, Manassas, VA) were 
cultured in serum-free keratinocyte medium supplemented with 25 µg/mL bovine 
pituitary extract and 0.15 ng/mL recombinant epidermal growth factor.  Human dermal 
fibroblasts (PCS-201-010, ATCC, Manassas, VA) were cultured in Dulbecco‘s Modified 
Eagle‘s Medium supplemented with 8% FBS (Gibco, Austria). HDFs were 
supplemented with an antibiotic cocktail consisting of penicillin, streptomycin, and 
amphotericin (Sigma-Aldrich, St. Louis, MO). HEKs were supplemented with 
streptomycin only. Incubation took place at 37°C with humidity and 5% CO2. Cells were 
grown to 80% confluency in 6-well plates, then exposed to CdSe/ZnS-COOH quantum 
dots (Ocean Nanotech, LLC, AR) (30 nM and 60 nM final exposure concentrations) or 
held for a negative control. Each experiment was performed in triplicate.  
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2.2.3. Cell viability 
HEK and HDF cells were cultured in 24-well plates as previously described, then 
exposed to QDs to give final well concentrations of 1, 30, 60, 90, and 120 nM. Cells 
were washed in plates treated for 8 and 48 hrs, and then phenol red-free media was 
added to wells. A resazurin dye (Sigma-Aldrich) was applied to cells (10% v/v final 
concentration) and mixed thoroughly on a rocker for 1 min. Plates were returned to the 
incubator for 2-1/2 hrs, then fluorescence was measured with a fluorescence plate reader 
(BioTek Synergy MX, Winooski, VT) using 560/590 nm excitation and emission 
wavelengths. Spectral compatibility data is presented in the appendix (Figure A-3); there 
was no interaction with the viability marker.  Experiments were done in triplicate. A 
student‘s t-test was employed to calculate significant change in metabolic activity, as 
compared to the undosed control. 
 
2.2.4. Fluorescence and brightfield microscopy 
 HEK and HDF cells were cultured and exposed to identically to the viability 
experiments. Washed cells were then covered with phenol red-free media and imaged at 
a total magnification of 100X (HDF) and 200X (HEK) with an Olympus IX71 inverted 
fluorescence microscope (Center Valley, PA). Images were processed with Olympus 
CellSens software. 
 
2.2.5. Gene expression analysis  
Cells were harvested at each QD concentration at time points of 8 and 48 hours.   
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An RNeasy® Mini Kit (Qiagen, Frederick, MD) was used in conjunction with an on-
column genomic DNA digestion to lyse cells and extract total RNA. Thereafter, total 
RNA was prepared for a pathway-focused gene expression profiling PCR array system, 
specific for 84 genes of innate and adaptive immune responses (RT
2
 Profiler™, 
SABiosciences, Frederick, MD), of which data from 50 passed quality control and are 
discussed here. An RT
2
 First Strand Kit (C-03) from SABiosciences was utilized prior to 
qualitative real-time PCR (RT-PCR) to reverse transcribe messenger RNA into cDNA. 
After adding the cDNA to a mixture containing SYBR green, 25 µL of sample was 
loaded into all wells of 96-well plates pre-filled with primer sets including housekeeping 
genes, gDNA controls, reverse transcription controls, and positive PCR controls. Using a 
Roche LightCycler® 480 (Roche, Indianapolis, IN) for RT-PCR, a two-step thermal 
cycling program was followed: 1 cycle at 95°C for 10 min, then 45 cycles of 95°C for 15 
s, then 60°C for 1 min. The Roche LightCycler® 480 software was utilized for raw data 
acquisition and calculation of Ct (threshold cycle) values.  
 
2.2.6. Protein expression alteration 
HDF cells cultured in the same conditions as above were washed in ice cold 1X 
PBS, then protease inhibitor cocktail (Sigma-Aldrich) and high salt lysis buffer were 
added to wells. Protein was isolated by collecting supernatant via centrifugation. 
Fractionated NF-κB samples were harvested without the use of lysis buffer. An NF-κB 
activation assay kit (FIVEphoton Biochemicals, San Diego, CA) was utilized to obtain 
nuclear and cytosolic NF-κB fractions from cells. Samples were loaded into 10 or 12% 
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SDS-PAGE gels, depending on protein of interest, and run at 120 mV. Gels were 
transferred to PVDF membranes, which were blocked in 5% milk/PBST and incubated 
in different primary antibody solutions overnight: HMOX-1, mouse, 1:400 (Santa Cruz 
Biotechnology, Santa Cruz, CA), IL-10, rabbit, 1:500 (Abcam Inc., Cambridge, MA), 
TNF-α, goat, 1:200 (Santa Cruz), IL-1B, mouse, (Abcam), or p65 NF-κB, rabbit, 1:1500 
(Santa Cruz). Membranes were washed in PBST several times before secondary 
antibody (Goat, anti-mouse or anti-rabbit, or donkey, anti-goat 1:5,000, Santa Cruz) 
prepared in fresh 5% milk/PBST solution was added. Membranes were incubated in the 
secondary antibody at room temperature, then washed again in PBST. Immobilon™ 
Western Chemiluminescent HRP substrate (Millipore, Billerica, MA) was added to 
membranes and film exposures were taken. β-actin, 1:10,000 (Sigma) and lamin A/C 
1:5,000 (Santa Cruz) were used as loading controls. 
 
2.2.7. NF-κB transcriptional activity 
 A luciferase gene reporter assay was used to determine the state of NF-κB 
transcriptional activity in HDF cells exposed to QDs, as well as unexposed cells. Briefly, 
plasmid vectors containing either an NF-κB response element and a firefly luciferase 
gene or a Renilla luciferase control sequence (Promega, Madison, WI.) were amplified 
in competent cells, followed by plasmid DNA purification in endotoxin-free miniprep 
spin columns (Zymo Research Corp., Irvine, CA). Cells were seeded in triplicate wells 
24 hrs prior to transfection in DMEM supplemented with 10% FBS and allowed to reach 
80% confluency. Transfection of HDF cells was accomplished with Fugene HD 
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Transfection Reagent (Promega) in Opti-MEM media (Gibco, Austria) without serum, 
antibiotics, or phenol-red. Transfected cells were then exposed to 30 and 60 nM QDs for 
8 or 48 hours. Wells of unexposed transfected and untransfected cells were included for 
comparison, as well as transfected cells treated with positive control, TNFα (20ng/mL). 
The Dual-Glo Luciferase Assay System (Promega) was utilized to separately measure 
luminescence of the NF-κB sequence-containing DNA and the normalization Renilla 
control vector in a Packard LumiCount luminometer. Background values from wells 
containing untransfected cells were subtracted from all measurements. Relative ratios for 
each well were calculated by dividing the ratio of unexposed well firefly 
luminescence/Renilla luminescence by the ratio of exposed well firefly 
luminescence/Renilla luminescence. The resultant data was graphed as a function of 
relative luminescence and length and type of exposure. A Student‘s t-test was utilized to 
determine significance of results at the p<0.05 level.  
  
2.2.8. Calculations of gene expression changes 
A total of five housekeeping (potential reference) genes were assayed on the 
plate and included those encoding β2-microglobulin, hypoxanthine 
phosphoribosyltransferase 1, ribosomal protein L13a, glyceraldehyde-3-phosphate 
dehydrogenase, and β-actin. Analytical estimation of internal control gene stability 
indicated that the ribosomal protein gene (RPL13A) was most stable (M value = 0.013), 
and RPL13A was utilized for subsequent normalization (Vandesompele et al., 2002). 
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Changes in gene expression were estimated using the 2
-ΔΔCt
 method (Huang et 
al., 2010; Livak and Schmittgen, 2001), with RPL13A utilized as the stable reference 
gene for all experimental situations. The fold changes in gene expression were calculated 
with respect to the expression level of the genes in the respective control group. For 
example, 2-fold change of gene A indicates that expression of gene A was twice as large 
in the treatment group compared to its expression in the control group, while 0.5-fold 
change of gene A indicates that the expression of that gene was two times less in the 
treatment group compared to its expression in the control group. More detailed gene 
annotations, array layout, and gene tables regarding the array are available at 
http://www.sabiosciences.com/genetable.php?pcatn=PAHS-065A. Information 
regarding the manufacturer‘s estimates for array performance, sensitivity, specificity, 
and reproducibility are available at 
http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-052A.html#accessory.  
 
2.3 Results 
2.3.1. Cellular morphology 
 HDF and HEK cells were exposed to a range of CdSe/ZnS QDs from 1 nM to 
120 nM for 8 and 48hrs (Figure 2.2). Phase and fluorescence images revealed an internal 
accumulation of QDs, which increased with both time and concentration.  As a result of 
these exposures, HEK cell density decreased more severely than HDF cell density 
(Figures 2.3-2.4). The decreasing number of HEK cells corresponds to the amount of 
detectable fluorescence at the plane of the cells. Few detectable morphological changes  
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Fig. 2.2.  Cellular morphology and QD uptake. Cellular morphology and intracellular QD 
fluorescence in HDF and HEK after exposure to 60 nM CdSe/ZnS QDs at 8 and 48 hrs. HDF (A-
D) and HEK (E-H) cells were imaged at 8 hrs (left side) and 48 hrs (right side) and either treated 
with 60nM QDs (C,D,G,H) or left undosed (A,B,E,F). 
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Figure 2.3. HEK morphology at 8 hrs exposure. Cellular morphology and intracellular QD 
fluorescence after exposure to HEK cells 8 hrs. Scale bar=50µm. 
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Figure 2.4. HEK morphology at 48 hrs exposure. Cellular morphology and intracellular QD 
fluorescence after exposure to HEK cells 8 hrs. Scale bar=50µm. 
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Figure 2.5. HDF morphology at 8 hrs exposure. Cellular morphology and intracellular QD 
fluorescence after exposure to HDF cells 8 hrs. Scale bar=100µm. 
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Figure 2.6. HDF morphology at 48 hrs exposure. Cellular morphology and intracellular QD 
fluorescence after exposure to HDF cells 48 hrs. Scale bar=100µm. 
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occurred in the HDF cells, which remained adhered through the 48 hr time point 
(Figures 2.5-2.6). The 120 nM concentration at 48 hrs did produce fluorescence images 
elucidating some deterioration in the HDF morphology, which suggests that 120 nM is 
no longer within the tolerable exposure concentration range.  
 
2.3.2. Cellular viability 
 As a measure of cellular viability, changes in metabolic activity were measured 
in HDF and HEK cells exposed to a range of QD concentrations from 1 nM to 120 nM. 
These responses were compared to those of undosed cells (Figure 2.7). Results indicated 
a differential response between the two cell types, suggesting that the fibroblasts were 
less susceptible to death in these experiments. A strong dose-response relationship was 
found in both cell types, with HEKs and HDFs decreased to 66.5% and 90.0% viability 
at the highest QD exposure concentration at 8 hrs, respectively. By 48 hrs, viability was 
decreased to 12.6% and 57.1%, showing a consistent differential between cell types. 
These findings corroborate our cellular morphology microscopy data (Figure 2.2-2.6). 
There were no interactions between the QD particles and the viability marker (Appendix 
Figure A-3). 
 
2.3.3. Gene expression alterations often involve the NFκB pathway 
Gene expression changes in HDF cells were assayed after treatment with 
CdSe/ZnS-COOH QDs at exposure concentrations of 30 nM or 60 nM and at 8 or 48 
hours after initial exposure. Figure 2.8 employs a heat map to summarize 50 genes with  
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Fig. 2.7.  Metabolic activity of HDF and HEK cells dosed with QDs. Metabolic activity of 
HDF (black) and HEK (white) cells dosed with QD over dose-response at (A) 8 hrs and (B) 48 
hrs exposure time points.   *p-val<0.05; **p-val<0.001. 
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8 hrs 48 hrs
30 nM 60 nM 30 nM 60 nM
4.5315355 7.061624 ADORA2A 1.2141949 1.4439292
1.0792282 0.9075192 C5 0.8010699 0.8066418
0.8705506 1.2141949 CASP1 1.2570134 1.6817928
0.9265881 0.8705506 CASP4 0.9395227 1.2226403
4.0278222 6.6807034 CCL2 1.1328839 1.5691682
0.5904963 0.3609823 CCR3 0.8766057 1.0792282
0.2002675 0.5823668 CD14 1.0942937 0.6029039
0.8526349 0.9012505 CD55 1.3947437 1.6245048
0.8645372 0.8766057 CHUK 1.057018 1.4742692
0.8888427 0.6328783 COLEC12 0.4665165 0.5823668
0.9460576 0.9201877 FN1 1.1328839 1.0497167
0.0406669 0.0493776 HM OX1 1.6021398 2.3133764
0.0412346 0.231647 IFNA1 2.3294672 0.882703
0.5509526 1.3851095 IFNB1 2.1734697 1.9453099
1.1250585 1.3195079 IFNGR1 1.057018 1.0069556
1.3755418 1.4339552 IFNGR2 1.1250585 1.0424658
1.1728349 1.1728349 IKBKB 1.5157166 1.1328839
0.1842837 0.1258694 IL10 1.6701758 1.6934906
1.1892071 1.5583292 IL1A 2.4116157 0.4537596
7.621104 12.996038 IL1B 2.0139111 2.1885874
0.9012505 1.1407637 IL1F7 2.1435469 1.1728349
0.6973718 0.6783022 IL1R1 0.7474246 0.7791646
0.8888427 0.8585654 IL1RAP 1.2058078 0.9592641
0.2570285 0.2932087 IL1RL2 0.6070974 0.2932087
7.1602006 11.794154 IL6 2.0420243 2.1584565
1.2141949 0.9592641 IRAK1 0.7955365 0.8950251
2.8481004 4.2574807 IRAK2 1.0792282 1.9185282
1.5691682 1.6358041 IRF1 1.1328839 1.0210121
0.8645372 0.7845841 LY96 1.0069556 1.6586391
0.9395227 0.8645372 M APK14 0.8766057 0.823591
1.1407637 1.1407637 M APK8 1.2745606 1.2226403
1.0069556 0.9794203 M IF 1.0352649 1.4845236
1.2311444 1.3472336 M YD88 0.8467453 0.8010699
1.9318727 2.2191389 NFκB1 1.0497167 1.5052467
0.7526234 0.6877709 NFκB2 0.933033 0.6372803
2.2038102 2.6573716 NFκBIA 1.1407637 1.3660403
1.0424658 0.9930925 NLRC4 1.3013419 1.905276
1.7052698 0.7071068 PGLYRP1 1.3947437 0.9794203
2.1885874 2.9485384 SERPINA1 0.8293195 1.2570134
0.9201877 0.9138315 SERPINE1 1.0792282 1.0942937
0.9862327 0.5396141 SFTPD 0.6925547 0.7684376
0.9265881 0.882703 TGFB1 1 0.8179021
1.0139595 1.8531761 TLR2 0.8766057 1.4640857
0.9726549 1.3566043 TLR3 0.7631296 0.659754
0.6783022 0.7169776 TLR4 0.7737825 1.0867349
0.8888427 0.6736168 TLR6 0.6830201 0.6461764
0.5509526 1.1407637 TNF 1.591073 0.2812646
0.9460576 0.933033 TNFRSF1A 1.1647336 1.5800826
0.952638 1.0497167 TOLLIP 1.1892071 1.3851095
0.9460576 0.8122524 TRAF6 1.0497167 0.9930925
 
Fig. 2.8.  Gene expression heat map. Heat map of pathway-specific gene expression changes in 
HDF. Central column shows genes in bold, columns to the left and right show fold change in 
expression levels in response to the treatment (labeled at top), compared to untreated controls 
assessed at the same time point. Fold suppressions of <0.5 are colored dark green and 0.5-0.8 
light green. Fold inductions of 1.2-2.0 are pink and >2.0 red.    
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complete data for all of the samples (two experimental and one negative control for each 
time point). Fold upregulation or downregulation of mRNA levels is shown compared to 
that of untreated control cells, all normalized to the selected most stable housekeeping 
gene of the five analyzed, RPL13A. Scatter plots call attention to a smaller dataset that 
exceeded thresholds of 2-fold induction or 0.5-fold suppression shown individually for 
each experimental condition (Figure 2.9).  Database curation information for all genes 
attempted in this study is included in Appendix Table A-1, along with a key that defines 
the four queried toxicological responses in which each gene is involved. Many of the 
genes have functions along several intertwined pathways. IKBKB, which spurs the 
release of NF-κB from the cytosol, is one such example, as it can be categorized as 
relating to oxidative stress, inflammatory response, and/or non-inflammatory immune 
response.  
Since this can be one of the difficulties in assessing gene profiles, we chose a 
focused pathway array and searched for common relationships and downstream actions 
of these genes that were affected, finding that many genes modulated by QD treatments 
were linked to the NF-κB pathway. Specific results follow. 
 
2.3.3.1. Inflammatory response 
Inflammation is a sophisticated immune and homeostatic response by vascular 
tissue to irritants and damaged cells as well as pathogens. Many genes in the array tested 
for mediators of inflammation, and the expression of many genes was considerably 
altered in these exposures, including NF-κB pathway modulation. Transcripts regulating  
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Fig. 2.9.  Modulated gene scatterplots. Comparison of up and downregulated genes in HDF 
cells: (A) 30 nM QD-exposed cells vs. unexposed cells at 8 hrs exposure, (B) 30 nM QD-
exposed cells vs. unexposed cells at 48 hrs exposure, (C) 60 nM QD-exposed cells vs. unexposed 
cells at 8 hrs exposure, and (D) 60 nM QD-exposed cells vs. unexposed cells at 48 hrs exposure. 
Red triangles indicate genes that were upregulated by at least 2.0-fold, green triangles represent 
genes downregulated at least 0.5-fold compared to the control. 
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inflammation produced a complex profile of induction and repression and were detected 
at the two day time point with QD exposure. Members of the IL-1 and IFNγ families, as 
well as CCR3, TLR4, TLR6, TNFα, IL-6, and IL-10 were all modulated in response to 
QDs. It is important to note that while pro-inflammatory IL-6 was strongly upregulated 
early in the response at 8 hrs (11.94-fold with 60 nM), anti-inflammatory IL-10 was 
simultaneously downregulated (0.13-fold with 60 nM).   
 
2.3.3.2. Non-inflammatory immune response 
This study extended to the regulation of innate immune genes not overtly 
involved with inflammation and mediators of adaptive immunity. Several genes 
perturbed in these experiments dictate that pattern recognition receptors are activating 
antigen presenting capabilities to be able to trigger T cell mediated immunity. These 
genes pleiotropically contribute to multiple physiological pathways, often via the NF-κB 
pathway and hint that inflammation is not the only effect QDs have on biological 
systems. A serine protease inhibitor (SERPINA1), which was upregulated nearly 3-fold 
at the 8 hr timepoint, and innate pattern recognition receptors, such as members of the 
collectin and PGLYRP families, showed that diverse responses were being initiated by 
the QDs. Message levels of IFNA1 were transiently downregulated at 8 hrs in response 
to QD treatment, then later upregulated at 48 hrs. CD14 (along with TLR4) is a 
component of the classic LPS receptor. Its suppression by the lower concentration of 
QDs is particularly curious, suggesting unheralded physiology of this receptor for 
recognition of moieties other than conserved patterns in prokaryotic cell walls. 
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2.3.3.3. Apoptotic response 
Mediators of the programmed cell death pathway were assayed to determine their 
level of induction or suppression in response to nanoparticle treatment. The gene for the 
adenosine receptor (ADORA2A) has been implicated in programmed cell death 
(Trincavelli et al., 2003) and was upregulated by CdSe/ZnS-COOH QDs. Tumor 
necrosis factor binds its receptor ligand to initiate the extrinsic apoptotic pathway. 
Upregulation (1.58-fold) of TNFRSF1A implicate this apoptotic pathway as a common 
result of exposure. Tumor necrosis factor receptor superfamily member 1A (CD120a) is 
a receptor for TNF-α. NLRC4, CASP1, and CASP4 modulation suggest that apoptosis 
was induced at the 48 hr time point. The NLR family CARD (caspase recruitment 
domain) containing protein 4 (NLRC4) has been shown to interact with caspase 1 and 
NOS2 (Damiano et al., 2004). NF-κB is necessary for the transcription of many key 
mediators in these apoptotic pathways (Graham and Gibson, 2005) and, although 
cytosolic levels of NFKB1 mRNA were perturbed, message levels of NFKB2 were down 
at both 8 and 48 hrs and inhibitory NFKBIA was up at both 8 and 48 hrs. 
 
2.3.3.4. Stress caused by reactive oxygen intermediates and/or metals  
Our results suggest that nanoparticle exposure may perturb the cytosolic reducing 
environment of exposed cells, causing toxic effects from macromolecular damage dealt 
by peroxides and free radicals. Heme oxygenase-1 is an essential enzyme in heme 
catabolism and protects against oxidative stress (Yachie et al., 1999 ). CdSe/ZnS-COOH 
QDs in low and high concentrations downregulated HMOX1 mRNA expression at 8 hrs 
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(0.04-fold), but it was induced at 48 hrs (up to 2.3-fold), presumably to provide 
protection from oxidative stress. Analysis of other genes such as IKBKB (up 1.5-fold at 
48 hrs) and nuclear factor κB p100 subunit, NFκB2, (downregulated 0.6-0.7-fold) also 
point to stress caused by QD treatment.  
 
2.3.4. Protein expression alterations in the NF-κB pathway 
While the changes in the mRNA levels are indicative of the activation of this 
pathway, additional evidence at the protein level strengthens support for such a 
hypothesis. Induction of various proteins involving oxidative stress, inflammatory 
response, apoptosis, and immunoregulation in HDF was assayed after treatment with 
QDs at exposure concentrations of 30 nM or 60 nM and at 8 or 48 hrs after initial 
exposure. Figure 2.10 displays the results acquired from western blotting. Induction of 
oxidative stress protein HMOX-1, inflammatory and apoptotic protein TNF-α, and 
inflammatory promoters and regulators IL-1B and IL-10 are shown after exposure to 
QDs at 8 and 48 hours. NF-κB subunit RelA protein analysis of total cell lysates 
revealed a decrease in expression in response to treatments, corroborating the 
modulation seen in NF-κB message after QD treatment. All protein expression data is 
compared to that of untreated control cells. 
 
2.3.4.1. IL-1β and IL-10 
 Interleukin-1β (IL-1β) protein was induced at both time points and exposure 
concentrations, corroborating messenger RNA. IL-1β, a crucial mediator of  
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Fig. 2.10.  HDF protein expression. Western blots of protein expression along pathway specific 
proteins. Lane 1: undosed control; 2: CdSe/ZnS-COOH 30 nM after 8 hrs exposure; 3: 
CdSe/ZnS-COOH 60 nM after 8 hrs exposure; 4: CdSe/ZnS-COOH 30 nM after 48 hrs 
exposure; 5: CdSe/ZnS-COOH 60 nM after 48 hrs exposure. 
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inflammatory, proliferation and apoptotic responses, is produced by fibroblasts, as well 
as other cell types and macrophages. Stronger upregulation was seen at the later time 
point, especially at the 30 nM concentration.  
 Interleukin-10 (IL-10) was probed as a bellwether of immunoregulatory protein 
up regulation following exposure to QDs (Saraiva and O'Garra, 2010). When compared 
to the unexposed control, both of the 48 hr time point sample sets were upregulated, in 
addition to a mild increase in expression of the 8 hr QD-treated samples. The increase in 
cytoplasmic levels of this cytokine are indicative of the diverse mRNA upregulation 
from immune genes observed by qPCR.  
 
2.3.4.2. TNFα and HMOX1 
 Tumor necrosis factor-alpha (TNFα) expression was slightly induced at the later 
time point when compared to undosed cells. Although the primary role of TNFα is that 
of an acute phase mediator of inflammation, this protein also plays a role in 
immunoregulation, apoptosis, inhibition of replication and tumor surveillance 
(Kamohara et al., 2004; Waetzig et al., 2004). 
Heme oxygenase-1 (HMOX-1) response from QD exposure proved to be neither 
solely related to time or concentration, although expression at both time points was 
consistently increased when compared to the undosed control cells and corroborated the 
qPCR data for HMOX1. 
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2.3.4.3. NF-κB 
 NF-κB is involved in regulating many aspects of cellular activity, including 
stress, injury and especially pathways of the complex immune response. NF-κB is a 
cytosolic transcription factor, which binds to nuclear DNA and activates transcription of 
target genes. NF-κB both responds to and induces IL-1β and pro-inflammatory TNFα. 
While the ultimate gene targets of NF-κB are diverse, its activation has been shown to 
block apoptosis (Antwerp et al., 1996; Beg and Baltimore, 1996; Liu et al., 1996; Wang 
and Ron, 1996). Western blot results indicated that while cytosolic NF-κB remained 
unchanged with QD exposure, nuclear levels decreased over time. Secondary blotting for 
lamin, a constitutive nuclear protein, revealed that the 48 hr samples exhibited a more 
concentrated nuclear constituent, suggesting an even stronger suppression than what is 
shown in the nuclear fraction blot. Probing for NF-κB (p65) in total cell lysates resulted 
in a fairly consistent degradation of NF-κB levels with QD treatments.  
 
2.3.5. NF-κB transcriptional activity 
 To confirm the suppressive effect of QDs on transcriptionally active levels of 
NF-κB, an NF-κB-dependent luciferase gene reporter activity assay was employed. NF-
κB and Renilla control vectors were transiently transfected into the HDF cells. As shown 
in Figure 2.11, constitutive NF-κB reporter activity was significantly modulated in 
transfected cells, agreeing with the western blot and RT-PCR results (Figures 2.8-2.10). 
Interestingly, the 30 nM QD exposure provoked more significant deviations from the 
undosed control cells. Luciferase data indicate an initial increase in NF-κB activity at the  
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Fig. 2.11.  NF-κB transcriptional activity. Changes in transcriptional activity were measured in 
a dual luciferase gene reporter assay. Luciferase reporters driven by either NF-κB firefly or 
Renilla luciferase response elements were transiently cotransfected into HDF cells. Luciferase 
activities were quantified using a dual-luciferase reporter assay system. Exposed wells were 
compared to unexposed transfected cells, which were assigned the value of 1. *p< 0.05 
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earlier timepoint (1.85 and 1.49 fold induction for 30 and 60 nM QDs), followed by 
suppressed levels (0.403 and 0.612 fold induction for 30 and 60 nM QDs) by 48 hrs.  
 
2.4. Discussion 
QD particles modulated gene and protein expression relating to oxidative stress, 
apoptosis, inflammation, and non-inflammatory immune response pathways, especially 
genes typically included in the NF-κB pathway. Similar to previously published high 
exposure concentration studies with nanoparticles, we found that the observed low 
exposure concentration effects were dependent on QD dosing concentration and 
exposure time (Delehanty et al., 2006; Hoshino et al., 2004; Kirchner et al., 2005b; 
Prasad et al., 2010; Su et al., 2009; Tang et al., 2008).  
A schematic displaying many of the genes with modulated mRNA expression the 
NF-κB pathway is shown in Figure 2.12. From this figure, it can be deduced that 
although the message level of NFKB1 was up at both 8 and 48 hrs, NFKB2 message was 
down at both 8 and 48 hrs. This downregulation of NFKB2 corresponds with the NF-κB 
protein analysis data in the western blots. Also, the inhibitory gene, NFKBIA, was 
upregulated, which likely assisted in the prevention of NF-κB translocation in this study. 
These findings help explain why pro-inflammatory and apoptotic TNFα is allowed to 
increase in expression over time, since the presence of activated NF-κB can restrict its 
actions in the cell. There also appears to be a feedback mechanism taking place between 
IL-10, TNFα, and HMOX1, as the message levels of each were all down at 8 hrs, but all 
upregulated at 48 hrs. IL-10 has also been shown to inhibit NF-κB (Sanjiv et al., 2009).  
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Fig. 2.12.  Genes modulated along the NF-κB pathway in HDF exposed to QDs.  Colored shapes correlate to modulated genes 
in HDF cells at 8 hrs (left) and 48 hrs (right).   
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The upregulation of HMOX1, caused by oxidative stress and inflammation has been 
found to be upregulated and mediated by the NF-κB pathway (Wijayanti et al., 2004). Its 
corresponding protein, HMOX-1, increased in expression also, as evidenced by western 
blot. 
IL-1 was upregulated strongly at the early time point, but tapered off by 48 hrs 
after QD exposure. In response to this increase, as well as the presence of TNFα, pro-
inflammatory cytokine IL-6 was upregulated. IL-6 is a well known responder to cellular 
injury and helps to regulate the acute phase inflammatory response (Kopf et al., 1994; 
McFarland-Mancini et al., 2010). In a 2007 publication by Ryman-Rasmussen et al., 
similar increases in IL-1 and IL-6 were found when dermal cells were treated with 
CdSe/ZnS-COOH QDs (Ryman-Rasmussen et al., 2007). CCL2, which is responsible for 
recruiting T-cells, monocytes, and dendritic cells to the site of injury, was upregulated 
early (Fantuzzi et al., 2008; Wolter et al., 2008). SERPINA1 was also upregulated early 
at both dosing concentrations to help protect tissues from inflammatory cell enzymatic 
activity. The ligands for the initially suppressed C-C type chemokine receptor CCR3 are 
cytokines including eotaxin, MCP-3, MCP-4 and RANTES, contributing to recruitment 
and activation of inflammatory cells by HDF (Huber et al., 2000). Platelet activating 
factor, the ligand of the PTAFR gene product, which was upregulated with exposure to 
QDs, is a potent phospholipid activator and mediator of inflammation, as well. The A2A 
adenosine receptor (A2AAR) is known to mediate anti-inflammatory actions in a variety 
of cell types, where upregulation of the receptor is part of a delayed feedback 
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mechanism initiated through NF-κB to terminate the activation of  macrophages 
(Murphree et al., 2005). 
Cellular decisions to resist apoptosis occurred early, as evidenced by induction of 
NFκB1 and NFKBIA, as well as the gene for A2AAR, ADORA2A, which also acts to 
block apoptosis by inhibiting TNFα (Ohta and Sitkovsky, 2001). However, pro-apoptotic 
genes were upregulated by 48 hrs post-exposure. For example, casp1, the gene coding 
for an enzyme known to cleave IL-1β into its mature form (Cerretti et al., 1992) and 
induce apoptosis when overexpressed (Miura et al., 1993) became upregulated at the 
later time point. Casp4, NLRC4, and TNFα also increased by 48 hrs. In regard to 
concentration, the higher 60 nM dose at 48 hrs provoked 75% of the apoptosis pathway 
genes analyzed to upregulate (Figure 2.13).  
Interestingly, Ramage et al (2004) both found that ultrafine carbon black 
particles also modulate the NF-κB pathway.  Ramage showed that exposure to carbon 
black particles caused an over expression of CRP in human long epithelial cell line 
(A549), which in turn is dependent on the NF-κB pathway. They found that CRP is 
synthesized and the NF-κB pathway is modulated in cells when IL6, TNFα, IFNγ, and 
IL1β are expressed (Ramage et al., 2004).  Both ultrafine carbon black and engineered 
quantum dot particles modulate similar genes, thus both particle-types seem to operate 
under the same mode of action intracellularly. 
In general, the cells exposed to QD nanocrystals induced a widespread 
modulation of genes and proteins, overall, when compared to unexposed control cell 
populations.  Genes such as ADORA2A, CCL2, IL1B, IL6, IRAK2, NFκBIA, and  
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Figure 2.13. Gene modulation summary. A comparison of percent up and downregulation of 
genes in response to 30 and 60 nM CdSe/ZnS-COOH  at 8 and 48 hrs time points. Data is 
categorized into the following 5 groups: All 50 genes (A), oxidative stress genes (B), 
inflammatory genes (C), apoptotic genes (D), and non-inflammatory immune genes (E). Graphs 
represent data from heat map, where values <0.8 were considered for downregulation (gray) and 
>1.2 (black) were considered for upregulation. 
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SERPINA1 for example, are upregulated after exposure to QDs, in addition to proteins, 
such as HMOX-1, IL-10, IL-1B, and TNF-α. Western blotting, however, indicated a 
decrease in NF-κB translocation, which likely played a role in the increase in apoptotic 
markers at the later time point. These modulated genes and proteins are indicators of 
oxidative stress, apoptosis, inflammation, and more general immune responses. 
Luciferase data revealed nearly a 2-fold induction in NF-κB levels at 8 hrs, followed by 
suppression at 48 hrs, as compared to control values, indicating transcriptional 
modulation. Immunocytochemistry demonstrating NF-κB nuclear translocation events 
revealed similar trends (Figure 2.14). This difference in levels mirrors the mRNA data, 
as well as protein levels at the 48 hr time point. While this work provides a more specific 
mechanistic analysis of fundamental toxicological pathways induced or suppressed after 
QD exposure, future studies require the use of animal models to validate these findings 
and bridge these data to human exposure scenarios.  
The research presented herein offers an alternate methodology and increased 
understanding of low-concentration nanotoxicological immune research specific to 
CdSe/ZnS-COOH water-suspendable QD systems. Future in vivo work will attempt to 
corroborate these findings in the more complex cellular environment of animal 
exposures and assign temporal sequence to the NF-κB-mediated processes perturbed. 
Salient points to be learned from this research: 
 The response to QDs is cell-type specific. 
 NF-κB and associated inflammatory/oxidative stress pathway-related genes and 
proteins are perturbed after exposure to QD nanoparticles. 
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Figure 2.14. NF-κB translocation. Effects of nanoparticles on nuclear accumulation or 
suppression of NF-κB in HDF. Localization of the p65 subunit of NF-κB was assessed by using 
immunofluorescence. HDF were either A) untreated, treated with B) TNFα (20 ng/mL) as a 
positive control, or C) 20 ppm QD suspensions for 8 or 48 hrs. QDs induced nuclear 
translocation of NF-κB at the earlt time point, but NF-κB levels subsided by 48 hrs, even as QDs 
increased within the cytosol. Scale bar=10 μm. 
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Questions remaining unanswered: 
 What are the downstream effects of NF-κB on oxidative stress mechanisms? 
 To what extent does NF-κB play a role in cells exposed to various nanoparticles? 
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CHAPTER III 
DISTINCT IMMUNOMODULATORY EFFECTS OF A PANEL OF 
NANOMATERIALS IN HUMAN DERMAL FIBROBLASTS* 
 
3.1 Introduction 
There has been rapid progress in the field of nanotoxicology in recent years; 
however, information regarding the potential for adverse health outcomes arising from 
nanoparticle exposures is still lacking. For example, the cellular immunoregulatory 
response to nanoparticles is not well understood. Materials on the nanometer size scale 
are thought to impose different types of chemical and/or biological effects on organisms 
compared to materials of the same chemical composition but on the micrometer size 
scale.  This phenomenon is attributed to the finer size and corresponding larger surface 
area per unit mass that is characteristic of all engineered nanoparticles (Maynard and 
Kuempel, 2005; Monteiller et al., 2007; Oberdorster et al., 2005). However, it is largely 
unknown which specific pathways or subcellular mechanisms of action are triggered as a 
result of nanoparticle exposure. Some studies have shown that nanoparticles can be 
internalized into cells.  Other studies have shown various uptake mechanisms for 
nanoparticles (Duan and Nie, 2007; Jaiswal et al., 2003; Zhang and Monteiro-Riviere, 
2009).  But few studies have investigated the subsequent mechanisms of injury, 
including key genes and proteins that participate on the molecular level. A key missing 
___________  
*Reprinted with permission from ―Distinct Immunomodulatory Effects of a Panel of 
Nanomaterials in Human Dermal Fibroblasts‖ by Romoser, et al., 2012. Toxicology 
Letters, In Press, Copyright [2012] by Elsevier Ltd. 
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component of most nanotoxicology studies is the query and determination of 
toxicological process development. We hypothesized that immune mediators of 
inflammation, such as the transcription factor, NF-κB, may be initiated in the exposed 
cell layers, and followed by upregulation of inflammatory response proteins. NF-κB may 
be partially affected by MAPKs, such as ERK1/2 and p38, which are known to 
phosphorylate the NF-κB inhibitor (Müller et al., 2002). We have found that these 
initiators are, at least in part, dependent on nanoparticle type and the cellular stress 
response ability of the cell.    
We previously showed that quantum dot exposure modulates NF-κB in human 
dermal fibroblasts (HDFs) (Romoser et al., 2011b). NF-κB is a major transcription factor 
responsible for regulating genes of both the innate and adaptive immune response 
(Livolsi et al., 2001). NF-κB becomes activated through distinct signaling components: 
inactivated, cytosolic NF-κB is complexed with the inhibitory IκBα (NFKBIA) protein. 
A variety of extracellular signals can be recognized via integral membrane receptors, 
which can lead to the activation of the enzyme IκB kinase (IKK or IKBKB). The role of 
IKK is to phosphorylate the NF-κB-associated IκBα protein, resulting in ubiquination 
and dissociation of IκBα from NF-κB.  IκBα is degraded by the proteosome and the 
liberated NF-κB is then translocated into the nucleus where it binds to specific DNA 
motifs in promoters, termed response elements. Here, it can upregulate genes involved in 
immune cell development, and maturation, as well as those dedicated to survival, 
inflammation, and lymphoproliferation (Zandi, 1997). 
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In an attempt to elucidate these immune response mechanisms, primary HDF cells 
were utilized to investigate the molecular toxicological mechanisms of a collection of 
similarly sized nanoparticles. Fibroblasts are the most common cell-type in the dermis, 
and their ubiquity makes them more appropriate for this study than the rare patrolling 
macrophages. Contact with the skin is one of the major routes of both intentional and 
accidental exposure to nanoparticles. Four dermally relevant nanoparticles, citrate-
stabilized silver, hydroxylated fullerenes (fullerol), CdSe/ZnS-COOH quantum dots, and 
anatase titanium dioxide, were chosen to compare and contrast cellular responses.  
Because of their unique characteristics, quantum dots are used at increasing rates 
for a wide variety of industrial and consumer-based applications, including biomedical 
imaging agents, inks, and solar panels (Alivisatos et al., 2005; Gao et al., 2004; Michalet 
et al., 2005; Roco, 2003). Zhang et al. (2008) and Mortensen et al. (2008) both 
concluded that quantum dots of similar or identical structure and composition to those 
used in this study could penetrate through the epidermis into the dermis, especially with 
flexing of the skin or by way of hair follicles (Mortensen et al., 2008; Zhang and 
Monteiro-Riviere, 2008). Microscopy from their publications revealed that a 
considerable portion of the dose penetrated to the dermis. Silver is currently being 
utilized as an antimicrobial agent in many dermal applications and has been found to 
penetrate intact and damaged skin (Larese et al., 2009; Samberg et al., 2010). Titanium 
dioxide, a common ingredient in sunscreens and cosmetics, is generally recognized as 
safe for dermal exposure. However, while most titanium dioxide studies involving 
healthy skin report an absence of penetration, this may not necessarily be the case with 
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damaged skin (Senzui et al., 2010) (L‘Oreal unpublished study-2009-2011). We also 
examined the effects of fullerol exposure on dermal cells in this study. Fullerol has been 
reported to possess antioxidant abilities (Djordjevic et al., 2005; Mirkov et al., 2004; 
Wang et al., 1991) and has, for that reason, been added to cosmetic preparations with the 
intention of preventing oxidative damage to the skin due to aging and sun exposure.  But 
there have also been reports of toxicity associated with exposure to fullerol and other 
carbonaceous cage nanostructures. For example, Xia et al. (2010) have recently reported 
that, depending on the vehicle composition, pristine fullerene nanoparticles can penetrate 
deeply into the stratum cornea in healthy skin, as tested both in vitro and in vivo (Xia et 
al., 2010). In another study, fullerol caused delayed cell death characteristic of apoptosis, 
including DNA damage in rodent and human glioma cells, which was determined to be 
caused in the absence of ROS (Isakovic et al., 2006). The dermal permeation capability 
or toxicity of fullerol, specifically, has not been assessed, although fullerene-based 
peptides were shown to penetrate intact skin, which was exaggerated with mechanical 
stress leading to infiltration into the dermis (Rouse et al., 2007). 
In an effort to increase current knowledge regarding pathways of the human 
cellular response to aqueous silver, fullerol, quantum dots, and titanium dioxide, we 
have quantitatively investigated effects of exposure on the expression of 84 unique genes 
in HDF cell cultures. In this study, we compared the dose-response and time-course 
effects of four nanoparticles in dermal cells capable of exhibiting inflammatory 
response, immunoregulation, apoptosis, and cellular stress. Additionally, we tested 
whether NF-κB was modulated, as was found in our previously published study  
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Fig. 3.1.  Experimental design. Progression of experiments with four disparate nanoparticles 
tested in primary dermal fibroblasts with or without NF-κB signaling competency. Arrows relate 
viability, antioxidant, transcriptional and protein assays with nanoparticle concentrations cells 
and exposure times.  
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(Romoser et al., 2011b), in cells exposed to other nanoparticles and determined to what 
extent NF-κB played a role in the cellular response to NPs by overexpressing the 
inhibitor, IκBα. We have included an experimental design flowchart that outlines all 
experiments carried out (Figure 3.1). 
 
3.2 Methods 
3.2.1. Nanoparticle characterization 
Aqueous citrate-stabilized silver particles (NanoComposix, San Diego, CA); 
hydroxylated fullerenes (MER Corp., Tucson, AZ); CdSe/ZnS-COOH crystalline 
quantum dots (Invitrogen Corp., Carlsbad, CA); and anatase titanium dioxide 
(NanoAmor, Houston, TX) characterization data is summarized in Table 3.1. The 
hydrodynamic diameter and zeta potential of all four nanoparticles were measured using 
a Zeta Sizer Nano Series ZEN 3600 Spectrometer (Malvern Instruments Ltd, Malvern, 
Worcestershire, UK).  Particle characterization was performed on the particles 
suspended in Milli-Q ultrapure water (18.2 mΩ), as well as in DMEM supplemented 
with 10% FBS at 0, 24, and 48 h time points. Elemental analyses were determined via 
inductively coupled plasma-mass spectroscopy (Elan DRC II, Perkin Elmer SCIEX). 
Transmission electron microscopy (TEM) grids were glow discharged using PELCO 
easiGlow (Ted Pella, Inc., Redding, CA) in order to make the grid surface hydrophillic.   
Fifteen microliters of solution was applied to 200 lines/inch square mesh copper grids 
(Electron Microscopy Sciences, Hartfield, PA). Grids were analyzed on a FEI Tecnai G2  
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Table 3.1.  Characterization table. Nanoparticle size as measured by manufacturer, 
transmission electron microscopy, and dynamic light scattering, zeta potential, and density of 
silver, fullerol, quantum dots, and titanium dioxide.  
 
Characterization Silver Fullerol QD TiO2 
Primary particle 
size reported by 
manufacturer 
(nm) 
25 15 16 25 
Primary particle 
size measured 
by TEM (nm) 
20 - 10 15 
Density (g/cm
3
)  10.5 0.8 (fullerene) 
4.95 
(CdSe/ZnS) 
3.90 
Size measured 
by DLS (nm) Water Media Water Media Water Media Water Media 
0 hr 
53.5 
 2.3 
169.1 
 2.3 
238.5 
 9.0 
101.6 
 5.0 
12.7 
 0.3 
27.3 
 1.0 
40.1 
 2.7 
313.9 
 63 
24 hr 
354.2 
 23 
123.2 
 4.1 
30.6 
 0.6 
121.1 
 4.7 
23.1 
 1.6 
22.5 
 0.6 
155.8 
 29 
16.9 
 0.6 
48 hr 
345.1 
 3.0 
166.3 
 3.4 
31.0 
 0.4 
194.8 
 4.2 
38.5 
 7.8 
25.1 
 0.8 
1331.9 
 540 
248.8 
 150 
         
Zeta potential 
(mV) Water Media Water Media Water Media Water Media 
0 hr 
-48.2 
 8.5 
-9.1 
 2.0 
-51.3  
 6.9 
-13.2 
 1.1 
-50.7 
 5.9 
-4.4 
 1.0 
+41.5 
 8.4 
-11.3 
 1.0 
24 hr 
-54.8 
 1.9 
-10.3 
 1.3 
-10.4 
 4.5 
-14.5 
 0.8 
-7.9 
 2.8 
-1.1 
 0.2 
+10.9 
 0.9 
-11.8 
 1.3 
48 hr 
-55.7 
 3.0 
-11.3 
 1.4 
-26.6 
 3.0 
-14.7 
 0.3 
-39.4 
 6.5 
-5.2 
 0.8 
-0.5 
 0.4 
-13.2 
 0.4 
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F20 at an accelerating voltage of 200 kV. Images were recorded using a Gatan CCD 
camera. 
 
3.2.2. Cell culture and experimental dosing 
Human dermal fibroblasts.  Cryopreserved primary HDF cells (PCS-201-010, 
ATCC, Manassas, VA) were cultured in Dulbecco‘s Modified Eagle‘s Medium 
supplemented with 10% FBS (Gibco, Austria). Media was supplemented with an 
antibiotic cocktail consisting of penicillin, streptomycin, and amphotericin (Sigma-
Aldrich, St. Louis, MO). Incubation took place at 37°C with humidity and 5% CO2. 
Cells were grown to 80% confluency in 6-well plates, then exposed to nanoparticles (20 
ppm final exposure concentrations) or untreated for a negative control. Cells treated with 
nanoparticle suspensions were very briefly exposed to light in the cell culture hood at the 
points of exposure and harvesting. Cellular incubations with nanoparticles took place in 
the dark. 
 Stable transduction of HDF cells.  An additional group of HDF cells was virally 
transduced to overexpress IKBα, the inhibitor of NF-κB, to assess differences in 
viability, antioxidant usage, and protein expression with and without NF-κB 
competency. HEK-293T Ampho-Phoenix packaging cells, capable of carrying plasmids 
for long-term stable production of lentivirus, were obtained with permission
 
from Gary 
Nolan at Stanford University and maintained in DMEM containing 10% FBS at 37°C 
with 5% CO2. HDF cells were maintained as aforementioned. This transduced HDF cell 
line is referred to as ―NF-κB knockdown‖ cells throughout the manuscript. 
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Construction of plasmid. IκB-SR (Super Repressor) was amplified with primers 
5′-ATG TTC CAG GCG GCC GAG-3′ and 5′-TCA TAA CGT CAG ACG CTG GC-3′, 
cloned onto pCR2.1 TOPO (Invitrogen) and subcloned onto pLPCX (Clontech) using 
EcoRI restriction sites.  
 Stable transduction in cell lines.  HEK-293T amphotrophic Phoenix cells were 
transfected with 10 g retroviral vectors (pLPCX) with or without insert.  After 24 h, 
cells were placed at 32
o
C.  Viral media was harvested 48 and 72 h after transfection and 
used to infect cells.  After 24 h of resting in nonselective media, cells were selected with 
0.4 g/ml puromycin for 48 h. Empty vector does not appreciably alter gene expression 
profile. Real time PCR compared expression of genes from cells treated with empty 
vector (no NF-κB construct) to the cells that received no nanoparticle and were 
harvested at 8 hours (data not shown). 
 
3.2.3. Cell viability 
HDF and NF-κB knockdown cells were cultured in 24-well plates as described 
above.  Cells were then exposed to silver, fullerol, quantum dots, or titanium dioxide to 
give final well concentrations of 0, 10, 50, 100, 150 or 200 ppm. Cells treated for 24 or 
48 h were washed, trypsinized, and resuspended in cell culture media. Percentages of 
viable cells were measured by mixing equal volumes of cell suspension and trypan blue 
stain, followed by membrane permeability-based counting in an automated cell counter 
(Countess, Invitrogen). Viability experiments were done in quadruplicate. A student‘s t-
test was employed to calculate significant change in viability, as compared to the 
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untreated control samples. Statistical significance was also calculated for differences 
between normal and NF-κB knockdown cells. 
 
3.2.4. GSH oxidation assay 
A luminescence-based assay (V6611, Promega, Madison, WI) was utilized to 
detect and quantify levels of oxidized glutathione (GSSG) in both untreated and 20 ppm 
nanoparticle-treated HDF and NF-κB knockdown cells. GSSG determinations were 
based on a reaction scheme consisting of GSH-dependent conversion of a GSH probe to 
luciferin by a glutathione S-transferase enzyme. Both GSH and GSSG are present in 
cells. Therefore, in order to measure oxidized glutathione only, cells were lysed and 
GSH was blocked. The resulting GSSG was reduced to GSH to measure oxidized 
glutathione. Antioxidant experiments were done in triplicate.  
  
3.2.5. Gene expression analysis  
Cells cultured and exposed to 20 ppm nanoparticle suspensions were harvested at 
time points of 8 or 24 h. An RNeasy® Mini Kit (Qiagen, Frederick, MD) was used in 
conjunction with an on-column genomic DNA digestion to lyse cells and extract total 
RNA. An RT
2
 First Strand Kit (C-03) from SABiosciences was utilized prior to 
quantitative real-time PCR (RT-PCR) to reverse transcribe messenger RNA into cDNA. 
This cDNA was prepared for a pathway-focused gene expression profiling PCR array 
system, specific for 84 genes of innate and adaptive immune responses (RT
2
 Profiler™, 
SABiosciences, Frederick, MD), of which data from 42 passed quality control in all 
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conditions and are compared here. After adding the cDNA to a PCR reaction master mix 
containing SYBR green, 25 µL of sample was loaded into all wells of 96-well plates pre-
filled with primer sets including housekeeping genes, gDNA controls, reverse 
transcription controls, and positive PCR controls. Using a Roche LightCycler® 480 
(Roche, Indianapolis, IN) for RT-PCR, a two-step thermal cycling program was 
followed: 1 cycle at 95°C for 10 min, then 45 cycles of 95°C for 15 s, then 60°C for 1 
min. The Roche LightCycler® 480 software was utilized for raw data acquisition and 
calculation of Ct (threshold cycle) values.  
 
3.2.6. Protein expression alteration 
HDF and HDF transduced with empty vectors (i.e. no IκBα overexpression 
capability) were cultured in the same conditions as above. Nanoparticle-treated and 
untreated cells were washed in ice cold 1X PBS, then protease inhibitor cocktail (Sigma-
Aldrich) and high salt lysis buffer were added to wells. Protein was isolated by 
collecting supernatant via centrifugation. Fractionated NF-κB samples were harvested 
without the use of lysis buffer. An NF-κB activation assay kit (FIVEphoton 
Biochemicals, San Diego, CA) was utilized to obtain nuclear and cytosolic NF-κB 
fractions from cells. Samples were loaded into 10% SDS-PAGE gels and run at 120 mV. 
Gels were transferred to PVDF membranes, which were blocked in 5% milk or 
BSA/PBST and incubated in different primary antibody solutions overnight: p-IκBα, 
1:1000 (Abcam Inc., Cambridge, MA), p-ERK1/2, 1:1000 (Cell Signaling Technology, 
Danvers, MA), HMOX-1, 1:1000 (Santa Cruz Biotechnology, Santa Cruz, CA), p-P38, 
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1:1000 (Cell Signaling Technology), IL-6, 1:500 (Santa Cruz) or p65 NF-κB, 1:1500 
(Santa Cruz). Membranes were washed in PBST several times before secondary 
antibody (Goat, anti-mouse or anti-rabbit, 1:5000, Santa Cruz) prepared in fresh 5% milk 
or BSA/PBST solution was added. Membranes were incubated in the secondary 
antibody at room temperature, and then washed again in PBST. Immobilon™ Western 
Chemiluminescent HRP substrate (Millipore, Billerica, MA) was added to membranes 
and film exposures were taken. GAPDH, 1:10,000 (AM4300, Ambion, Austin, TX) and 
Lamin A/C 1:5000 (sc-6215, Santa Cruz) were used as loading controls. Blots are 
representative of duplicate or triplicate experiments. 
 
3.2.7. Calculations of gene expression changes 
A total of five housekeeping (potential reference) genes were assayed on the 
plate and included those encoding β2-microglobulin, hypoxanthine 
phosphoribosyltransferase 1, ribosomal protein L13a, glyceraldehyde-3-phosphate 
dehydrogenase, and β-actin. Analytical estimation of internal control gene stability 
indicated that hypoxanthine phosphoribosyltransferase 1 (HPRT1) was most stable based 
upon lowest variance and standard deviation, and HPRT1 was utilized for subsequent 
normalization (Vandesompele et al., 2002). 
Changes in gene expression were estimated using the 2
-ΔΔCt
 method (Rouse et al., 
2007; Rzigalinski and Strobl, 2009), with HPRT1 utilized as the stable reference gene 
for all experimental situations.  The fold changes in gene expression were calculated 
with respect to the expression level of the genes in the respective control group. For 
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example, 2-fold change of gene A indicates that expression of gene A was twice as large 
in the treatment group compared to its expression in the control group, while 0.5-fold 
change of gene A indicates that the expression of that gene was two times less in the 
treatment group compared to its expression in the control group. More detailed gene 
annotations and array layout are available at 
http://www.sabiosciences.com/genetable.php?pcatn=PAHS-065A. Information 
regarding the manufacturer‘s estimates for array performance, sensitivity, specificity, 
and reproducibility are available at 
http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-052A.html#accessory. 
 
3.3 Results 
3.3.1. Nanoparticle characterization 
 Nanoparticle characterization results can be found in Table 3.1 and Figures 3.2-
3.3. Primary particle size and morphology for all nanoparticles were determined via 
transmission electron microscopy; dynamic light scattering was utilized to measure the 
hydrodynamic diameter of the particles when suspended in water and complete cell 
culture media. Specific results can be found in Table 3.1.  Lastly, the densities of the 
particles are reported to be 3.90 g/cm
3
 for titanium dioxide, 10.50 g/cm
3
 for silver, 4.95 
g/cm
3
 for CdSe quantum dots, and 0.80 g/cm
3
 for fullerols. No metal impurities were 
detected via inductively coupled plasma-mass spectroscopy elemental analysis. 
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Figure 3.2. Sizing profiles of silver, fullerol, quantum dots, and titanium dioxide particles. Size 
was measured via dynamic light scattering spectroscopy at a particle concentration of 20 ppm. The 
size distribution of each particle was measured and graphed as percent intensity versus 
hydrodynamic diameter.   
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Fig. 3.3.  Transmission electron microscopy. A) titanium dioxide, B) silver, and C) quantum 
dots. Samples were diluted to 20 ppm in Milli-Q water. Characterization was done in cell-free 
conditions. 
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Fig. 3.4.  Effects of nanoparticles on cellular viability. Comparison of normal and NF-κB 
knockdown HDF cellular viability, as measured with the trypan blue exclusion assay. 
Measurements were taken 24 and 48 h after exposure to 0-200 ppm A) silver, B) fullerol, C) 
quantum dots, or D) titanium dioxide. *Statistically significant (p<0.05) compared to untreated, 
cell-type matched cells. **Statistically significant (p<0.001) compared to untreated, cell-type 
matched cells. 
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3.3.2. Cell viability 
Cellular viability was measured in HDF cells exposed to each nanoparticle over a 
dose-response ranging 0 to 200 ppm resulting in a differential cytotoxicity for each 
particle (Figure 3.4). The trypan blue assay revealed that cell viability decreased 
(increase in membrane permeability) with increasing concentration of nanoparticle 
exposures.  In addition, the cellular response to particles was found to be different when 
NF-κB was inhibited in cells. Specifically, the knocked down cells were generally more 
robust after exposures than normal HDF cells. Conversely, NF-κB knockdown cells 
were more sensitive to titanium dioxide than normal cells. In normal HDF cells, viability 
was affected more severely compared to untreated HDF cells when treated with silver, 
fullerol, or quantum dots. Increasing exposure time to 48 h with quantum dots, fullerols, 
and titanium dioxide also negatively affected viability, when compared to cells exposed 
for 24 h.  
 Regarding the possibility of the citrate stabilizer in the silver material we used to 
generate additional cellular toxicity, Uboldi et al. (2009) recently concluded that sodium 
citrate concentrations as high as 0.7 mM resulted in only mild toxicity by 72 h 
continuous exposure (viability 70%) (Uboldi et al., 2009). They found their data to be 
consistent with other findings regarding the use of sodium citrate to stabilize 
nanoparticle suspensions (Connor et al., 2005; Shukla et al., 2005). 
 
3.3.3. Glutathione oxidation assay  
Glutathione (GSH) plays an important role in antioxidant defense in eukaryotic 
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Fig. 3.5.  GSH conversion in response to exposures. Oxidized GSH was measured in normal 
and NF-κB knockdown HDF cells after 20 ppm nanoparticle treatment for 1 h.  Responses from 
untreated cells were also included for comparison purposes.  The assay is based on a luciferin 
conversion reaction catalyzed by glutathione-S-transferase.  *Statistically significant (p<0.05) 
compared to untreated, cell-type matched cells. †Statistically significant (p<0.05) compared to 
normal HDF, treatment-matched cells. 
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cells. To assess antioxidant response after nanoparticle exposures, oxidized GSH was 
measured in normal and NF-κB knockdown cells after 20 ppm nanoparticle treatment for 
1 h (Figure 3.5). Responses from untreated cells were also included for comparison 
purposes.  Knocked down cells exhibited a greater antioxidant response after 1 h than 
normal cells when exposed to nanoparticles. Silver and titanium dioxide caused more 
GSH oxidation compared to fullerol and quantum dot-treated cells. This finding 
indicates that NF-κB plays a substantial role in antioxidant generation after nanoparticle 
exposures. Oxidative stress leads to the accumulation of oxidized glutathione (GSSG), 
thus GSSG measurements can be used as an indicator of cellular antioxidant protection 
effort. GSH experiments were done in quadruplicate.  
 
3.3.4. Gene expression analysis  
 In general, the 24 h time point revealed much higher upregulation of immune 
response related genes after nanoparticle exposures (Figure 3.6).  This trend was 
opposite for HMOX1 and TLR3, however. Upregulation of genes was similar between 
particle types, except for HMOX-1, which was only significantly upregulated with silver 
exposures. IL-1 family proteins were influenced most. Upregulation of IL-1 family and 
other genes in normal cells exposed to nanoparticles occurred at 24 h, with the exception 
of HMOX-1, which was induced at 24 h, but even more so at the earlier 8 h time point. 
 Analyzing this data by gene function reveals more trends. Many of the genes 
assayed belong to the IL-1/TLR families and are involved in pathways of inflammation  
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8 h 24 h
silver fullerol
quantum
dot
titanium 
dioxide
silver fullerol
quantum
dot
titanium 
dioxide
0.787051 1.211301 1.013124 1.02573 C5 0.822634 1.76545 1.122325 1.45233
0.678842 0.798502 0.867781 0.94385 CASP1 1.202008 1.713478 1.398478 1.062551
1.181734 0.846405 0.883879 1.051487 CASP4 1.281375 1.269965 0.999482 1.033253
0.807926 0.620606 0.770603 0.878257 CCL2 0.955503 0.824657 1.071036 1.360168
0.648396 0.995355 0.807837 0.715519 CCR3 1.013537 0.912837 0.242431 0.745969
1.117703 1.014018 1.0133 1.050887 CD55 1.944037 2.259959 1.50254 0.949858
0.945798 0.626212 0.774316 0.837511 CHUK 1.757865 1.59291 1.283451 0.770262
0.65388 1.12919 0.933772 0.963171 COLEC12 0.877244 1.441902 0.971321 0.810629
0.545163 1.106976 0.917183 1.13946 FN1 1.685278 2.240159 1.762759 1.732216
27.62624 1.134066 0.739606 0.795604 HMOX1 11.15652 1.789593 1.47583 0.627373
0.48317 0.955931 0.862369 1.01174 IFNA1 1.129738 1.342659 1.455518 2.157943
0.946122 1.02411 0.691254 0.915071 IFNGR1 1.311767 1.615386 1.491095 1.331356
0.90871 0.759634 0.86652 0.824512 IFNGR2 0.904378 1.698645 1.726759 1.417314
0.919781 1.202393 1.000195 1.138626 IKBKB 1.124253 2.259182 1.151727 1.683708
0.785339 1.233687 0.502482 1.344926 IL10 1.455074 1.075551 0.682485 1.896191
0.604935 1.261321 1.360976 0.791104 IL1A 5.126188 2.258488 2.374054 2.181059
0.77767 0.79801 0.550142 1.089502 IL1B 4.239394 1.898308 1.257041 2.264511
0.281275 1.324322 0.967479 0.521844 IL1F7 29.4958 14.72715 13.95561 36.11215
0.650817 0.825178 0.857081 0.930799 IL1R1 0.629524 1.555087 1.165923 0.960521
0.919686 1.664466 1.027052 1.364563 IL1RAP 1.987711 2.388127 1.327138 2.130558
1.112131 0.653168 0.991762 0.558336 IL1RL2 0.402954 1.637586 1.086281 1.204675
1.515109 0.814319 0.878784 0.76937 IL6 2.644589 2.418571 1.575249 1.080797
0.889451 1.196182 1.180819 1.876057 IRAK1 2.705934 2.290316 3.190869 3.198401
0.768085 0.580344 0.700698 0.644157 IRAK2 1.389267 0.63022 0.739464 0.820053
0.756594 1.298571 0.819848 1.206801 IRF1 0.765784 1.544705 1.454166 1.81314
0.841934 1.045441 0.847914 1.036783 LY96 1.81717 1.237528 1.093432 0.899157
0.728868 1.054536 0.920605 1.148761 MAPK14 1.263439 1.582953 1.48081 1.509829
0.778221 0.849029 0.940049 0.937174 MAPK8 1.557534 1.809499 1.575276 1.626119
0.93551 1.197374 0.998168 1.161725 MIF 1.669149 1.350508 1.085726 0.904124
0.769521 1.181326 1.180256 1.335096 MYD88 1.24971 1.742725 1.447172 1.784793
0.896798 0.901125 0.947684 0.902348 NFKB1 1.470511 1.298193 1.163194 0.802748
0.717022 1.292488 1.136991 1.288661 NFKB2 1.176044 1.768422 2.209136 1.356279
1.116988 1.034316 0.954438 0.995678 NFKBIA 1.014645 1.113415 1.113239 0.651718
0.366926 0.520977 0.813178 0.526272 NLRC4 1.91061 2.593054 1.993877 0.552395
0.788943 1.092441 0.797687 1.079198 SERPINE1 0.976771 1.473657 0.883685 1.296018
0.871343 1.033701 1.008989 1.135116 TGFB1 0.935146 1.548684 1.617412 1.765136
1.169104 2.587712 1.795992 1.920357 TLR3 0.744295 1.416087 1.379311 0.837324
1.134687 0.852946 0.930954 0.994483 TLR4 1.089543 1.005989 0.948598 0.87283
1.085593 1.84119 1.361282 0.969709 TLR6 1.278049 1.866017 1.377679 1.277796
0.895048 1.105621 0.9029 1.003586 TNFRSF1A 0.836797 1.133501 0.860867 0.36636
1.155955 0.707624 1.016029 0.753886 TOLLIP 1.389288 1.320937 1.216123 0.645548
1.133074 0.773713 0.979341 0.791635 TRAF6 1.374759 1.57876 1.376951 0.923974
 
 
Fig. 3.6.  Immune gene expression. Heat map of pathway-specific gene expression changes in 
normal HDF. Central column shows genes in bold, columns to the left and right show fold 
change in expression levels in response to the 20 ppm treatment (labeled at top), compared to 
untreated controls assessed at the same time point (8 or 24 h). Fold suppressions of <0.5 are 
colored dark green and 0.5-0.8 light green. Fold inductions of 1.2-2.0 are pink and >2.0 red.   
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and innate pattern recognition. TLR-6 message is upregulated at the later time point for 
all particles. The TLR-6 protein heterodimerizes with TLR-2 for surveillance of 
microbial moieties, primarily diacyl lipopeptides. The robust response of IL-1α and IL-1 
family member 7 messages after prolonged exposure shows preparation for 
inflammation. Targeted recruitment of monocytes through CCL2 is not strong, however. 
Neither the early nor the later time point recorded upregulation of the NF-κB inhibitor, 
NFKBIA, in fact it was downregulated in the 24 h titanium dioxide experiment. 
 
3.3.5. Protein expression alteration 
 As determined via western blot, NF-κB knockdown cells inhibit NF-κB nuclear 
translocation, preventing subsequent DNA binding and genetic upregulation; therefore, 
these cells were determined to be appropriate to assess the role of NF-κB after 
nanoparticle exposures (Figure 3.7). Real time PCR analysis of immune gene mRNA 
levels of cells treated with the empty pLPCX retroviral vectors confirmed that the gene 
knockdown system was not altering genes itself (data not shown).  
In assessing early transcription factor involvement, the severity of the NF-
κB/ERK response in nanoparticle-treated cells is as follows: silver>fullerol>quantum 
dot>titanium dioxide. ERK1/2 upregulation either precedes or is nearly concurrent with 
phosphorylation of the NF-κB inhibitor, IκBα, in silver, fullerol, and titanium dioxide-
treated cells, but not quantum dot-treated cells (Figure 3.8). Suppression of IκB 
phosphorylation suggests that NF-κB inhibition occurs. Induction of phosphorylated p38 
is seen at both time points after exposure to all four nanoparticle-types.  
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Figure 3.7. Differential NF-κB expression before and after NF-κB inhibition in HDF. 
Insertion of NF-κB inhibitor, IκB, or empty vector, which exerts antibiotic resistance, but 
absence of protein overexpression capability, were all probed for p65 NF-κB expression. While 
both cell types show the presence of NF-κB in cytosolic fractions, IκB overexpressed cells reveal 
no detectable NF-κB within the nucleus.  
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Fig. 3.8.  Early transcription factor stimulation. To determine nanoparticle-specific 
differences in early transcription factor modulation, NF-κB inhibitor, IKBα, and ERK1/2 MAP 
kinase modulation in normal HDF was assessed after 20 ppm nanoparticle exposure over 5-240 
min (A). Blots are grouped by nanoparticle type. GAPDH assured equal protein loading. Blots 
are representative of three identical experiments. Densitometric analysis was carried out to 
determine significance of p-IKBα (B) and p-ERK1/2 (C) expression differences in western blot 
results. Graphed results were normalized to GAPDH loading control and significance was 
compared between zero and all other exposure time points (zero equals untreated). *Statistically 
significant (p-val < 0.05).  
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Fig. 3.9.  Downstream protein expression. Western blot analysis of NF-κB pathway-related 
protein expression after 8 and 24 h exposure to 20 ppm silver, fullerol, quantum dot, and 
titanium dioxide. Phosphorylated p38, HMOX-1, and IL-1α protein levels were assessed in both 
normal and NF-κB knockdown HDF cells (A). GAPDH assured equal protein loading. Blots are 
representative of three identical experiments. Densitometric analysis was carried out to 
determine significance of p-p38 (B), HMOX-1 (C), and IL-1α (D) expression differences in 
western blot results. Graphed results were normalized to GAPDH loading control. Significance 
between untreated and treated samples within same time point and cell type is denoted with ―*‖ 
and significance between samples at same time point and treatment, but differing cell type is 
denoted with ―†‖. *,† Statistically significant (p-val<0.05).  
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To analyze downstream protein response arising from perturbation of earlier 
transcription factor modulation, we probed for induction of phosphorylated p38, 
HMOX-1, and IL-1α (Figure 3.9). Phosphorylated p38 expression was evident after 
exposure to all four nanoparticle-types, but was notably less severe with NF-κB 
knockdown. HMOX-1 expression was limited to silver-treated cells, indicating ROS 
generation and resistance to protein damage. By 24 h, knockdown cells reveal less 
HMOX-1 induction. P38 and HMOX-1 results indicate that 24 h exposure with silver 
and quantum dots causes partial dependency upon NF-κB for oxidative stress-related 
signaling. IL-1α blots suggest that NF-κB is responsible for controlling much of the 
inflammatory response in the dermal cells tested.  
 
3.4 Discussion 
Specific, pathway-driven cellular responses to nanoparticle exposures need to be 
further elucidated for improved drug delivery, immune/inflammatory response 
mechanism elucidation, and gathering of basic toxicological response data. Studies 
comparing multiple nanoparticle types and probing for specific uptake mechanisms and 
distinct signaling pathway responses are needed to assess the effects of altering unique 
physicochemical characteristics of particles, such as chemical composition, size, and 
surface charge on appropriately dosed cell and tissues in culture.  
This research describes a unique systematic investigation designed to assess the 
impact of a key inflammatory response mediator, namely NF-κB, after exposure to a 
panel of nanoparticle-types in human skin cells. It is important to note that the cell type 
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used in the assays was primary in nature, thus the results reported in this study are a 
better representation of an in vivo hazard assessment when compared to results obtained 
from an immortalized cell line. Lastly, these studies were conducted using very low 
doses and, thus, may be more physiologically relevant than results from studies that use 
higher dosing concentrations.  
A summary of experiments is outlined in an experimental flowchart (Figure 3.1). 
The left side (black text) of the chart represents experiments with normal, primary HDF 
cells, whereas the right side (red text) explains experiments carried out with virally 
transduced NF-κB knockdown HDF cells. We utilized a step-wise approach, beginning 
with coarse analyses of viability and antioxidant depletion.  Then, we examined the finer 
analyses of gene and protein modulation. Investigations with knockdown cells were 
critical to determine the amount of NF-κB contribution after treatments, therefore 
helping to elucidate one of the primary immune and inflammatory response mechanisms 
in nanoparticle exposures. By analyzing resultant response data, we were able to make 
several speculations regarding the relationship between nanoparticle characteristics and 
cellular stress or inflammatory response outcomes.  
The characteristics of every particle-type used in these studies were measured for 
size and agglomeration state, surface charge, purity, density, and crystallinity. These 
particles were selected because they were (1) produced in the liquid-phase with specific 
surface modifications to remain as suspensions in the aqueous phase for longer than 30 
days on the shelf and (2) engineered to be of equivalent primary particle size. The silver 
particles were citrate stabilized, the fullerols were fully hydroxylated, the quantum dots 
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were modified with carboxyl acid groups, and the titanium dioxide particles were 
functionalized with acetic acid groups. While these particles were designed to be water-
suspendable and intended to remain at a primary size of ~20 nm, the physiologic fluid 
(i.e. cell culture media) significantly changed the zeta potential of the particles.  The 
change in zeta potential influenced a change in the suspension iso-electric point, which 
is defined as the pH at which a particle has no net charge. Changes in iso-electric point 
cause particles that, under ultrapure water conditions, are normally monodisperse to 
agglomerate and fall out of suspension at differential rates. Here, we observed the silver 
particles to settle at a much faster rate than any of the other particles. Therefore, the 
direct interaction between these nanoparticles and the HDF cells took place over a longer 
time period and with a greater concentration of particles when compared to the other 
particle-types used in the study. These observations (combined with the increased 
propensity to produce ROS) led to the heightened NF-κB/ERK response in the cells after 
exposure to silver.  Interestingly, even though titanium dioxide also induced high levels 
of GSSG, the NF-κB/ERK response in these cells was not elevated. This result further 
emphasizes that ROS production is not the only physicochemical property of 
nanoparticles responsible for toxicological response; instead, multiple physicochemical 
properties often act synergistically or antagonistically to produce a range of biological 
responses. 
Each of the four particles exhibits different physicochemical properties, either in 
size, charge, or density, that correlate to other results found in this study. For example, 
the density of silver is much greater than that of the other particles; Quantum dots 
  
88 
acquire a relatively neutral surface charge in media, but remain very small compared to 
the other three particles; Fullerols agglomerate similarly in water compared to silver, but 
exhibit a highly negative surface charge early, which could cause an increase in 
interaction with biological components, such as cell membranes. 
We previously reported that quantum dots modulated the transcription factor NF-
κB in HDF cells (Romoser et al., 2011b). Lee et al. found that upregulation of ERK1/2 
occurred in monocytes, THC-1 cells, and BALB/c mice after exposures to CdSe/ZnS 
quantum dots (Lee et al., 2009). There are conflicting data in the literature reporting both 
pro- and anti-oxidant properties after fullerol exposures. C60 fullerenes have been 
shown to be toxic to HDF cells, but hydroxylated fullerenes have not been tested in 
dermal cells (Sayes et al., 2004; Sayes et al., 2005). As for silver, Rolla et al. found in a 
multi-nanoparticle study assessing possible modulation of many cellular signaling 
pathways that silver significantly downregulated the SMAD/TGF-β pathways, but 
upregulated the HIF-1α pathway (Rallo et al., 2011). Titanium dioxide has been shown 
to modulate the NF-κB pathway in both NIH-3T3 and BAES-2B cells exposed to 10 
ng/mL and 10 μg/mL, respectively (Chen et al., 2011; Ge et al., 2011). These studies 
tested aggregated P25 Degussa particles however, unlike the present study.  
To evaluate the response to nanoparticles in normal cells, we assayed 
transcriptional response via a RT-PCR gene array, as well as translational activity by 
way of protein analysis. A theme that emerges in the immune-transcriptional profile of 
cells treated with any of the assayed nanoparticles is a preparation for inflammation. 
Those that were upregulated were pattern recognition receptors (PRRs), their signal 
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transduction machinery, inflammatory cytokines, and their receptors. Not only was 
inflammation induced, but transcripts were prepared to put the cell on a hair-trigger to 
escalate this response. TLR messages were upregulated to survey for pathogen-
associated molecular patterns (PAMPs). NF-κB message levels were up and its 
inhibitors levels were down. MYD88 was prepared to convey recognition of a threat by a 
PRR. The MAP kinase cascade was primed. The complement cascade was attenuated 
(via CD55/Decay-accelerating factor) in favor of general inflammation. Additionally, 
IL-1 message levels increased, initiating the inflammatory cascade.   
In evaluating early transcription factor activity, it was evident that the MAP 
kinase protein ERK1/2 was upregulated very early (within a few minutes of exposure) in 
the case of each type of nanoparticle exposure. Phosphorylation of IκB seemed to either 
be concurrent with or immediately followed ERK1/2 activation. Guma et al has recently 
reported that in mice NF-κB does not trigger destructive inflammation unless MAPKs 
(ERK and p38) are concurrently expressed (Guma et al., 2011). Silver-treated cells 
continued to cause upregulation of this signal transduction protein, which was possibly 
due to its relatively dense nature (see Table 3.1) and ability to settle out faster than the 
other particles. This density-dependent property of silver potentially exposed the cells to 
a greater concentration of particles over time.  
To assess the extent of NF-κB dependency in cells exposed to a variety of 
nanoparticles, we analyzed differences in viability, antioxidant depletion, and 
downstream protein upregulation between knockdown and normal dermal cells. To 
avoid confounding toxicological effects that can occur with the use of pathway inhibitors 
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as a method to silence a particular cellular pathway, we virally transduced our cells to 
specifically overexpress IκBα. In the viability assay, NF-κB knockdown cells were more 
resistant to death when treated with silver, fullerol, or quantum dots, however, when 
exposed to titanium dioxide exhibited an opposite trend. NF-κB is known to play a role 
in apoptosis and may be delaying or preventing apoptosis in these nanoparticle-treated 
cells. Decreased cell death in knockdown cells may also be partially due to decreased 
nanoparticle uptake, as compared to normal HDF (data not shown). Our antioxidant data 
suggests that NF-κB knockdown cells are hypersensitive to insult, compared to normal 
cells, and allow more antioxidant involvement (increase in GSSH) to occur, possibly 
protecting cells from ROS generated from nanoparticles and nanoparticle-cell 
interaction. In other words, NF-κB may be acting to suppress some of the antioxidant 
response in cells exposed to NPs. We observed that silver was more dense and 
precipitated out of the media, possibly resulting in higher exposures. That, combined 
with the fact that titanium dioxide was the only positively charged particle in the study, 
may be reasons for the exaggerated GSH responses with silver and titanium dioxide 
exposures. As for differences in downstream protein expression, phosphorylation of p38 
was evident after exposure to all four NP types, but was notably less severe with NF-κB 
knockdown. This finding coincides with earlier studies, which have shown in vivo that 
NF-κB inhibition can lead to anti-inflammatory effects (Broide et al., 2005; Greten et al., 
2004). P38 is phosphorylated in response to IL-1 upregulation and further aids in 
activation of IL-6 (see Figure 3.10). Phosphorylation of p38 and JNK leads to activation  
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Fig. 3.10.  NF-κB pathway schematic. Proposed schematic of HDF NF-κB pathway and related 
protein involvement after nanoparticle exposures. Protein classification is denoted as such: 
kinase=pentagon; transcription factor=hexagon; cytokine=diamond; and other proteins=oval. 
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of NF-κB and inflammatory response. This cascade is driven by ROS and results in 
downstream upregulation of inflammatory cytokines, such as IL-6, which was 
upregulated in the gene expression analysis at the later time point with all nanoparticles 
except titanium dioxide. P38 and HMOX-1 results indicate that 24 h exposure with 
silver and quantum dot causes partial dependency upon NF-κB for oxidative stress-
related signaling. These findings, along with the IL-1α protein levels, suggest that NF-
κB is responsible for controlling the majority of the inflammatory response in the dermal 
cells tested. 
The HDF system employed here allowed for the cellular and molecular analysis 
of potential immunotoxicological pathways triggered by relevant exposures to 
chemically and physically disparate nanoparticles (Benn et al., 2011; Gopee et al., 2009). 
Such carefully chosen in vitro approaches should expedite and direct subsequent in vivo 
studies to evaluate the safety of these materials. 
Salient points to be learned from this research: 
 All nanoparticle types caused transient NF-κB and ERK1/2 responses, with the 
exception of silver, which caused prolonged expression of these proteins. 
 NF-κB functions in the oxidative stress response of normal cells by allowing less 
antioxidant response, thus increased induction of oxidative stress proteins. 
Questions remaining unanswered: 
 What other mechanisms of toxicity develop as a result of nanoparticle exposure? 
 Does nanoparticle-induced oxidative stress lead to DNA damage? 
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CHAPTER IV 
LOW DOSE EXPOSURES WITH ROS-PRODUCING METAL OXIDE 
NANOPARTICLES CAUSE DNA DAMAGE IN PRIMARY HUMAN DERMAL 
FIBROBLASTS 
 
4.1 Introduction 
Nanomaterials are defined as materials that have at least one dimension between 
1-100 nm (1 nm = 10
-9
 m) and typically exhibit physicochemical properties not shared 
by coarser particles of the same chemical composition (2004; Hansen et al., 2007; 
Nanoscale Science Engineering and Technology Subcommittee, 2004; 2004). The actual 
size threshold whereby these new properties can be seen is still a matter of debate and 
one study has reported that 30 nm and less for metal and metal-oxide particles is nearer 
to the point at which this phenomenon actually occurs (Auffan et al., 2009a). At this 
scale, the much larger particle surface-to-volume ratio plays a significant role in 
interaction at the biological interface. Due to the 'non-bulk' properties of nanoparticles, 
including their atypical surface structure and surface reactivity, processes such as 
dissolution, redox reactions and the generation of reactive oxygen species may be 
enhanced. Such properties may elicit biological responses that would not be produced by 
larger particles of the same chemical composition. Nanotechnology is among the fastest 
growing areas of scientific research and has important applications in a wide variety of 
fields. The nanotechnology industry is expected to generate revenues between $2.6 
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trillion and $3.1 trillion by the years 2014 and 2015, respectively (Dai, 2010; Schmidt, 
2009). 
Nanoparticles are present in many products that come into contact with human 
skin. Relevant to this research, titanium dioxide (TiO2) and zinc oxide (ZnO) are present 
in many sunscreens to protect against UV-induced skin damage. Metal oxides do not 
undergo any chemical decomposition as organic compounds do when exposed to UV 
radiation, which makes them an attractive alternative (Damiani et al., 1999; Knowland et 
al., 1993). Additionally, they offer a more complete range of protection compared to 
other products of organic nature (Mitchnick et al., 1999; Serpone et al., 2007). Recently, 
more products for dermal application utilize finer, nano-sized TiO2 and ZnO since they 
are transparent and more esthetically pleasing to consumers at this size. TiO2 
nanoparticles are also used in other products that present dermal contact exposures, such 
as clothing and surface cleaning agents. CeO2 nanoparticles have proposed and current 
uses in the areas of biomedicine, cosmetic products, polishing materials, and automotive 
fuel additives (Hochino et al., 2001; Jung et al., 2004; Masui et al., 2003; Yabe and Sato, 
2003). Opportunities for these types of nanoparticle exposures are increasing on a daily 
basis (Crosera et al., 2009), as the products containing these materials are quite common 
and society is increasingly aware of the importance of UV protection, in general, and the 
use of improved materials.  Since little is known regarding the mechanisms of toxicity 
for these materials, more research is necessary. The data that has been presented up to 
now in the literature is sparse and contradictory regarding the effects of nanoparticle 
exposure in dermal models. 
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Only a handful of studies in the literature have investigated the ability of 
nanoparticles to penetrate skin (Baroli et al., 2007; Chen and Schluesener, 2008; EPA, 
2007; Filon et al., 2006; Gopee et al., 2009; Isakovic et al., 2006; Kielhorn et al., 2006; 
Mortensen et al., 2008; Oberdorster et al., 2005; Rouse et al., 2007; Samberg et al., 
2010; Senzui et al., 2010; Xia et al., 2010; Zhang and Monteiro-Riviere, 2008) The skin 
is often considered less permeable and the risk perception by this route is generally less 
than that of respiratory exposure (Donaldson et al., 2006; Limbach et al., 2007; Nel et 
al., 2006; Oberdorster et al., 2005; Shimada et al., 2006). However, in the literature there 
are studies which suggest that the skin is an important route of entry for nanoparticles 
both in occupational and consumer settings (Gopee et al., 2009; Mortensen et al., 2008; 
Ryman-Rasmussen et al., 2006; Sonavane et al., 2008; Vogt et al., 2006) and it has been 
specifically shown that certain particles are more prone to dermal penetration based 
upon their physicochemical properties or the nature of the vehicle they are suspended in 
(Xia et al., 2010). Bennat and Mϋller-Goymann (2000) found that different formulations 
had different penetration abilities: according to their experiments, microfine TiO2 
penetrated deeper into human skin from an oily dispersion than from an aqueous one, 
and encapsulation of the pigments into liposomes caused a higher penetration into the 
skin (Bennat and Muller-Goymann, 2000). Furthermore, penetration was greater when 
applied to hairy skin, suggesting a surface penetration through hair follicles or pores. 
Recently, studies have emerged that have actually quantified the percentage of 
nanomaterial that breached the stratum corneum and migrated further into the dermis or 
traveled to distal organ sites (Benn et al., 2011; Gopee et al., 2009; Wu et al., 2009). The 
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fate of these NPs, when applied to human skin, is still not completely understood, 
however. In particular, the damage to resident fibroblasts that are numerous and most 
capable of immune excitation is poorly understood. 
Other specific cases of dermal nanoparticle penetration have been documented. 
For example, it has been concluded that quantum dots can penetrate through the 
epidermis into the dermis, especially with flexing of the skin or by way of hair follicle 
(Mortensen et al., 2008; Zhang and Monteiro-Riviere, 2008). Microscopy from these 
publications revealed that a considerable portion of the dose penetrated to the dermis. 
Silver is currently being utilized as an antimicrobial agent in many dermal applications 
and has been found to penetrate both intact and damaged skin (Filon et al., 2009; 
Samberg et al., 2010). Titanium dioxide, a common ingredient in sunscreens and 
cosmetics, is generally recognized as safe for dermal exposure. However, while most 
titanium dioxide studies involving healthy skin report an absence of penetration, this 
may not necessarily be the case with damaged skin (Mortensen et al., 2008; Senzui et al., 
2010) and the realistic exposure may be perpetuated by mechanical flexing, irritant 
detergents, and chemicals (Filon et al., 2006; Nielsen et al., 2007) or repetitive 
application (Wu et al., 2009).  
Imbalances resulting from the production or presence of excess reactive oxygen 
species (ROS) plays an important role in numerous pathologies, such as cancer and 
aging (Droge, 2002; Halliwell, 2007; Halliwell, 2009; Toyokuni and Akatsuka, 2007). It 
is widely accepted that an excess of ROS is damaging to cellular components, including 
nucleic acids, proteins and lipids, thereby increasing the likelihood of apoptosis or 
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necrosis (Dean et al., 1997; Finkel and Holbrook, 2000). Moreover, ROS causes DNA 
damage, specifically DNA double strand breaks (DSBs), which are considered the most 
severe type of nuclear lesion (Droge, 2002; Halliwell, 2009; Thannickal and Fanburg, 
2000).  
Many proteins are involved in maintaining the cellular genomic integrity. 
Although maintaining this integrity is essential to avoid cancer initiation, limited DNA 
damage may be tolerated by the cell through a system of repair mechanisms. Should 
repair pathways fail, replication of damaged DNA may induce changes in the genetic 
sequence inherited by the daughter cells. Inability to maintain the genomic material may 
lead to accumulation of DNA damage. Loss of genome integrity further leads to changes 
in gene expression, resulting from deletions or duplications. Several different repair 
pathways, equipped with precisely-tuned sensing mechanisms, are present in eukaryotic 
cells and specific to the type of damage that is present. 
Induction of DNA damage or replicative stress triggers a complex network of 
proteins known collectively as the DNA damage response (DDR). DNA damage is 
recognized by sensor proteins that recruit and activate transducer and effector or 
mediator proteins, inducing those which control cell cycle progression (Petrini and 
Stracker, 2003). This signaling cascade may induce cell cycle arrest to allow time for 
DNA repair or cell death via apoptotic mechanisms.  
DSBs can lead to phosphorylation of H2AX as part of the DNA damage response 
(Hanasoge and Ljungman, 2007). Histone H2AX, a variant histone that represents 
approximately 10% of the total H2A histone proteins in normal human fibroblasts, is 
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required for checkpoint-mediated cell cycle arrest and DNA repair following double-
stranded DNA breaks (Yuan et al, 2010) The phosphorylation signal on histone H2AX 
functions as a scaffold for the recruitment of repair factors to the site of the strand break 
(Elvers, 2011). The phosphorylated form of H2AX is denoted as γ-H2AX. 
Both ATM and ATR are known to phosphorylate BRCA1, as well as p53 (Cortez 
et al., 1999; Siliciano et al., 1997; Tibbetts et al., 1999), allowing for nucleotide excision 
repair (NER) to occur (Ford and Hanawalt, 1995, 1997). But the DDR pathway can also 
function independently of p53. The p38 MAPK pathway is activated in response to a 
variety of environmental stressors (UV, ionizing radiation, and oxidative stress), as well 
as inflammatory cytokines (e.g. TNFα) (Zarubin and Han, 2005). Interestingly, although 
activation of the p38 MAPK pathway by cytokines and receptor ligands normally leads 
to cell differentiation, activation of p38 MAPK through environmental stress can 
mediate cell death. In response to DNA damage stimuli that induce DSBs, it has been 
shown only within the last decade that activation of p38 MAPK can lead to the induction 
of a G2/M cell cycle checkpoint through p53-dependent and independent mechanisms 
(Bulavin et al., 2001; Kurosu et al., 2005; Mikhailov et al., 2005; She et al., 2001; She et 
al., 2000; Thornton and Rincon, 2009). Specifically, p38 phosphorylates CDC25B and 
CDC25C via MK2, which induces cell cycle arrest after UV exposures (Manke et al., 
2005) and other DNA damaging agents (Reinhardt et al., 2007). Involvement of p38 in 
the DDR has been shown with both single-walled carbon nanotubes (Pacurari et al., 
2008) and silver nanoparticles (Eom and Choi, 2010). This is the first body of work, 
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however, that outlines the DDR pathway mechanism in such detail for CeO2, TiO2, and 
ZnO. 
Few studies have been published which investigate the ability of CeO2, TiO2, or 
ZnO to cause DNA damage (Auffan et al., 2009b; Prasad et al., 2009; Sharma et al., 
2011; Trouiller et al., 2009). As mentioned before, this data is fairly inconsistent and 
needs further investigation. More specifically, additional information is needed 
regarding the mechanism by which these particles exert DNA damage, if at all. Trouiller 
et al reported that mice given Degussa P25 TiO2 in drinking water gave rise to γ-H2AX-
positive cells, but at high doses of 50-500 ppm, among which micronuclei formed at the 
highest 500 ppm concentration (Trouiller et al., 2009). Another study using TiO2 and 
ZnO in a dermal context found that their particles could catalyze oxidative damage to 
DNA (determined via the comet assay) in cultured human fibroblasts (Dunford et al., 
1997). Sharma et al also reported significant DNA damage from comet assay results in 
primary human keratinocytes with 14 ppm ZnO (Sharma et al., 2011). Auffan et al found 
that, in human dermal fibroblasts, a concentration as low as 6 ppm could induce 
significant SSBs and binucleate cells (Auffan et al., 2009b). Furthermore, a study of the 
mechanistic effects of DNA damage response is needed on a more detailed level, while 
considering the nanoparticle physicochemical property influences. 
Several studies have shown recently that some nanoparticles can cause cell cycle 
arrest in response to DNA damage. For example, G1 arrest was observed in mouse lung 
epithelial cells exposed to C60 and SWCNT (Jacobsen et al., 2008), and carbon black 
coated with benzo(a)pyrene gave rise to S-phase arrest in human lung epithelial cells 
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(Mroz et al., 2007). Additionally, AshaRani et al. reported that starch-coated silver NPs 
induced concentration-dependent G2/M phase arrest and DNA damage in human 
glioblastoma cells and fibroblasts (AshaRani et al., 2009). Silver NPs were also found to 
induce S and G2/M phase arrest in Jurkat T cells (Eom and Choi, 2010), but G1 arrest in 
RAW264.7 macrophages (Park et al., 2010) using similar concentrations of 
nanomaterials. Additionally, SiO2 NPs induced G2/M arrest in human embryonic 
embryo cells (Wang et al., 2009). A perturbation of the cell cycle associated with an 
accumulation of cells in S-phase leading to cell death, is typical of compounds inhibiting 
DNA synthesis (Binková et al., 2000; Black et al., 1989). Eukaryotic cells enter mitosis 
via cdc2 kinase activation, a process which includes cyclin binding and phosphorylation 
of cdc2 at Thr161 (Atherton-Fessler et al., 1994). However, activation of cdc2 during 
progression into mitosis requires the critical regulatory step of dephosphorylation of 
cdc2 at Tyr15 and Thr14 (Norbury et al., 1991). Therefore, cells arrested or partially 
arrested in the S-phase leading up to the G2/M phase will express higher levels of p-cdc2 
(Tyr15). 
This work is an effort to elucidate the DDR mechanism potential in a dermal 
model exposed to three metal oxide nanomaterials, while considering the influence of 
physicochemical characteristics of the nanoparticles. We hypothesize that smaller 
particle agglomerates and their corresponding large zeta potentials will generate more 
ROS-driven DNA damage, as compared to nanoparticles which have agglomerated more 
severely. In this study, changes in viability and protein expression are measured, as well 
as differences in ROS generation, resulting DNA damage and cell cycle arrest. These 
  
101 
studies examining the toxicological effects stemming from nanoparticle exposure are 
examined utilizing an in vitro system to model human health effects.  
 
4.2 Methods 
4.2.1. Nanoparticle characterization 
Cerium oxide (Sigma Aldrich, St. Louis, MO), titanium dioxide (Evonik, 
Parsippany, NJ), and zinc oxide (Sigma Aldrich) hydrodynamic diameter and zeta 
potential were measured using a Zeta Sizer Nano Series ZEN 3600 Spectrometer 
(Malvern Instruments Ltd, Malvern, Worcestershire, UK).  Particle characterization was 
performed on the particles suspended in Milli-Q ultrapure water (18.2 mΩ), as well as in 
DMEM supplemented with 10% FBS at 0, 24, and 48 h time points. Manufacturer‘s 
reported primary particle size was <25 nm, 21 nm, and <100 nm for CeO2, TiO2, and 
ZnO, respectively. TEM analysis was done to determine the primary particle size of the 
three particle types. BET analysis using an accelerated surface area and porosimetry 
analyzer was employed to determine the surface area of the three particle types 
(Micromeretics Instrument Corporation, ASAP202, Norcross, GA). Prior to analysis, 
samples were degassed at 110°C for 2 h. 
 
4.2.2. Cell culture and experimental dosing 
Cryopreserved primary human dermal fibroblasts (HDF) cells (PCS-201-010, 
ATCC, Manassas, VA) were cultured in Dulbecco‘s Modified Eagle‘s Medium 
supplemented with 10% FBS (Gibco, Austria). Media was supplemented with an 
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antibiotic cocktail consisting of penicillin, streptomycin, and amphotericin (Sigma-
Aldrich). Incubation took place at 37°C with humidity and 5% CO2. Cells were grown to 
80% confluency in well plates, then exposed to nanoparticles (20 ppm final exposure 
concentrations) or untreated for a negative control. Cells treated with nanoparticle 
suspensions were very briefly exposed to light in the cell culture hood at the points of 
exposure and harvesting. Cellular incubations with nanoparticles took place in the dark. 
 
4.2.3. Cell viability 
HDF cells were cultured in 24-well plates, as described above.  Cells were then 
exposed to CeO2, TiO2, or ZnO to give final well concentrations of 0, 10, 50, 150, 200 or 
500 ppm to generate dose-response data. Cells treated for 24 or 48 h were rinsed three 
times, trypsinized, and resuspended in cell culture media. Percentages of viable cells 
were measured by mixing equal volumes of cell suspension and trypan blue stain, 
followed by membrane permeability-based counting in an automated cell counter 
(Countess, Invitrogen). Viability experiments were done in quadruplicate. A student‘s t-
test was employed to calculate significant change in viability, as compared to the 
untreated control samples.  
 
4.2.4. ROS generation 
 Intracellular oxidant production was measured after incubation with 20 ppm 
cerium oxide, titanium dioxide, or zinc oxide nanoparticles at 1, 6, and 24 hrs. Briefly, 
cells in 96-well plates were incubated with 200 μM non-fluorescent DCFH-DA (2',7'-
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dichlorfluorescein-diacetate) in DMEM with 10% FBS for 30 min, then rinsed. Freshly 
prepared nanoparticle suspensions in new media were added to the cells. The cells were 
rinsed twice in PBS before reading in DPBS. Hydrogen peroxide was utilized as a 
positive control at a concentration of 200 μM. Relative fluorescence of the enzyme-
cleaved DCFH molecule was determined in a fluorescence microplate reader (BioTek 
Synergy MX, Winooski, VT) utilizing an excitation/emission spectra of 480/530 nm. All 
responses were reported as a percentage of untreated control cells. Experiments were 
carried out with eight replicates per nanoparticle type. Additionally, separate plates of 
cultured and treated cells were imaged after 1 h exposures. Cells were imaged at a total 
magnification of 200X with an Olympus IX71 inverted fluorescence microscope (Center 
Valley, PA). Images were processed with Olympus CellSens software.  
 
4.2.5. Protein expression alteration 
HDF were cultured in the same conditions as above. Nanoparticle-treated and 
untreated cells were washed in ice cold 1X PBS, then protease inhibitor cocktail (Sigma-
Aldrich) and high salt lysis buffer were added to wells. Protein was isolated by 
collecting supernatant via centrifugation. Samples were loaded into 6-12% SDS-PAGE 
gels and run at 120 mV. Gels were transferred to PVDF membranes, which were 
blocked in 5% milk or BSA/PBST and incubated in primary antibody solutions 
overnight at a concentration of 1:1000: p-p38, (Cell Signaling Technology Danvers, 
MA), HMOX-1, (Santa Cruz Biotechnology, Santa Cruz, CA), superoxide dismutase-1 
(SOD1), (Cell Signaling Technology), p-p53, (Cell Signaling Technology), p-cdc2, (Cell 
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Signaling Technology), or H2AX, (Cell Signaling Technology). Secondary antibody 
(Goat, anti-mouse or anti-rabbit, 1:5000, Santa Cruz) was prepared in fresh 5% milk or 
BSA/PBST solution and incubated at room temperature. Immobilon™ Western 
Chemiluminescent HRP substrate (Millipore, Billerica, MA) was added to membranes 
and film exposures were taken. β-actin, 1:10,000 (Sigma, St. Louis, MO) was used as a 
loading control. Blots shown are representative of several independent experiments. 
 
4.2.6. Comet assay 
 Primary HDF were cultured as explained above and exposed to 20 ppm cerium 
oxide, titanium dioxide, or zinc oxide nanoparticles for 24 h. The Comet assay was then 
conducted under alkaline conditions. Briefly, treated cells were washed, trypsinized, and 
suspended in agarose before being placed onto comet assay slides. Slides were then 
immersed in pre-chilled lysis solution for 30 min, then placed in alkaline unwinding 
solution consisting of 200 mM NaOH and 1 mM EDTA. Slides were then drained and 
electrophoresed for 40 min at 220 mA. Slides were rinsed thoroughly in water, followed 
by a wash in 70% ethanol.  Slides were allowed to dry, then SYBR green was directly 
applied to wells. SlowFade Gold (Invitrogen, Calsbad, CA) was also applied and 
allowed to cure in the dark for 24 h to stabilize fluorescence for imaging. Seventy 
images from each sample type were selected for the experiment, which was carried out 
in duplicate. Cells were imaged at 200X total magnification with an inverted 
fluorescence microscope (Olympus IX71, Center Valley, PA). DNA damage was 
expressed as the tail moment using an image analysis computerized method 
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(CometScore, TriTek Corporation, Sumerduck, VA). A student‘s t-test was employed to 
calculate significant changes in DNA damage, as compared to the untreated control 
samples. 
 
4.2.7. Immunocytochemistry 
HDF cells were cultured on sterile coverslips in 6-well plates and exposed 
identically to the viability experiments described in 2.3. Double strand break inducer, 
etoposide, was utilized as a positive control (10 μM) for comparison purposes. Rinsed 
cells were then fixed in 4% paraformaldehyde. Cell membranes were permeabilized with 
a 0.25% (v/v) Triton X-100/PBS solution. Cells were blocked in 1% BSA/PBST with 
0.3M glycine for 30 minutes, then incubated in a 1:500 primary antibody dilution 
(gamma-H2AX, CellBiolabs) with 1% BSA/PBST for 1 hr. Goat anti-rabbit 647 
AlexaFluor labeled secondary antibody (Invitrogen, A21244) in 1% BSA/PBST was 
used at a 1:4000 dilution for 1 hr with all samples. Cells were rinsed several times and 
counterstained with 400nM DAPI for 1 min. Coverslips were mounted onto glass slides 
with a drop of ProLong SlowFade (P36934, Invitrogen). Slides were imaged at a total 
magnification of 600X with an Olympus IX71 inverted fluorescence microscope (Center 
Valley, PA). Images were processed with Olympus CellSens software.  
 
4.2.8. Cell cycle alteration  
To determine the potential presence and location of cell cycle perturbation after 
nanoparticle exposures, HDF cultured to 80% confluency in 6-well plates were treated 
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with 20 ppm nanoparticle suspensions for 6 h or 24 h. Both nanoparticle-treated cells 
and control cells treated with an equal volume of Milli-Q water were collected via 
trypsinization, centrifuged, and suspended in PBS. Cells (1 x 10
6
) were fixed in 70% 
ethanol for two hours on ice, then held at -20°C overnight before suspension in a 
propidium iodide/Triton X-100 staining solution with RNase A. Flow cytometry was 
performed using excitation and emission spectra of 488 nm and 585 nm with a FACS 
instrument (Becton Dickinson FACSCalibur, Franklin Lakes, NJ) for DNA content 
evaluation. Data was analyzed utilizing DNA content frequency histogram 
deconvolution software (ModFit LT). Dead cells and aggregates were excluded from 
analysis by gating cells in a FL2-A versus FL2-W scatter plot. 
 
4.3 Results 
4.3.1. Determination of nanoparticle size, agglomeration state, surface charge, and 
surface area 
Dynamic light scattering (DLS) and zeta potential measurements were taken at 0, 
24, and 48 h in both water and cell culture media (Table 4.1). Changes in DLS and zeta 
potential readings over time reveal trends. As zeta potential migrates further from zero 
(neutral), agglomeration state decreases. The decrease in zeta potential for TiO2 is not 
significant enough to prevent agglomeration, however. A sharp drop in ZnO zeta 
potential (-9.24, -11.05, and -34.00 at 0, 24, and 48 hrs respectively) correlates with 
decreasing particle size (249.5, 51.57, and 37.89 nm at 0, 24, and 48 hrs respectively), 
which is represented in Figure 4.1. The significantly negative zeta potential at 48 hrs is  
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Table 4.1  Nanoparticle characterization reveals trends in toxic capability. Transmission 
electron microscopy (A-C), dynamic light scattering (D), and zeta potential measurements (E) of 
20 ppm CeO2, TiO2, and ZnO in water and complete media at 0, 24 and 48 h.  
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Figure 4.1. Nanoparticle agglomeration state and zeta potential changes over time. Changes in 
zeta potential (A) and size (B) of 20 ppm CeO2, TiO2, and ZnO in media at 0, 24 and 48 hrs. The 
sharp decrease in ZnO zeta potential (-9.24, -11.05, -34.00 at 0, 24, and 48 hrs respectively) 
correlates with decreasing particle size (249.5, 51.57, and 37.89 nm at 0, 24, and 48 hrs 
respectively). The strongly negative zeta potential at 48 hrs is deviated far enough from zero to 
maintain smaller particle agglomerates. 
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deviated far enough from zero to maintain smaller particle agglomerates. BET analysis 
yielded surface area values of 50.441, 59.138, and 11.625 m
2
/g for CeO2, TiO2, and 
ZnO, respectively. These values correspond with particle size measured by TEM 
analysis. Perhaps the most important finding was that CeO2 and TiO2 remained severely 
aggregated over time in complete media, whereas ZnO aggregated initially, but 
decreased in agglomeration state over time. By 48 h, the hydrodynamic size of ZnO 
decreased nearly to its primary particle size. 
 
4.3.2. Concentration-dependent cell death 
HDF cells treated with CeO2, TiO2, and ZnO exhibited dose-dependent (10-500 
ppm) cell death, as determined via the trypan blue assay (Figure 4.2). Cell death was 
most significant with ZnO exposures, followed by TiO2 and CeO2 exposures at both 24  
and 48 h. For all particle-types, cell viability decreased significantly as a function of 
nanoparticle dose. Brightfield images, which display the differential results after 
exposure to these three materials are also provided to show changes in morphology at 6 
and 24 h (Figure 4.3).  
 
4.3.3. ROS generation and resulting oxidative stress 
 To investigate the potential role of oxidative stress as a mechanism of metal 
oxide toxicity, intracellular oxidant production was measured after incubation with 20 
ppm CeO2, TiO2, or ZnO nanoparticles. Separate plates of cells were treated and 
analyzed individually after 1 h exposures (Figure 4.4A). Differences in intracellular  
  
110 
 
A
B
0
20
40
60
80
100
120
10 50 150 200 500
Pe
rc
en
t V
ia
b
ili
ty
 (n
o
rm
al
iz
ed
 to
 u
n
d
o
se
d
 
co
n
tr
o
l c
el
ls
)
Nanoparticle Exposure Concentration (ppm)
CeO2
TiO2
ZnO
*
*
*
**
***
*
*
* **
0
20
40
60
80
100
120
10 50 150 200 500
Pe
rc
en
t V
ia
b
ili
ty
 (n
o
rm
al
iz
ed
 to
 u
n
d
o
se
d
 
co
n
tr
o
l c
el
ls
)
Nanoparticle Exposure Concentration (ppm)
CeO2
TiO2
ZnO
*
*
*
*
*** **
*
**
**
 
 
Fig. 4.2.  Cell death correlates with increasing nanoparticle exposure. Percent viability after 
10, 50, 150, 200, and 500 ppm CeO2, TiO2, and ZnO, as determined via a trypan-blue exclusion 
assay. Measurements were taken at both 24 (A) and 48 h (B) and are normalized to untreated 
cells. *Statistically significant (p<0.05) compared to untreated cells. **Statistically significant 
(p<0.001) compared to untreated cells. 
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Figure 4.3. HDF morphology differences after nanoparticle treatments. HDF treated for 
either 6 or 24 h with 20 ppm cerium oxide, titanium dioxide, or zinc oxide reveal differential 
morphological responses. Scale bar=50µm. 
 
 
  
112 
A
B H2O2Undosed
CeO2 TiO2 ZnO
0
50
100
150
200
250
300
H2O2 CeO2 TiO2 ZnO
R
F
U
 (
%
 o
f 
c
o
n
tr
o
l)
Treatment
*
**
HMOX-1
p-p38
β-actin
Unt
6 h
CeO2
6 h
TiO2
6 h
ZnO
6 h
CeO2
24 h
TiO2
24 h
ZnO
24 h
Unt
24 h
SOD1
β-actin
C
 
Fig. 4.4. Nanoparticle-driven ROS generation and oxidative stress. Intracellular oxidant 
production was measured after incubation with 20 ppm cerium oxide, titanium dioxide, or zinc 
oxide nanoparticles at 1 h (A). Fluorescence images correspond to graph (B). Hydrogen peroxide 
was utilized as a positive control at a concentration of 200 μM. All responses were reported as a 
percentage of untreated control cells. *Statistically significant (p<0.05) compared to untreated 
cells. Upregulation of oxidative stress proteins was measured via western blot after 6 and 24 h 
exposure to 20 ppm CeO2, TiO2, and ZnO (C). Phosphorylated p38, HMOX-1, and SOD1 
protein levels were assessed in primary HDF cells following these exposures. β-actin served as a 
loading control. Blots are representative of three identical experiments. 
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oxidant production were observed with CeO2 and ZnO exposures, which caused 
increases in ROS generation, as compared to untreated cells. H2O2 (200 µM) was also 
utilized as a positive control. All treated samples were normalized to untreated cells. 
Fluorescence was also measured at 6 and 24 h (data not shown), but fluorescence 
intensity was slightly higher at the 1 h time point. Representative images of cells 
processed identically to those read photospectrometrically are provided (Figure 4.4B). 
 Western blot analysis was performed to assess specific perturbation of oxidative 
stress proteins (Figure 4.4C). HDF were exposed for 6 and 24 h to CeO2, TiO2, and ZnO. 
Oxidative stress, as indicated by an increase in HMOX-1, is upregulated at 6 and 24 h 
with exposure to ZnO. A similar trend was evident with the phosphorylation of oxidative 
stress and DNA damage protein, p38, where ZnO induced a distinct isoform of the 
protein. Induction in lysates at 24 h was similar to untreated cells, except in ZnO-treated  
cells. SOD1 was upregulated with CeO2 exposure, as compared to untreated control 
cells. This finding was most obvious at 6 h. 
 
4.3.4. Nanoparticle induced DNA damage  
A combination of single and double stand break DNA damage was measured in a 
comet assay (Figure 4.5A). HDF cells were exposed to 20 ppm CeO2, TiO2, and ZnO. 
Damage was measured after 24 hrs and is reported as tail moment. An untreated control 
was included for comparison. ZnO caused the most significant amount of strand breaks. 
Representative images are included for comparison (Figure 4.5B). 
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Fig. 4.5. Calculation of DNA strand break damage. Single and double stand break DNA 
damage was assayed after HDF cells were exposed to 20 ppm CeO2, TiO2, or ZnO (A). Cells 
were analyzed after 24 h exposure in a comet assay. Undosed control cells were included for 
normalization purposes. Seventy cells were imaged per treatment group. Representative images 
from each treatment group are included (B). *Statistically significant (p<0.05) compared to 
untreated cells. **Statistically significant (p<0.001) compared to untreated cells. Western blot 
analysis of DDR pathway-related protein expression after 6 and 24 h exposure to 20 ppm CeO2, 
TiO2, and ZnO was performed (C). Activation of γ-H2AX histone variant, as well as 
phosphorylation levels of p53 and cdc2 were investigated and compared to untreated control 
cells. β-actin served as a loading control. Blots are representative of three identical experiments. 
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 Western blot analysis was performed to assess specific perturbation of DDR 
pathway proteins (Figure 4.5C). Cdc2, a marker of cell cycle progression to mitosis is 
also phosphorylated in both ZnO-treated samples and slightly with TiO2 treatment at the 
later time point. The cell cycle is allowed to progress to mitosis when cdc2 becomes 
dephosphoylated at Tyr15. Therefore, an accumulation of p-cdc2 indicates halting in the 
S-phase. Specific double strand break repair protein γ-H2AX is only induced with 24 h 
ZnO treatment. A lack of expression of activated H2AX with the other nanoparticles 
suggests that ZnO is the only particle type that induces DSBs. This damage pathway is 
p53-independent, as notable changes in band intensity were absent for this protein at 6 
and 24 h. Phosphorylation of p53 was also absent at multiple time points from 0-4 h 
(data not shown). 
Immunocytochemistry in ZnO-treated cells revealed notable DNA double strand 
breaks, as evidenced by a marked increase in the presence of gamma-H2AX foci in HDF  
exposed to 20 ppm concentrations at 24 hrs (Figure 4.6). Moreover, foci in ZnO-treated 
cells were visibly more punctuate, indicating increased condensation of chromatin. 
Compared to untreated control cells, a slight increase in the number of foci are also 
present in CeO2 and TiO2-treated samples (Figure 4.7). 
 
4.3.5. Cell cycle perturbation 
Cell cycle arrest is a critical component of the DDR, as it allows sufficient time 
for DNA damage repair to occur before progression into mitosis, thereby protecting 
genome integrity. We examined the effect of three metal oxides on the cell cycle using  
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Fig. 4.6. DNA strand break damage, as determined by immunocytochemistry. Differential 
γ-H2AX expression in HDF treated with 20 ppm nanoparticles for 24 h. DAPI was used as a 
nuclear control. Etoposide was utilized at a concentration of 100 µM for 1 hr as a positive 
control. Untreated cells were also included for comparison purposes. ZnO-treated cell images 
indicate the most significant double strand break damage compared to untreated control cells. 
*Statistically significant (p<0.05) compared to untreated cells. **Statistically significant 
(p<0.001) compared to untreated cells. Scale bar = 10 μm. 
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Figure 4.7. Average number of gamma-H2AX foci per cell. Differential γ-H2AX expression 
in HDF treated with 20 ppm nanoparticles for 24 h are compared here to untreated and positive 
control-treated cells.  Etoposide was utilized at a concentration of 100 µM for 1 hr as a positive 
control. Of the three nanoparticle types tested, ZnO-treated cells indicated the most significant 
double strand break damage compared to untreated control cells. *Statistically significant 
(p<0.05) compared to untreated cells.  
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Fig. 4.8. Cell cycle perturbation histograms. Number of cells counted in each phase of the cell 
cycle is represented above for HDF dosed at 6 and 24 hrs with 20 ppm CeO2, TiO2, or ZnO. 
Untreated control samples are included for comparison. 
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Fig. 4.9. ZnO induces S-phase arrest. Changes in cell cycle were assayed via FACS after 
exposure to 20 ppm CeO2, TiO2, or ZnO for 6 (A) and 24 (B) h. Following nanoparticle 
treatments, cells were ethanol-fixed and stained with propidium iodide for analysis.  
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propidium iodide coupled with flow cytometry (Figure 4.8). At 6 h exposure, ZnO 
induced S-phase arrest in HDF, whereas no changes were observed in CeO2 and TiO2-
treated cells, in comparison with water-treated cells (Figure 4.9A). After 24 h exposure, 
ZnO continued to cause S-phase arrest (Figure 4.9B). When compared to untreated cells 
at this time point, CeO2 and TiO2 caused less severe arrest. At the later time point, 
percentages of cells in G0/G1, S, and G2/M phases were 78.9, 9.3, and 11.9 respectively 
for water-treated cells, 67.3, 16.1, and 16.6 for CeO2-treated cells, 61.8, 18.9, and 19.3 
for TiO2-treated cells, and 46.4, 35.8, and 17.9 for ZnO-treated cells. S-phase arrest is 
indicative of DNA damage and consistent with repair taking place.  
 
4.4   Discussion 
While nanomaterials possess many desirable characteristics, the possibility of 
DNA damage response in dermal cells exposed to nanoparticles needs further evaluation 
due to the fact that humans are increasingly exposed to products containing metal oxide 
particles on the nanoscale. Differences in the potential responses between particle types 
also need to be investigated since the physicochemical properties of each nanomaterial 
differ greatly, which may influence the resulting biological response upon exposure. 
Most needed is a mechanism by which researchers can correlate biological damage with 
specific properties of the materials in question. This is the first study to analyze the DDR 
in dermal cells exposed to these three metal oxides, while considering the role of 
nanoparticle physicochemical characteristics in the postulating of nanoparticle-induced 
genotoxic capability. 
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Our nanoparticle characterization revealed distinct differences between particle 
types, which assist in explaining the differential toxicity that was seen throughout the 
experiments carried out. ZnO remained close to its primary particle size in media over 
time, while CeO2 and TiO2 became severely aggregated over time. Aggregation state of 
these materials closely correlated with the zeta potential exhibited at each time point. 
ZnO became increasingly negative, compared to the other two particle types, decreasing 
particle-particle interaction and possibly increasing the likelihood of biological 
interactions. Additionally, Zn
2+
 ions are known to dissociate from ZnO in dermal 
exposure scenarios and this fact is noteworthy since zinc is an essential trace element 
capable of competing for cell surface receptors and initiating cell death pathways when 
in excess . In fact, the presence of ―free‖ zinc ions may be the cause of ROS-driven 
cytotoxicity, rather than the presence of zinc-containing nanoparticles (Song et al., 
2010).  
Interestingly, cellular zinc depletion induces apoptosis due to increased oxidative 
damage and activity of pro-apoptotic enzymes (Truong-Tran et al., 2001; Zalewski et al., 
1993), which is thought to be caused by decreased PARP-1 catalyzed base excision 
DNA repair (Mocchegiani et al., 2000). However, it has also been shown that an excess 
of zinc causes toxic free radicals and apoptosis or necrotic cell death (Fraker and 
Telford, 1997; Kim et al., 1999; Watjen et al., 2002).  
CeO2 caused oxidative stress, as the DCFH-DA assay and SOD1 protein results 
suggest, but significant DNA damage did not occur at this concentration. This may be 
due to the fact that CeO2 did not remain in its primary particle size and likely did not 
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break down into ions within the cell, as ZnO has been reported to do (Miao et al., 2010; 
Xia et al., 2008). TiO2 also induced some level of oxidative stress, as indicated by a 
slight increase in DCF fluorescence detection, but no significant DDR occurred at the 
concentration and time point we assessed. It has been documented that the increased 
surface area of nanoparticles generates increased levels of ROS, as compared to their 
compositionally identical bulk counterparts (Nel et al., 2006). 
Figure 4.10 outlines the DDR after exposure to nanoparticles. DNA strand breaks 
activate ATM and/or ATR, which initiate the DDR cascade. We have found that p38 is 
activated with ZnO exposures, leading to an accumulation of phosphorylated cdc 
(Tyr15), which further indicates cell cycle arrest. Our finding that S-phase arrest was 
induced by ZnO is consistent with the remainder of our results indicating significantly 
increased levels of ROS production, decrease in viability, protein expression, and DNA 
damage levels. Interestingly, none of the materials tested induced the better-studied p53 
pathway, which is known to play a role in the DDR and apoptosis. P21 was also 
unaffected at time points from 0-4 h, 6 h, or 24 h (data not shown). As previously stated, 
p38 has been shown to act independently of p53 in inducing cell cycle arrest. Here, we 
elucidate a mechanism behind the DDR in primary HDF exposed to low concentrations 
of CeO2, TiO2, and ZnO nanoparticles. 
Eom and Choi recently published results of studies in Beas-2B human bronchial 
epithelial cells treated with nano-sized silver, where they found activation of the p38 
pathway leading to S and G2/M phase cell cycle arrest with H2AX phosphorylation at 
12 and 24 h in silver (Eom and Choi, 2010). The same group also published findings in  
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Fig. 4.10. Proposed DNA damage response schematic. Proposed schematic of HDF DDR 
pathway and related protein involvement after nanoparticle exposures. 
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2009 of ROS-induced p38 phosphorylation in Beas-2B cells after CeO2 exposures, but 
did not investigate DNA damage potential (Eom and Choi, 2009a). Here, we have 
assessed ROS generation and stress, as well as DNA damage potential in primary human 
cells resulting from exposure to three metal oxides found in commercially available 
products. 
Although ZnO has been found to be superior to TiO2 as a sunscreen and cosmetic 
ingredient since it is more protective against long-wave UVA and is less opaque upon 
application (Pinnell et al., 2001), it may be more damaging to DNA in the underlying 
dermal tissue than TiO2 or CeO2 at the concentration tested. While many have found 
penetration of similar nanoparticles to be limited to the stratum corneum or only 
occasionally reaching the viable epidermis (Baroli et al., 2007; Cross et al., 2007; 
Zvyagin and Zhao, 2008), others have found that exposures over time or factors such as 
flexing of the skin before application of such particles dramatically increases the depth 
and amount of translocation (Gopee et al., 2009; Rouse et al., 2007; Tinkle et al., 2003; 
Wu et al., 2009). It is quite common for metal oxide nanomaterials to be applied daily in 
the form of cosmetics or sunscreens, which fill the hair follicle and are then less likely to 
be removed during skin cleansing. It is critical that in vivo studies considering such 
realistic, confounding exposure scenarios continue, keeping in mind the potential for 
ROS-driven DNA damage with metal oxide exposures.  
Salient points to be learned from this research: 
 NP characterization suggests toxicity can be at least partially predicted by trends in 
zeta potential and agglomeration state. 
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 ROS generation did not always lead to significant DNA damage. 
 ZnO induced the most serious DDR with halting of the cell cycle in S-phase. 
 DDR was p53-independent, but involved p38 in altering the cell cycle in primary 
HDF.  
Questions remaining unanswered: 
 Does nanoscale ZnO penetrate through the stratum corneum? 
 Can properties of potentially toxic nanoparticles, such as surface charge or surface 
composition, be altered to allow for their safe use in dermal applications? 
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CHAPTER V 
MITIGATION OF QUANTUM DOT CYTOTOXICITY BY 
MICROENCAPSULATION* 
 
5.1 Introduction 
Nanoscale materials are promising contenders for diagnostics, therapeutics, and 
imaging agents due to their size, functionality, and unique optical properties. Many of 
the proposed biomedical applications for nanomaterials revolve around their 
employment as targeted drug delivery vehicles in the circulatory system (Emerich and 
Thanos, 2006; West, 2009). Another potential biomedical application of nanomaterials 
includes their incorporation into medical implants, such as devices placed in the 
subcutaneous tissue or even as functional elements of ―smart‖ tattoo-like biosensors 
(McNichols and Cote, 2000; McShane, 2002; McShane, 2006). Such concepts require 
engineered structures and materials with the desired function (e.g., optical sensing) 
within a fully biocompatible and/or biodegradable platform (McShane, 2006). As an 
example, many biosensors require mobility of sensing reagents—the sensors/reagents 
must be able to freely associate and dissociate, while being physically constrained to 
enable continuous use in one location (McShane and Ritter, 2010; McShane, 2006). 
Inorganic nanoparticles offer unique properties that enable innovative biosensing  
___________  
*Reprinted with permission from ―Mitigation of Quantum Dot Cytotoxicity by 
Microencapsulation‖ by Romoser, et al., 2011. PLoS ONE, 6, e22079, Copyright [2011] 
by Romoser et al. 
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techniques. However, it is difficult to localize the nanoparticles for long periods of time. 
Additionally, the prospective use of nano-enabled biosensors for such in vivo 
applications has raised concerns regarding the possible localized and systemic 
toxicological effects in humans. Mechanistic analyses of these effects in humans are 
needed when assessing the risks due to the use of nanomaterials in medicine and 
biological imaging. 
QDs with a cadmium selenide core (CdSe) and a zinc sulfide (ZnS) shell remain 
the most studied, produced, and proposed luminescent nanomaterial. Offering significant 
advantages for energy transfer-based biosensors, QDs are photobleaching resistant, have 
high quantum yield, and possess broad absorption/narrow emission bands that are size 
tunable (Ipe et al., 2005). However, since CdSe/ZnS QDs have been shown to enter 
living cells (Chang et al., 2006; Duan and Nie, 2007; Jaiswal et al., 2003; Ryman-
Rasmussen et al., 2007; Ryman-Rasmussen et al., 2007b; Zhang et al., 2008), their 
toxicological characterization and mitigation is extremely relevant to 
nanobiotechnology.  It has been shown that the addition of a ZnS outer shell can 
minimize damage to the cell (Su et al., 2009); however, the potential for substantial 
damage from leaching cadmium, selenium, and/or excess zinc still exists (Das et al., 
2009; Mahendra et al., 2008).  In addition, because QDs are intrinsically redox-active, a 
portion of their toxic potential may also arise from such native properties without regard 
to their composition, surface properties, or cellular internalization potential. Quantum 
dots can transfer absorbed optical energy to adjacent oxygen molecules, thus 
spontaneously generating reactive oxygen species (ROS) such as hydroxyl radical (
•
OH), 
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superoxide
 
(O
2-
), and singlet oxygen (
1
O2) (Ipe et al., 2005; Przybytkowski et al., 2009; 
Yu et al., 2006).  Further modification of the QD surface with silanes (Gerion et al., 
2001), oligomeric phosphines (Kim and Bawendi, 2003), phospholipids (Dubertret et al., 
2002), and amphiphilic triblock copolymers (Gao et al., 2004) has been demonstrated as 
an effective means to further mitigate toxicity by protecting the QD surface from 
deterioration in biological media. However, these capping agents increase overall QD 
size enough to preclude efficient energy transfer to an acceptor (Medintz et al., 2005). 
Therefore, although these bulky capping agents protect the QD from degradation, 
biosensing schemes requiring intimate contact between QDs and analytes/reagents (e.g., 
transduction via energy transfer) can incur a loss in biosensor functionality. 
As an alternative to protecting individual QDs, microencapsulation provides a 
means to modulate interfacial interactions between the cells and QDs without the need to 
deposit bulky surface coatings on the QDs. Our work is separate from a large body of 
work focused on encapsulating individual QDs, as we are microencapsulating an 
ensemble of QDs within each polyelectrolyte microcapsule (2.05e10 
QDs/microcapsule).  It is also noteworthy that the QDs used in this study are 
microencapsulated within the hollow interior (i.e., void) volume of the polyelectrolyte 
microcapsule, which should be distinguished from QD entrapment within the 
polyelectrolyte film itself (Kirchner et al., 2005a) and results in an interaction among the 
QDs, the solvent, and other molecules that permeate the film. Although the two seem 
similar superficially, important differences exist with respect to interactions with 
surroundings and apparently toxicity, as evidenced by our data.  
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Microcapsules and nanoparticle surface coatings can function as protective layers 
to prevent or inhibit erosion, oxidation, and leaching of core components; however, the 
leaching of core components is a central challenge for the microencapsulation field 
(Parthasarathy and Martin, 1994).  Numerous studies have shown that microcapsules 
synthesized via the layer-by-layer (LbL) process inhibit the release of core components 
and show promise for the development of new types of nano-enabled biosensors 
(Almeida et al., 1993; Marchesiello and Genies, 1993; Parthasarathy and Martin, 1994). 
Even one of the smallest enzymes, trypsin (Mw = 23.3 kDa; corresponding to an average 
diameter of ~1-3 nm) does not leach from an LbL microcapsule (Parthasarathy and 
Martin, 1998). The PEI-coated QD materials (termed CdSe/ZnS-PEI) used in this study 
are ~15 nm in all dimensions and are thus well contained within the microcapsule 
(Figure 5.1).  However, it is important to note that the permeability of the microcapsules 
to ions, small molecules, and even macromolecules can be tailored in a number of ways, 
including modulation of the pH (during and post-construction), ionic strength (during 
and post-construction), solvent (during and post-construction), polymer composition, 
and shell thickness (Antipov and Sukhorukov, 2004). Therefore, given a sufficiently 
large disparity in molecular weight/size between the analyte and the QD (or other assay 
components), a number of strategies can be employed to entrap the sensing assay, while 
maintaining permeability of ions and small molecules (e.g., the analyte).  Again, because 
the polyelectrolyte microcapsules are hollow, the QDs retain their responsiveness to the 
environment.  Therefore, the purpose of this study was to examine the protective effects  
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Fig. 5.1. Quantum dot-loaded microcapsule characterization.  (A) Schematic representation 
of the formation of QD-loaded microcapsules. (B) Histogram of the size distribution of QDMCs.  
(C) Brightfield and (D) fluorescence images of the QDMCs, showing that the microcapsules are 
monodisperse and contain QDs (ex/em 380/545). 
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of additional surface constructs, namely polymer microcapsules, in comparison with the 
toxicological effects of free CdSe/ZnS-PEI QDs. 
To more thoroughly mitigate the potential cellular toxicity caused by reported 
dissociated metal ions (Derfus et al., 2004) or ROS generation from the QDs, we set out 
to microencapsulate CdSe/ZnS-PEI in an effort to nullify the adverse effects of free QDs 
on cellular morphology and metabolism, cytotoxicity, and apoptotic or necrotic response 
(Figure 5.2).  Specific to the case of implantable biosensors under epidermal layers of 
skin, we have developed a model that investigates the potential cytotoxicity, uptake, and 
apoptotic response of QD-loaded microcapsules (QDMC).  Human dermal fibroblasts 
(HDF), the cells that compose the majority of the viable dermal layer, were exposed to 
CdSe/ZnS-PEI QDs microencapsulated within PEG-terminated microcapsules 
comprised of poly(styrene sulfonate) (PSS) and poly(allylamine hydrochloride) (PAH). 
The near-neutral surface charge of PEG-terminated microcapsules results in minimized 
contact with cells, providing an excellent biomedical tool, while retaining desirable QD 
qualities.  However, it is important to note that microencapsulating other types of 
nanoparticles is not only possible, but potentially advantageous.  For example, noble 
metal nanoparticles that possess antioxidative effects (e.g., reactive oxygen species 
scavengers) might benefit from microencapsulation to prevent cellular internalization, 
while simultaneously preserving surface-dependent biomimetic properties.  Another 
potential application is the controlled release of a drug from polymeric nanoparticles, 
wherein the drug to be delivered acts on cell surface receptors and must be delivered 
extracellularly (e.g., vascular endothelial growth factor).  
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Fig. 5.2. Experimental design. Flowchart of the protocol used for testing the cellular response 
(cytotoxicity and morphology) of human dermal fibroblasts (HDF) to free quantum dots (QD) 
and quantum dot loaded microcapsules (QDMC). Cultured cells were exposed to either QD or 
QDMC for all experiments. CdCl2 was used in some experiments as a positive control. 
Cytotoxicity, including % dead, metabolism, and apoptosis, were determined over a dose-
response, while cellular morphology and uptake were determined over a time course. 
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5.2 Methods  
5.2.1. QD synthesis 
Core/shell (CdSe/ZnS) QDs were synthesized in a coordinating solvent tri-n-
octylphosphine oxide (TOPO, 99%, Aldrich) in accordance with previously published 
procedures (Peng and Peng, 2001). The synthesis was performed in a single mode CEM  
Discover® microwave reactor operating at 300 W, 2.45 GHz. Cadmium oxide (CdO, 
99.99%, Alfa Aesar, 0.0514 g, 0.4 mM) along with tetradecylphosphonic acid 
(TDPA,98%, Alfa Aesar, 0.2232 g, 0.8 mM) and TOPO (3.7768, 9 mM) were heated 
with continuous stirring in a 125 mL glass flask. The mixture was heated to 
approximately 300 °C under argon (Ar) flow for 15 min. A selenium stock solution 
(0.0411 g, 0.5 mM, Aldrich, 99 %) dissolved in 2.4 mL (2 g) of tri-n-octylphosphine 
(TOP, 99%, Aldrich) TOP) was injected at 270 °C and QDs were allowed to grow for 
150 s. A ZnS shell was grown on the CdSe cores by injecting a mixture of Zn and S 
precursors: 1.6 mL (12 mM) dimethylzinc (DMZ-1M in heptane, Aldrich), 0.42 mL (2 
mM) hexamethyldisilathiane (HMDS, Aldrich), and 6.3 mL (14 mM) TOP. The reaction 
mixture was heated for 30 min at 200 °C. The quantum yield of the QDs increased on 
annealing the particles at a temperature of ~100 ºC for a period of two hours.  
The QDs were surface modified with high molecular weight branched PEI (b-
PEI) (Aldrich, MW 25,000) using similarly reported procedures (Nann, 2005). Briefly, a 
10 mg/mL solution of b-PEI in chloroform was mixed with an equal volume of 4-5 µM 
QDs. The mixture was tumbled overnight at room temperature. QDs were precipitated 
from the mixture by addition of excess cyclohexane (Sigma-Aldrich, >99%) and 
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suspended in deionized water. Excess PEI was extracted from the aqueous QD solution 
by addition of fresh chloroform, which phase-separated from water. The zeta potential of 
the PEI coated QDs was measured at approximately +29.7 ± 6.2 mV by a Zetasizer Nano 
ZS (Malvern Corp, Worcestershire, UK).  The quantum yield of PEI coated QDs as 
produced is estimated to be 11.1 %. 
 
5.2.2. QD microencapsulation 
To microencapsulate the QDs in microcapsules (Figure 5.1), QDs were first 
entrapped in CaCO3 microparticles using a modification of Petrov‘s protocol (Petrov et 
al., 2005).  Briefly, 2.4 mL of a 2.17 μM PEI-coated QD solution was added to 7.6 mL 
of a Na2CO3 solution containing 40 mg of PSS (Mw = 70 kDa) for a final Na2CO3 
concentration of 0.2 M.  While stirring the Na2CO3 solution, 10 mL of a 0.2 M CaCl2 
solution was quickly added.  After stirring for 30 s, the resulting particle suspension was 
centrifuged at 2500 g for 5 min to remove any remaining free QDs and unreacted salts; 
the precipitate was rinsed three times with deionized water and imaged using an inverted 
epifluorescence microscope (Nikon Eclipse TE2000-U) with a 40X objective (Nikon 
Plan Fluor, 0.75), 1.5X secondary magnification, and a color digital camera (Nikon DS-
Fi1).  Particle size measurements were performed using an Elzone II Particle Size 
Analyzer equipped with a 30 μm orifice tube (Micromeritics, Norcross, GA).  Particle 
diameter was validated via optical microscopy.  Zeta potential measurements, as an 
indicator of microcapsule surface charge, were performed using a Zetasizer Nano ZS 
(Malvern Corp, Worcestershire, UK).  Encapsulation efficiency was estimated by 
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measuring the fluorescence intensity of the QDMC solution and dividing by the sum of 
the fluorescence intensities of the QDMC solution and the supernatant solution 
recovered from the CaCO3 microparticle precipitation, which contained unencapsulated 
QDs.  Due to the high scattering of the samples, a PC1 photon counting 
spectrofluorometer (ISS, Champaign, IL) was modified using a bifurcated fiber optic 
bundle to collect fluorescence using 180° collection geometry.  Empty CaCO3 
microcapsules (containing no QDs) were prepared using the aforementioned protocol, 
with the exception that 2.4 mL of deionized water was substituted for the PEI-coated QD 
solution. 
Nanofilms were deposited on the CaCO3 template using the LbL method, in 
which substrates are immersed in polyelectrolyte solutions of alternating charge (Caruso 
et al., 1998; Decher, 1997; Volodkin et al., 2004b).  The first ten bilayers were 
comprised of polyelectrolytes PSS and PAH (Mw = 52 kDa).  The surface charge of 
CaCO3 microparticles at or below pH 8 is positive, so anionic PSS was the first 
polyelectrolyte deposited, followed by cationic PAH (Volodkin et al., 2004a).  
Deposition of each polyelectrolyte layer was achieved by suspending the particles in 1 
mL of a 2 mg/mL polyelectrolyte solution containing 0.2 M NaCl.  Lastly, the particles 
were coated with a terminal bilayer comprised of PSS and poly-L-lysine(100)-g[4.5]-
polyethylene glycol(114) (PLL-g-PEG, Alamanda Polymers, Mw = 129 kDa), yielding 
CaCO3 microparticles coated with a (PSS/PAH)10/(PSS/PLL-g-PEG) nanofilm.  
Dissolution of the CaCO3 template was accomplished via a mild treatment with 0.1 M 
ethylenediaminetetraacetic acid (EDTA) adjusted to pH 7.6; complete core dissolution 
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was visually confirmed using phase microscopy. Note: (PSS/PAH)5/(PSS/PLL-g-PEG) 
nanofilm QDMCs were also made and compared to (PSS/PAH)10/(PSS/PLL-g-PEG) 
QDMCs in figures 5.6-5.8. 
 
5.2.3. Microscopy 
HDF cells (ATCC, Manassas, VA) were cultured in Dulbecco‘s Modified 
Eagle‘s Medium (DMEM, Gibco, Austria), which was supplemented with 10% FBS and 
an antibiotic cocktail consisting of penicillin, streptomycin, and amphotericin (Sigma-
Aldrich, St. Louis, MO). Incubation took place at 37°C with humidity and 5% CO2. Live 
cells were cultured in this manner and treated with 50 pM QD and QDMC for 30 min, 4 
hrs, 12 hrs, 24 hrs, and 48 hrs to determine the manner and extent of QD uptake into the 
fibroblasts.  An undosed control was also included for comparison. Then, 0.25 µL stock 
solution Syto 63 (Invitrogen, Carlsbad, CA) was directly added to 1 mL of media in the 
borosilicate, dual-well chamber slides (Lab-Tek, Nagle Nunc Intl., Rochester, NY) for a 
30 min incubation at 37°C.  A Zeiss 510 Meta confocal microscope was utilized at 40X 
(1.3 NA, oil immersion) to image the treated and stained live cells. A 488 nm Ar ion and 
a 633 nm He-Ne laser were employed to excite the QDs and stain, respectively. Zeiss 
LSM 510 Software was used to acquire the images. 
 
5.2.4. Metabolism 
Cell populations (n=4) were then seeded in 24 well plates, allowed to grow to 
80% confluency, and dosed with 0.05-50 nM concentration range for both the QD and 
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QDMC or left undosed as a negative control. A 20 and 120 μM CdCl2 solution was 
utilized as a positive indicator for absence of fluorescent probe metabolism. The dosed 
media was aspirated after 12, 24, or 48 hr. The cells were washed with PBS and phenol 
red-free DMEM media was added. Resazurin dye (10% v/v, Sigma Aldrich, St. Louis, 
MO) was added and the cells were incubated for an additional 3 hr. Fluorescence 
intensity was obtained by exciting at 560 nm and recording emission at 590 nm. 
Fluorescence compatibility was measured prior to assay (Appendix Figure A-3).  QD 
and QDMC toxicity to cells was measured in terms of percent healthy cells via 
microscopy. 
 
5.2.5. Metallothionein expression  
HDF were cultured in the same conditions as above. Cells in 6-well plates were 
treated with 30 nM QDs, 30 nM QDMCs, 30 µM cadmium chloride salt, 30 µM 
hydrogen peroxide, or left untreated. After 24 hrs exposure, cells were washed in ice 
cold 1X PBS, then protease inhibitor cocktail (Sigma-Aldrich) and high salt lysis buffer 
were added to wells. Protein was isolated by collecting supernatant via centrifugation. 
Samples were loaded into 10% SDS-PAGE gels and run at 120 mV. Gels were 
transferred to PVDF membranes, which were blocked in 5% milk and incubated in an 
anti-metallothionein primary antibody solution overnight at a concentration of 1:1000 
(Santa Cruz Biotechnology, Santa Cruz, CA). Secondary antibody (Goat, anti-mouse, 
Santa Cruz) was prepared in fresh 5% milk solution at 1:5000 dilution and incubated at 
room temperature for two hours. Immobilon™ Western Chemiluminescent HRP 
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substrate (Millipore, Billerica, MA) was added to rinsed membranes and film exposures 
were taken. β-actin, 1:10,000 (Sigma, St. Louis, MO) was used as a loading control. 
Blots shown are representative of several independent experiments. 
 
5.2.6. Sample supernatant metal analysis  
To ensure microcapsule integrity after storage in 4°C conditions, cadmium, 
selenium, and zinc content within the supernatant from QDMC samples stored for a one 
month duration was analyzed using inductively coupled plasma-mass spectroscopy (ICP-
MS). Supernatant was collected from vials of both empty and QD-loaded microcapsules 
stored in water for one month and compared with two types of digested QD samples at 
approximately the same concentration as would be present if all microcapsules their 
entire contents into the supernatant. All suspensions were digested under heat (60°C) and 
acid (5% HCl and 1% nitric acid, by volume), and analyzed for metal content via 
inductively coupled plasma mass spectroscopy (ICP-MS) using an Elan DRC II, Perkin 
Elmer SCIEX (Waltham, MA). 
  
5.3 Results  
5.3.1. Microencapsulation and QD-loading efficiency 
The average microparticle diameter was determined to be 5.24 μm as measured 
with a particle size analyzer, with a standard deviation of 1.25 μm (95% confidence 
interval:  5.165 - 5.317 μm) (Table 5.1 and Figure 5.1B).  This diameter was also  
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Table 5.1. QD and QDMC characterization table. *As measured on CaCO3 microparticles 
coated with (PSS/PAH)10/(PSS/PLL-g-PEG) nanofilms. 
 
Property QD QDMC 
Size in water 14-16 nm 3-5 µm 
Surface charge  +29.7 ± 6.2 mV near neutral* 
Interior volume - 14.14-65.45 µm
3
  
Calculated surface area ~706 nm
2
 28.27-78.54 µm
2
 
No. of QDs/microcapsule - 2.05e10
 
 
No. of Cd
+2
 ions/system 265.8
 
 5.46e12
 
 
Excitation/Emission 380/545 nm 380/545 nm 
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observed via optical microscopy.  The encapsulation efficiency was determined to be 
~30.57%, resulting in about 9,000,000 QDs/microcapsule. At this encapsulated 
concentration, the volume occupied by the microencapsulated QDs is ~0.1% of the total 
microcapsule interior volume.  Based on the diameter of the microcapsule, the average 
surface area would be 7.854×10
-11
 m
2
 (i.e., 78.54 µm
2
). 
Figure 5.1 depicts the process used to form the QDMC.  Morphology of the 
microcapsules was determined with microscopy. Following core dissolution, brightfield 
and fluorescence images of the resulting microcapsules were acquired (Figure 5.1 C-D).  
The brightfield image reveals a spherical morphology, and the fluorescence image 
confirms successful QD microencapsulation. Both the micrographs and the histogram 
show that the QDMC sample contains monodisperse microcapsules.  In addition, QDs 
do not show evidence of self-quenching (i.e., red-shift of emission peak) once 
microencapsulated, as shown by the fluorescence emission spectra in Appendix Figure 
A-4. 
 
5.3.2. Differential metabolism effects 
Cellular viability was measured in two independent studies.  First, viable cells 
were counted using brightfield microscopy (data not shown).  Second, changes in 
metabolic activity were measured using the conversion of resazurin to resorufin (Figure 
5.3).  In both studies, HDF cells were exposed to QDs, QDMCs, and CdCl2 (positive 
control). For comparison, the total number of QDs at each concentration was kept 
constant between the QD and QDMC samples; e.g., 5 nM QDMC refers to enough MCs  
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Fig. 5.3. Differential cytotoxicity. Cytotoxicity was measured at A) 12 hrs, B) 24 hrs, and C) 48 
hrs via fluorescence intensity of reduced resazurin. HDF cells at all time points were either 
exposed to 0.05-50 nM QDs or microencapsulated QDMCs, 20 or 120 μM cadmium chloride 
positive control, or unexposed. * p-val < 0.05, ** p-val < 0.001. Note: the QDMC concentrations 
refer to the total concentration of QDs contained in the microcapsules.  
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to provide a total QD concentration of 5 nM. All responses were compared to those of 
undosed cells. Results indicated a strong dose- and time-dependent response relationship 
present in QD and CdCl2-treated cells, but no significant changes in metabolic activity 
were found by 48 hr in QDMC-treated cells. Cells exposed to empty microcapsules were 
also examined for changes in viability and metabolic activity and no significant changes 
were found.  
It is important to note that QDs are similarly toxic at much lower concentrations 
than the cadmium chloride positive control.  This is not surprising since there are factors 
other than chemical composition (e.g. surface charge, particle size, ROS generation 
potential) that must be considered when evaluating nanoparticle cytotoxicity. For 
example, it has been shown that cadmium-containing QDs are more toxic to bacteria 
than an equivalent cadmium concentration of cadmium salt due to higher ROS 
generation, damaged cell membranes, and the presence of Se
0
 and dissolved cadmium 
(Priester et al., 2009).  
 
5.3.3. Cellular uptake and morphological changes 
Metabolism study results corroborate the cellular uptake data (Figure 5.4), where 
the number of QD aggregates increases at approximately the same rate as toxicity 
progresses. Figure 5.5 illustrates that the free QDs visibly disrupted the cellular 
morphology, which became apparent after the 12 hr time point and progressed 
throughout the remainder of the experiment. Cells dosed with an equivalent Cd atom 
concentration of the QD-loaded microcapsules displayed no evidence of particle uptake  
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Fig. 5.4. QD association and cellular morphology. (A) QD accumulation in HDF mitochondria 
(Confocal, 60X, Zeiss).  (B) The number of QD aggregates accumulating in HDF increases over 
time.   
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Figure 5.5. Comparative cell morphology over time in response to QDs and QDMCs. Fluorescence microscopy of micrographs B 
through F show the cellular morphology of HDFs exposed to QDs over a 30 minute to 48 hour time course study.  As exposure time 
increases, the cells exhibit compromised cytoplasmic membranes. Micrographs H through L show the cellular morphology of HDFs 
exposed to QDMC over a 30 minute to 48 hour time course study. Cells remain intact and healthy over the course of the 2-day study.  Z-
stack images indicate that microcapsules do not enter cells. Microcapsules are resting on top of cells, but do not enter cells. QDMC-treated 
cells were dosed at an equivalent amount of Cd+2 ions relative to the amount present in QD treatments. Cells dosed with an equivalent Cd 
concentration of the QD-loaded microcapsules displayed no evidence of particle uptake and remained viable with no sign of deterioration 
through the 48 hr time point. 
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and remained viable with no sign of deterioration through the 48 hr time point. 
 
5.3.4. Capsule integrity  
 Results from western blot analysis reveal differences in HDF metallothionein 
expression in response to presence or absence of microencapsulation and the number of  
bilayers applied to the template (Figure 5.6).  Here, 5-bilayer capsules did not afford 
cells protection from metals leakage, as evidenced by a marked increase in protein 
expression, which was comparable to the cadmium chloride positive control. The 10-
bilayer-treated cells, however, expressed very little metallothionein, which was slightly 
more than the untreated cells. 
 ICP-MS analysis of 10-bilayer capsules confirmed the effectiveness of the 10-
bilayer approach, as only negligible amounts of cadmium, zinc, and selenide were found 
in capsule supernatant after a one-month storage in 4°C conditions (Table 5.2). 
 
5.4 Discussion 
Due to the recent surge of nanoparticle development for imaging and therapeutic 
applications, there is reason to evaluate toxicity of nanomaterials. Some studies suggest 
nanoparticles do affect biological systems at the cellular, subcellular, and protein levels 
(Ale-Agha et al., 2010; Choi et al., 2010; Lunov et al., 2010). Other works indicate that 
nanoparticles are cleared from circulation by macrophages depending on particle 
composition, size, charge, surrounding pH, dose, or route of exposure  
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Figure 5.6. Metallothionein expression. HDF were treated for 24 hrs as follows: Lane 1, 
untreated; 2, 30 µM cadmium chloride salt; 3, 30 nM PEI-QD (positively charged); 4, 30 µM 
hydrogen peroxide; 5, 30 nM 5 bilayer microencapsulated QDs (positively charged); 6, 30 nM 
10 bilayer microencapsulated QDs (neutrally charged). Western blotting for metallothionein, a 
protein upregulated in the presence of intracellular heavy metals, revealed differences between 
samples. β-actin was used as a loading control. Experiment was performed in duplicate with 
similar results. 
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Table 5.2. Microcapsule leakage analysis. Inductively coupled plasma-mass spectroscopy was 
utilized as a method to assess possible trace amounts of microcapsule leakage of cadmium, 
selenide, and zinc from quantum dot contents. Supernatant was collected from vials of both 
empty and QD-loaded microcapsules stored in water for one month and compared with two 
types of digested QD samples at approximately the same concentration as would be present if all 
microcapsules their entire contents into the supernatant. Levels of the three metals in QD-loaded 
capsules were nearly identical to empty microcapsules.  
 
 
(mg/L) (mM) 
Sample ID Cd Se Zn Cd Se Zn 
DI water <0.00006 <0.00030 <0.0012 <0.000001 <0.000004 <0.00002 
microcaps w/o QDs 
supernatant <0.00006 <0.00030 0.0603 <0.000001 <0.000004 0.001 
microcaps with QDs 
supernatant <0.00006 0.00136 0.0141 <0.000001 0.00002 0.000 
PEI-QD digested 21.7 10.3 53.4 0.193 0.130 0.817 
DHLA-QD digested 79.2 35.5 62.4 0.705 0.450 0.954 
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(Dobrovolskaia et al., 2008; Moghimi and Gray, 1997; Moghimi and Szebeni, 2003; 
Semmler-Behnke et al., 2007). Nevertheless, there are concerns that Cd-containing QDs 
are toxic to both cell cultures and live animals because they contain a toxic heavy metal. 
Are there engineering solutions that can mitigate the nanoparticle toxicity while 
maintaining functionality? In this body of research, it can be concluded that 10-bilayer 
QD-loaded microcapsules are minimally cytotoxic, if at all, as Figures 5.3, 5.5, and 5.6 
suggest. ICP-MS analysis confirmed a lack of heavy metal leakage from the capsules 
over time (refer to Table 5.2).  
Preliminary studies with 5-bilayer capsules revealed the importance of a 
sufficient number of layers within the nanoshell. Figure 5.7 illustrates morphological 
differences via fluorescence microscopy after treatment with either QD-treated cells (top 
row), 5-bilayer QDMCs (middle row), or 10-bilayer QDMCs (bottom row).  5-bilayer 
microcapsules entered the cells and a few ruptured by the latest time point at 48 hrs. 
Upon examination of cellular morphology, 5-bilayer microcapsules caused altered 
cellular structure by 48 hrs, similar to QD-treated cells, whereas 10-bilayer 
microcapsules remained on the surface of cells and did not provoke any noticeable 
morphological changes. This suggests that the nanoshell partially degraded, changing the 
surface characteristics of the QDMCs and allowing entry across cytoplasmic 
membranes. Figure 5.8 depicts a proposed mechanism of the differences in interaction 
between single QDs and QDMCs with or without surface charge, where a neutral charge 
on a QDMC minimizes cellular contact and prevents uptake.  
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Previous studies have shown that the endocytosis of nanoparticles in acidic 
endosomes degrade nanomaterials and cause leaching of metals, thus producing stress, 
triggering apoptotic response, and eventual death (Xiao et al., 2010). We propose that 
the observed death could be mitigated by controlling uptake via microencapsulation and 
altering microcapsule outer surface charge. These mitigations can improve the 
biocompatibility of QDs by decreasing internalization. Data from the literature has 
indicated that particles that remain in the extracellular matrix are typically less toxic to 
cells than particles that have breached the cytoplasmic membrane (Brunner et al., 2006; 
Nel et al., 2006; Oberdorster et al., 2007) Research presented in this paper suggests that 
QDMC biocompatibility is due to lack of cellular uptake and is evidenced by normal 
mitochondrial function. Therefore, as new nanomaterials (including microencapsulated 
systems or composited materials) that possess useful physical and chemical properties 
are developed, understanding the propensity for cellular uptake and subsequent adverse 
cellular effects is vital.  
Cellular uptake is an additional parameter to be considered in the design and 
evaluation of biocompatible nanoparticles for biological applications. This data provides  
strong evidence that specific microencapsulation of CdSe/ZnS particles imparts 
substantial protection.  The most common capping strategies are known to decrease 
toxicity, but they also often decrease functionality by increasing the size of the QDs. We 
have shown here that by microencapsulation of the nanoparticle, toxicity is decreased, 
while luminescence – a precursor for functionality – remains uncompromised. 
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Salient points to be learned from this research:  
 Quantum dot microencapsulation results in decreased cellular uptake and 
toxicity in human dermal cells. 
 Microencapsulation of quantum dots does not alter their fluorescent properties. 
Questions remaining unanswered: 
 Although microencapsulated quantum dots remain intact in water for extended 
periods of time, do they also remain intact in vivo over time?  
 Is there any immunological response triggered in the dermal tissue resulting 
from exposure to quantum dot-loaded microcapsules?  
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Figure 5.7. Confocal microscopy reveals differences in cellular uptake, based on surface charge. Top row: HDF cells exposed over 
time to unencapsulated PEI QDs (positive chg); Middle row: HDF cells exposed over time to 5-layer microencapsulated QDs (positive 
chg); Bottom row: HDF cells exposed over time to 10-layer microencapsulated QDs (neutral chg). 
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Figure 5.8. Proposed cellular-QD or cellular-QDMC interactions. A) Passive diffusion/Receptor-mediated (single QDs); B) 
Phagocytosis/Macropinocytosis (aggregated QDs); C) Phagocytosis/Macropinocytosis (charged microcapsules); D) Lack of uptake 
(neutral microcapsules).
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CHAPTER VI 
CONCLUSIONS 
 
Due to the rapid growth of the nanotechnology sector, and thus an exponential 
increase in the number of consumer products utilizing nanomaterials, there is a need to 
determine whether the potential for negative human health effects exists. A 
precautionary approach in the incorporation of nanoparticles into consumer products is 
necessary because it remains possible that the same physicochemical properties which 
make nanomaterials beneficial, may also yield negative toxicological consequences.  
At the nanoscale, much larger particle surface-to-volume ratios play a significant 
role in interactions at the biological interface upon exposure. Due to the 'non-bulk' 
properties of nanoparticles, including increased surface reactivity, processes such as 
dissolution or the generation of reactive oxygen species may be enhanced. The 
likelihood of this ―enhancing effect‖ does heavily rely upon the physicochemical 
properties of each nanoparticle type, however. Additionally, particles at the nanoscale 
can gain access to cellular structures otherwise that would otherwise be restricted from 
entry of larger particles. 
Quantum dots were utilized in much of this work as a ―model‖ nanoparticle to 
study not only membrane penetrability, but also resulting toxicity. Their fluorescent 
properties and consistent size allowed for more sophisticated and precise data 
acquisition, as well as the ability to modify one physicochemical parameter at a time, 
such as surface charge.  In general, dermal cells exposed to QD nanocrystals induced a 
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widespread modulation of genes and proteins, overall, when compared to unexposed 
control cell populations. Modulated factors included indicators of oxidative stress, 
apoptosis, inflammation, and more general immune responses. The effects of QDs on 
cells in culture are dependent on a variety of factors including, but not limited to, 
exposure time and dosing concentrations. Cellular effects from 15 nm CdSe/ZnS-COOH 
QD exposure were found to primarily follow the NF-κB pathway. In addition, QDs 
induced a differential cytotoxicity in keratinocytes and fibroblasts at different exposure 
concentrations and time points, even at physiologically relevant doses, thus emphasizing 
the need to investigate potential mechanisms of action among different cell types within 
the same target organ. 
There are many efforts in understanding the effects of different nanoparticles on 
cell viability and metabolism, however, not much is known regarding the distinct 
molecular mechanisms of inflammation and cellular stress using low exposure 
concentrations. To address this gap in the literature, a novel experimental design was 
utilized that specifically probed the effects of a panel of commonly studied engineered 
nanomaterials along immunomodulatory pathways, including NF-κB. The panel of 
particles selected for this study included QD nanocrystals, titanium dioxide, 
hydroxylated fullerenes, and silver nanoparticles. Cell viability, antioxidant activity, 
select messenger RNA, and protein modulation were studied in primary human dermal 
fibroblasts (HDF) and NF-κB knockdown HDF cells. Differences in cellular response to 
nanoparticles in protein and antioxidant experiments were evident in NF-κB knockdown 
cells, emphasizing the importance and extent of NF-κB after nanoparticle exposures. All 
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nanoparticles used in the study caused concentration and time-dependent cell death, as 
well as NF-κB-dependent cell death where tested. Differential responses in NF-κB and 
ERK levels may be partially attributed to particle-specific physicochemical 
characteristics. For example, the more toxic response to silver particles may be 
associated with its relatively dense nature and/or instability in the aqueous phase that 
ultimately translates into higher exposure concentrations when compared to the other 
materials used in this study. Nanoparticles also caused modulation of genes known to be 
associated with inflammatory, immune, oxidative stress, and apoptotic responses. These 
methods, along with the resultant data sets, serve as a potential model for studying the 
complex pathway-specific biochemical responses in cell and tissue systems associated 
with nanoparticle exposures. 
It is well documented that various nanoparticles are known to induce reactive 
oxygen species generation. This imbalance in the redox state of the cell has also been 
shown to induce a DNA damage cascade in cells and tissues. Nanoparticles are common 
in dermal preparations, such as sunscreens, cosmetics, and pharmaceuticals, thus there is 
a critical need to evaluate their DNA damage production capability in dermal models. 
Primary human dermal fibroblasts (HDF) exposed to <100 nm cerium oxide (CeO2), 
titanium dioxide (TiO2), and zinc oxide (ZnO) were examined in an attempt to determine 
the effects of three different, yet similarly sized metal oxide particles through the 
analysis of reactive oxygen species (ROS) generation, relevant protein upregulation 
response, and subsequent single and double strand break DNA damage. Cell death was 
most elevated with ZnO, followed by TiO2 and CeO2. ROS generation was measured 
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and indicated that CeO2 and ZnO caused increases in relative fluorescence at the earlier 
time points, as compared to untreated cells. ZnO caused upregulation of HMOX-1 and 
phosphorylation of p38, whereas CeO2 caused upregulation of SOD1. Comet assay and 
gamma-H2AX immunocytochemistry results indicated that ZnO triggered significant 
DNA strand break damage in HDF at 20 ppm concentrations. Cell cycle arrest was 
confirmed in ZnO-treated samples by flow cytometry and western blot techniques. These 
data suggest that, of the three particle types tested, ZnO may be most toxic in an in vivo 
dermal exposure scenario. Further studies comparing the ability of these nanoparticles to 
penetrate both intact and damaged skin surfaces would prove beneficial and possibly aid 
in the development of improved nanomaterials. 
Lastly, QDs were microencapsulated in an effort to prevent cellular uptake and 
resulting toxicity of QDs in a dermal scenario with a particular nanomaterial application 
as the goal. When CdSe/ZnS-polyethyleneimine (PEI) quantum dots (QDs) are 
microencapsulated in polymeric microcapsules, human fibroblasts are protected from 
acute cytotoxic effects. Differences in cellular morphology, uptake, and viability were 
assessed after treatment with either microencapsulated or unencapsulated dots. 
Specifically, QDs contained in microcapsules terminated with polyethylene glycol 
(PEG) mitigate contact with and uptake by cells, thus providing a tool to retain particle 
luminescence for applications such as extracellular sensing and imaging.  The 
microcapsule serves as the "first line of defense" for containing the QDs. This enables 
the individual QD coating to be designed primarily to enhance the function of the 
biosensor. 
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APPENDIX 
 
A-1. Gene table I. Complete data set of all the genes studied by real time PCR. Key to classified 
responses: (1) oxidative stress, (2) apoptosis, (3) inflammation, (4) non-inflammatory immune 
responses. 
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8hr 
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ZnS 
48hr 
CdSe 
ZnS 
8hr 
CdSe 
ZnS 
48hr 
 
Pos Unigene GeneBank Symbol Description 
Gene 
Name 
low 
dose 
low 
dose 
high 
dose 
high 
dose 
low 
dose 
low 
dose 
high 
dose 
high 
dose 
Class 
      
         
A01 Hs.197029 NM_000675 ADORA2A Adenosine A2a receptor 
ADORA2/
RDC8 
0.60 0.82 0.77 0.50 4.53 1.21 7.06 1.44 2,3 
A02 Hs.494997 NM_001735 C5 
Complement component 
5 
CPAMD4 1.01 0.86 1.23 0.47 1.08 0.80 0.91 0.81 3,4 
A03 Hs.93210 NM_000562 C8A 
Complement component 
8, alpha polypeptide 
C8A 0.88 1.08 1.07 0.92 0.00 0.86 0.00 1.27 4 
A04 Hs.51120 NM_004345 CAMP 
Cathelicidin antimicrobial 
peptide 
CAP18/CR
AMP 
1.00 1.08 - 0.92 - 0.00 0.12 1.27 4 
A05 Hs.2490 NM_033292 CASP1 
Caspase 1, apoptosis-
related cysteine 
peptidase (interleukin 1, 
beta, convertase) 
ICE/IL1BC 0.89 1.64 0.91 1.18 0.87 1.26 1.21 1.68 2 
A06 Hs.138378 NM_001225 CASP4 
Caspase 4, apoptosis-
related cysteine 
peptidase 
ICE(rel)II/I
CEREL-II 
0.86 1.09 0.80 0.94 0.93 0.94 0.87 1.22 2 
A07 Hs.303649 NM_002982 CCL2 
Chemokine (C-C motif) 
ligand 2 
GDCF-
2/HC11 
0.77 0.71 0.77 0.51 4.03 1.13 6.68 1.57 3 
A08 Hs.506190 NM_001837 CCR3 
Chemokine (C-C motif) 
receptor 3 
CC-CKR-
3/CD193 
0.18 0.93 0.20 1.18 0.59 0.88 0.36 1.08 3 
A09 Hs.163867 NM_000591 CD14 CD14 molecule CD14 0.77 0.62 0.52 0.31 0.20 1.09 0.58 0.60 3,4 
A10 Hs.1799 NM_001766 CD1D CD1d molecule CD1A/R3 0.14 1.08 0.26 0.92 - 0.86 - 1.27 4 
A11 Hs.126517 NM_000574 CD55 
CD55 molecule, decay 
accelerating factor for 
complement (Cromer 
blood group) 
CR/CROM 0.92 1.44 0.93 1.17 0.85 1.39 0.90 1.62 4 
A12 Hs.198998 NM_001278 CHUK 
Conserved helix-loop-
helix ubiquitous kinase 
IKBKA/IKK
-alpha 
1.06 1.21 0.86 1.00 0.86 1.06 0.88 1.47 3 
B01 Hs.464422 NM_130386 COLEC12 
Collectin sub-family 
member 12 
CLP1/NSR
2 
0.84 0.62 0.76 0.54 0.89 0.47 0.63 0.58 4 
B02 Hs.709456 NM_000567 CRP 
C-reactive protein, 
pentraxin-related 
PTX1 0.88 1.08 1.07 0.92 0.92 0.86 0.99 1.27 3,4 
B03 Hs.593413 NM_003467 CXCR4 
Chemokine (C-X-C 
motif) receptor 4 
CD184/D2
S201E 
- 0.00 - 0.92 - 0.00 2.64 0.00 4 
B04 Hs.292356 NM_000397 CYBB 
Cytochrome b-245, beta 
polypeptide 
CGD/GP9
1-1 
0.88 - 1.07 - 0.00 - 0.99 0.12 1,3,4 
B05 Hs.105924 NM_004942 DEFB4 Defensin, beta 4 
DEFB-
2/DEFB10
2 
- 1.08 - 0.92 - 0.86 - 1.27 4 
B06 Hs.279611 NM_004406 DMBT1 
Deleted in malignant 
brain tumors 1 
GP340/mu
clin 
0.88 - 1.07 - 0.00 - 0.99 - 4 
B07 Hs.203717 NM_002026 FN1 Fibronectin 1 
CIG/DKFZ
p686F101
64 
0.84 0.88 0.91 0.75 0.95 1.13 0.92 1.05 1,4 
B08 Hs.517581 NM_002133 HMOX1 
Heme oxygenase 
(decycling) 1 
HO-
1/HSP32 
0.18 3.86 0.22 5.86 0.04 1.60 0.05 2.31 1,4 
B09 Hs.37026 NM_024013 IFNA1 Interferon, alpha 1 IFL/IFN 0.13 0.88 0.43 0.82 0.04 2.33 0.23 0.88 4 
B10 Hs.93177 NM_002176 IFNB1 
Interferon, beta 1, 
fibroblast 
IFB/IFF 0.60 1.54 1.48 1.51 0.55 2.17 1.39 1.95 4 
B11 Hs.520414 NM_000416 IFNGR1 
Interferon gamma 
receptor 1 
CD119/IFN
GR 
0.92 0.97 0.71 1.06 1.13 1.06 1.32 1.01 3,4 
B12 Hs.634632 NM_005534 IFNGR2 
Interferon gamma 
receptor 2 (interferon 
gamma transducer 1) 
AF-
1/IFGR2 
1.03 0.90 0.74 0.77 1.38 1.13 1.43 1.04 3,4 
  
199 
A-1 (cont.) 
      
CdSe 
8hr 
CdSe 
48hr 
CdSe 
8hr 
CdSe 
48hr 
CdSe 
ZnS 
8hr 
CdSe 
ZnS 
48hr 
CdSe 
ZnS 
8hr 
CdSe 
ZnS 
48hr 
 
Pos Unigene GeneBank Symbol Description 
Gene 
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low 
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dose 
low 
dose 
low 
dose 
high 
dose 
high 
dose 
Class 
C01 Hs.597664 NM_001556 IKBKB 
Inhibitor of kappa light 
polypeptide gene 
enhancer in B-cells, 
kinase beta 
IKK-
beta/IKK2 
1.12 1.12 1.44 0.86 1.17 1.52 1.17 1.13 1,3,4 
C02 Hs.193717 NM_000572 IL10 Interleukin 10 CSIF/IL-10 0.51 1.47 1.82 1.54 0.18 1.67 0.13 1.69 3,4 
C03 Hs.479347 NM_001559 IL12RB2 
Interleukin 12 receptor, 
beta 2 
RP11-
102M16.1 
0.41 1.00 0.43 0.03 0.51 0.82 0.43 0.66 4 
C04 Hs.1722 NM_000575 IL1A Interleukin 1, alpha IL-1A/IL1 0.43 0.53 0.48 1.42 1.19 2.41 1.56 0.45 3,4 
C05 Hs.126256 NM_000576 IL1B Interleukin 1, beta 
IL-1/IL1-
BETA 
0.68 1.42 0.61 0.56 7.62 2.01 13.00 2.19 3,4 
C06 Hs.306974 NM_173161 IL1F10 
Interleukin 1 family, 
member 10 (theta) 
FIL1-
theta/FKS
G75 
0.88 1.08 1.07 - 0.92 - 0.99 - 3 
C07 Hs.516301 NM_012275 IL1F5 
Interleukin 1 family, 
member 5 (delta) 
FIL1/FIL1(
DELTA) 
0.00 0.00 1.07 0.92 0.92 0.86 0.99 1.27 3 
C08 Hs.278910 NM_014440 IL1F6 
Interleukin 1 family, 
member 6 (epsilon) 
FIL1/FIL1(
EPSILON) 
0.88 0.00 1.07 0.00 0.92 0.00 - 0.00 3 
C09 Hs.166371 NM_173205 IL1F7 
Interleukin 1 family, 
member 7 (zeta) 
FIL1/FIL1(
ZETA) 
2.22 0.37 1.87 0.76 0.90 2.14 1.14 1.17 3 
C10 Hs.278909 NM_173178 IL1F8 
Interleukin 1 family, 
member 8 (eta) 
FIL1/FIL1-
(ETA) 
0.88 1.08 1.07 0.92 0.92 0.86 0.99 0.00 3 
C11 Hs.211238 NM_019618 IL1F9 
Interleukin 1 family, 
member 9 
IL-1F9/IL-
1H1 
2.17 1.08 - 0.92 - 0.86 - 1.27 3 
C12 Hs.701982 NM_000877 IL1R1 
Interleukin 1 receptor, 
type I 
CD121A/D
2S1473 
0.75 0.88 0.67 0.74 0.70 0.75 0.68 0.78 3 
D01 Hs.25333 NM_004633 IL1R2 
Interleukin 1 receptor, 
type II 
CD121b/IL
1RB 
0.19 0.00 0.08 0.00 0.07 0.86 0.08 0.00 3 
D02 Hs.478673 NM_002182 IL1RAP 
Interleukin 1 receptor 
accessory protein 
C3orf13/IL-
1RAcP 
0.79 1.19 1.08 0.95 0.89 1.21 0.86 0.96 3 
D03 Hs.675519 NM_017416 IL1RAPL2 
Interleukin 1 receptor 
accessory protein-like 2 
IL-
1R9/IL1R9 
0.22 0.40 0.35 0.33 0.03 0.54 0.31 0.04 3 
D04 Hs.659863 NM_003854 IL1RL2 
Interleukin 1 receptor-
like 2 
IL1R-
rp2/IL1RR
P2 
0.21 0.49 0.56 0.66 0.26 0.61 0.29 0.29 3 
D05 Hs.81134 NM_000577 IL1RN 
Interleukin 1 receptor 
antagonist 
ICIL-
1RA/IL-
1ra3 
1.00 1.08 0.05 0.92 0.21 0.86 - 0.00 3 
D06 Hs.654458 NM_000600 IL6 
Interleukin 6 (interferon, 
beta 2) 
BSF2/HGF 0.85 0.80 0.82 0.65 7.16 2.04 11.79 2.16 3,4 
D07 Hs.522819 NM_001569 IRAK1 
Interleukin-1 receptor-
associated kinase 1 
IRAK/pelle 1.74 0.86 1.07 1.00 1.21 0.80 0.96 0.90 3 
D08 Hs.449207 NM_001570 IRAK2 
Interleukin-1 receptor-
associated kinase 2 
IRAK-2 1.15 2.13 0.81 1.73 2.85 1.08 4.26 1.92 3 
D09 Hs.436061 NM_002198 IRF1 
Interferon regulatory 
factor 1 
IRF-1/MAR 0.89 0.97 0.86 0.83 1.57 1.13 1.64 1.02 3 
D10 Hs.72938 NM_002289 LALBA Lactalbumin, alpha- 
MGC1385
21 
0.88 0.00 1.07 0.00 0.92 0.86 0.99 0.00 4 
D11 Hs.154078 NM_004139 LBP 
Lipopolysaccharide 
binding protein 
MGC2223
3 
0.88 0.00 1.07 0.92 0.92 0.00 0.00 1.27 4 
D12 Hs.529517 NM_002343 LTF Lactotransferrin 
GIG12/HL
F2 
0.88 1.08 1.07 0.00 0.92 0.86 0.99 1.27 4 
E01 Hs.660766 NM_015364 LY96 Lymphocyte antigen 96 MD-2/MD2 0.64 1.34 1.02 1.22 0.86 1.01 0.78 1.66 3,4 
E02 Hs.524579 NM_000239 LYZ 
Lysozyme (renal 
amyloidosis) 
LZM/lysoz
yme 
44.63 - - - - 1.10 - - 4 
E03 Hs.485233 NM_001315 MAPK14 
Mitogen-activated 
protein kinase 14 
CSBP1/CS
BP2 
0.66 0.67 0.93 0.76 0.94 0.88 0.86 0.82 3 
E04 Hs.138211 NM_002750 MAPK8 
Mitogen-activated 
protein kinase 8 
JNK/JNK1 1.01 0.92 0.89 0.90 1.14 1.27 1.14 1.22 3 
E05 Hs.407995 NM_002415 MIF 
Macrophage migration 
inhibitory factor 
(glycosylation-inhibiting 
factor) 
GIF/GLIF 0.85 0.89 0.88 0.78 1.01 1.04 0.98 1.48 3,4 
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dose 
Class 
E06 Hs.82116 NM_002468 MYD88 
Myeloid differentiation 
primary response gene 
(88) 
MYD88D 1.09 0.91 0.86 0.73 1.23 0.85 1.35 0.80 3,4 
E07 Hs.474781 NM_000631 NCF4 
Neutrophil cytosolic 
factor 4, 40kDa 
NCF/P40P
HOX 
- 1.08 0.12 5.82 0.10 0.86 0.11 1.27 1,4 
E08 Hs.654408 NM_003998 NFKB1 
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 1 
DKFZp686
C01211/E
BP-1 
0.97 0.95 1.21 0.79 1.93 1.05 2.22 1.51 2,3,4 
E09 Hs.73090 NM_002502 NFKB2 
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 2 
(p49/p100) 
LYT-
10/LYT10 
0.89 1.04 0.72 0.73 0.75 0.93 0.69 0.64 1,3,4 
E10 Hs.81328 NM_020529 NFKBIA 
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 
inhibitor, alpha 
IKBA/MAD
-3 
1.07 0.91 1.01 0.75 2.20 1.14 2.66 1.37 2 
E11 Hs.574741 NM_021209 NLRC4 
NLR family, CARD 
domain containing 4 
CARD12/C
LAN 
0.67 2.39 1.07 1.61 1.04 1.30 0.99 1.91 2 
E12 Hs.709191 NM_000625 NOS2 
Nitric oxide synthase 2, 
inducible 
HEP-
NOS/INOS 
0.98 1.08 0.30 0.92 0.02 0.86 0.93 1.27 1,3 
F01 Hs.137583 NM_005091 PGLYRP1 
Peptidoglycan 
recognition protein 1 
PGLYRP/P
GRP 
1.13 0.67 0.93 1.08 1.71 1.39 0.71 0.98 4 
F02 Hs.282244 NM_052890 PGLYRP2 
Peptidoglycan 
recognition protein 2 
HMFT0141
/PGLYRPL 
- 1.08 1.07 - - - - 1.27 4 
F03 Hs.348266 NM_052891 PGLYRP3 
Peptidoglycan 
recognition protein 3 
PGRP-
Ialpha/PG
RPIA 
0.52 1.08 0.63 0.92 2.50 0.86 0.92 1.27 4 
F04 Hs.2164 NM_002704 PPBP 
Pro-platelet basic protein 
(chemokine (C-X-C 
motif) ligand 7) 
B-
TG1/Beta-
TG 
0.88 1.08 1.07 0.92 0.92 0.00 0.99 1.27 1 
F05 Hs.224698 NM_000312 PROC 
Protein C (inactivator of 
coagulation factors Va 
and VIIIa) 
PC/PROC
1 
0.70 0.58 4.59 0.03 - 0.39 0.25 0.58 2 
F06 Hs.709174 NM_000952 PTAFR 
Platelet-activating factor 
receptor 
PAFR 1.58 0.26 0.99 - 1.88 2.73 2.13 0.31 3,4 
F07 Hs.19413 NM_005621 S100A12 
S100 calcium binding 
protein A12 
CAAF1/CA
GC 
0.25 1.08 - 0.92 0.03 0.86 - 1.27 3,4 
F08 Hs.525557 NM_000295 SERPINA1 
Serpin peptidase 
inhibitor, clade A (alpha-
1 antiproteinase, 
antitrypsin), member 1 
A1A/A1AT 2.57 1.21 1.73 0.35 2.19 0.83 2.95 1.26 4 
F09 Hs.414795 NM_000602 SERPINE1 
Serpin peptidase 
inhibitor, clade E (nexin, 
plasminogen activator 
inhibitor type 1), member 
1 
PAI/PAI-1 0.85 0.84 0.74 0.82 0.92 1.08 0.91 1.09 4 
F10 Hs.253495 NM_003019 SFTPD Surfactant protein D 
COLEC7/P
SP-D 
0.98 0.78 1.10 0.80 0.99 0.69 0.54 0.77 4 
F11 Hs.645227 NM_000660 TGFB1 
Transforming growth 
factor, beta 1 
CED/DPD
1 
1.01 0.83 0.63 0.78 0.93 1.00 0.88 0.82 2 
F12 Hs.654532 NM_003263 TLR1 Toll-like receptor 1 
CD281/DK
FZp547I06
10 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3,4 
G01 Hs.120551 NM_030956 TLR10 Toll-like receptor 10 CD290 0.03 1.08 0.74 0.92 0.03 0.86 0.32 1.27 3,4 
G02 Hs.519033 NM_003264 TLR2 Toll-like receptor 2 
CD282/TIL
4 
0.16 1.01 2.13 1.41 1.01 0.88 1.85 1.46 3 
G03 Hs.657724 NM_003265 TLR3 Toll-like receptor 3 CD283 0.37 0.97 0.92 0.85 0.97 0.76 1.36 0.66 3,4 
G04 Hs.174312 NM_138554 TLR4 Toll-like receptor 4 
ARMD10/
CD284 
0.63 0.97 0.88 0.66 0.68 0.77 0.72 1.09 3 
G05 Hs.662185 NM_006068 TLR6 Toll-like receptor 6 CD286 0.75 0.60 0.82 1.21 0.89 0.68 0.67 0.65 3,4 
G06 Hs.660543 NM_138636 TLR8 Toll-like receptor 8 CD288 - 1.08 0.06 0.92 - 0.86 - 1.27 3,4 
G07 Hs.87968 NM_017442 TLR9 Toll-like receptor 9 CD289 0.01 1.08 0.34 0.92 0.01 0.00 0.01 0.00 3,4 
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A-1. (cont.) 
      
CdSe 
8hr 
CdSe 
48hr 
CdSe 
8hr 
CdSe 
48hr 
CdSe 
ZnS 
8hr 
CdSe 
ZnS 
48hr 
CdSe 
ZnS 
8hr 
CdSe 
ZnS 
48hr 
 
Pos Unigene GeneBank Symbol Description 
Gene 
Name 
low 
dose 
low 
dose 
high 
dose 
high 
dose 
low 
dose 
low 
dose 
high 
dose 
high 
dose 
Class 
G08 Hs.241570 NM_000594 TNF-α 
Tumor necrosis factor 
(TNF superfamily, 
member 2) 
DIF/TNF-
alpha 
0.26 1.74 1.07 0.44 0.55 1.59 1.14 0.28 2,3 
G09 Hs.279594 NM_001065 TNFRSF1A 
Tumor necrosis factor 
receptor superfamily, 
member 1A 
CD120a/F
PF 
0.82 1.29 0.78 1.22 0.95 1.16 0.93 1.58 2,3 
G10 Hs.368527 NM_019009 TOLLIP Toll interacting protein 
IL-
1RAcPIP 
1.20 1.54 1.04 1.49 0.95 1.19 1.05 1.39 3 
G11 Hs.591983 NM_004620 TRAF6 
TNF receptor-associated 
factor 6 
MGC:3310
/RNF85 
0.91 1.01 0.73 0.78 0.95 1.05 0.81 0.99 3,4 
G12 Hs.283022 NM_018643 TREM1 
Triggering receptor 
expressed on myeloid 
cells 1 
TREM-1 - - - - - 0.10 2.30 - 3 
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A-2.  Gene table II. Complete data set of all the genes studied by real time PCR. 
      
8h 24h 
Pos Unigene GeneBank Symbol Description 
Gene 
Name 
Sil Full QD TiO2 Sil Full QD TiO2 
          
A01  Hs.197029 NM_000675 ADORA2A Adenosine A2a receptor 
ADORA2/
RDC8 0.420 1.031 0.632 0.805 
A02  Hs.494997 NM_001735 C5 Complement component 5 CPAMD4 0.787 1.211 1.013 1.025 0.668  0.736 0.414 
A03  Hs.93210 NM_000562 C8A 
Complement component 8, 
alpha polypeptide 
C8A 
    0.822 1.765 1.122 1.45 
A04  Hs.51120 NM_004345 CAMP 
Cathelicidin antimicrobial 
peptide 
CAP18/CR
AMP         
A05  Hs.2490 NM_033292 CASP1 
Caspase 1, apoptosis-
related cysteine peptidase 
(interleukin 1, beta, 
convertase) 
ICE/IL1BC 
0.678 0.798 0.867 0.943     
A06  Hs.138378 NM_001225 CASP4 
Caspase 4, apoptosis-
related cysteine peptidase 
ICE(rel)II/I
CEREL-II 1.181 0.846 0.883 1.051 1.202 1.713 1.398 1.062 
A07  Hs.303649 NM_002982 CCL2 
Chemokine (C-C motif) 
ligand 2 
GDCF-
2/HC11 0.807 0.620 0.770 0.878 1.281 1.269 0.999 1.033 
A08  Hs.506190 NM_001837 CCR3 
Chemokine (C-C motif) 
receptor 3 
CC-CKR-
3/CD193 0.648 0.995 0.807 0.715 0.955 0.824 1.071 1.360 
A09  Hs.163867 NM_000591 CD14 CD14 molecule CD14     1.013 0.912 0.242 0.745 
A10  Hs.1799 NM_001766 CD1D CD1d molecule CD1A/R3     0.403 14.23 2.762 12.85 
A11  Hs.126517 NM_000574 CD55 
CD55 molecule, decay 
accelerating factor for 
complement (Cromer blood 
group) 
CR/CROM 
1.117 1.014 1.013 1.050     
A12  Hs.198998 NM_001278 CHUK 
Conserved helix-loop-helix 
ubiquitous kinase 
IKBKA/IKK
-alpha 0.945 0.626 0.774 0.837 1.944 2.259 1.50 0.949 
B01  Hs.464422 NM_130386 COLEC12 
Collectin sub-family 
member 12 
CLP1/NSR
2 0.653 1.129 0.933 0.963 1.757 1.592 1.283 0.770 
B02  Hs.709456 NM_000567 CRP 
C-reactive protein, 
pentraxin-related 
PTX1 
    0.877 1.441 0.971 0.810 
B03  Hs.593413 NM_003467 CXCR4 
Chemokine (C-X-C motif) 
receptor 4 
CD184/D2
S201E         
B04  Hs.292356 NM_000397 CYBB 
Cytochrome b-245, beta 
polypeptide 
CGD/GP9
1-1         
B05  Hs.105924 NM_004942 DEFB4 Defensin, beta 4 
DEFB-
2/DEFB10
2         
B06  Hs.279611 NM_004406 DMBT1 
Deleted in malignant brain 
tumors 1 
GP340/mu
clin         
B07  Hs.203717 NM_002026 FN1 Fibronectin 1 
CIG/DKFZ
p686F101
64 0.545 1.106 0.917 1.139     
B08  Hs.517581 NM_002133 HMOX1 
Heme oxygenase 
(decycling) 1 
HO-
1/HSP32 27.62 1.134 0.739 0.795 1.685 2.240 1.762 1.732 
B09  Hs.37026 NM_024013 IFNA1 Interferon, alpha 1 IFL/IFN 0.483 0.955 0.862 1.011 11.15 1.789 1.475 0.627 
B10  Hs.93177 NM_002176 IFNB1 Interferon, beta 1, fibroblast IFB/IFF     1.129 1.34 1.455 2.15 
B11  Hs.520414 NM_000416 IFNGR1 
Interferon gamma receptor 
1 
CD119/IFN
GR 0.946 1.024 0.691 0.915 0.861 2.598 1.521 3.281 
B12  Hs.634632 NM_005534 IFNGR2 
Interferon gamma receptor 
2 (interferon gamma 
transducer 1) 
AF-
1/IFGR2 
0.908 0.759 0.866 0.824 1.311 1.615 1.491 1.331 
C01  Hs.597664 NM_001556 IKBKB 
Inhibitor of kappa light 
polypeptide gene enhancer 
in B-cells, kinase beta 
IKK-
beta/IKK2 
0.919 1.202 1.000 1.138 0.904 1.698 1.726 1.417 
C02  Hs.193717 NM_000572 IL10 Interleukin 10 CSIF/IL-10 0.785 1.233 0.502 1.344 1.124 2.259 1.151 1.683 
C03  Hs.479347 NM_001559 IL12RB2 
Interleukin 12 receptor, 
beta 2 
RP11-
102M16.1 0.584 0.828 0.428 0.642 1.455 1.075 0.684 1.896 
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A-2. (cont.) 
      
8h 24h 
Pos Unigene GeneBank Symbol Description 
Gene 
Name 
Sil Full QD TiO2 Sil Full QD TiO2 
C04  Hs.1722 NM_000575 IL1A Interleukin 1, alpha IL-1A/IL1 0.604 1.261 1.360 0.791  1.041 2.123 5.595 
C05  Hs.126256 NM_000576 IL1B Interleukin 1, beta 
IL-1/IL1-
BETA 0.777 0.798 0.550 1.089 5.126 2.258 2.374 2.181 
C06  Hs.306974 NM_173161 IL1F10 
Interleukin 1 family, 
member 10 (theta) 
FIL1-
theta/FKS
G75     4.239 1.898 1.257 2.264 
C07  Hs.516301 NM_012275 IL1F5 
Interleukin 1 family, 
member 5 (delta) 
FIL1/FIL1(
DELTA)         
C08  Hs.278910 NM_014440 IL1F6 
Interleukin 1 family, 
member 6 (epsilon) 
FIL1/FIL1(
EPSILON)         
C09  Hs.166371 NM_173205 IL1F7 
Interleukin 1 family, 
member 7 (zeta) 
FIL1/FIL1(
ZETA) 0.281 1.324 0.967 0.521     
C10  Hs.278909 NM_173178 IL1F8 
Interleukin 1 family, 
member 8 (eta) 
FIL1/FIL1-
(ETA) 2.429 1.178 0.837 2.163 29.49 14.72 13.95 36.11 
C11  Hs.211238 NM_019618 IL1F9 
Interleukin 1 family, 
member 9 
IL-1F9/IL-
1H1 0.393 1.468      
C12  Hs.701982 NM_000877 IL1R1 
Interleukin 1 receptor, type 
I 
CD121A/D
2S1473 0.650 0.825 0.857 0.930  5.483 1.837  
D01  Hs.25333 NM_004633 IL1R2 
Interleukin 1 receptor, type 
II 
CD121b/IL
1RB 1.009 0.237 0.466 0.238 0.629 1.555 1.165 0.960 
D02  Hs.478673 NM_002182 IL1RAP 
Interleukin 1 receptor 
accessory protein 
C3orf13/IL-
1RAcP 0.916 1.664 1.027 1.364 0.634 0.617 0.241  
D03  Hs.675519 NM_017416 IL1RAPL2 
Interleukin 1 receptor 
accessory protein-like 2 
IL-
1R9/IL1R9 0.601 0.989 1.390 0.688 1.987 2.388 1.327 2.130 
D04  Hs.659863 NM_003854 IL1RL2 Interleukin 1 receptor-like 2 
IL1R-
rp2/IL1RR
P2 1.112 0.653 0.991 0.558  0.514 0.910 1.413 
D05  Hs.81134 NM_000577 IL1RN 
Interleukin 1 receptor 
antagonist 
ICIL-
1RA/IL-
1ra3 0.837 1.284 0.499 0.462 0.402 1.637 1.086 1.204 
D06  Hs.654458 NM_000600 IL6 
Interleukin 6 (interferon, 
beta 2) 
BSF2/HGF 
1.515 0.814 0.878 0.769     
D07  Hs.522819 NM_001569 IRAK1 
Interleukin-1 receptor-
associated kinase 1 
IRAK/pelle 
0.889 1.196 1.180 1.876 2.644 2.418 1.575 1.080 
D08  Hs.449207 NM_001570 IRAK2 
Interleukin-1 receptor-
associated kinase 2 
IRAK-2 
0.768 0.580 0.700 0.644 2.705 2.290 3.198 3.198 
D09  Hs.436061 NM_002198 IRF1 
Interferon regulatory factor 
1 
IRF-1/MAR 
0.756 1.298 0.819 1.206 1.389 0.630 0.739 0.820 
D10  Hs.72938 NM_002289 LALBA Lactalbumin, alpha- 
MGC1385
21     0.765 1.544 1.454 1.813 
D11  Hs.154078 NM_004139 LBP 
Lipopolysaccharide binding 
protein 
MGC2223
3         
D12  Hs.529517 NM_002343 LTF Lactotransferrin 
GIG12/HL
F2         
E01  Hs.660766 NM_015364 LY96 Lymphocyte antigen 96 MD-2/MD2 0.841 1.045 0.847 1.036     
E02  Hs.524579 NM_000239 LYZ 
Lysozyme (renal 
amyloidosis) 
LZM/lysoz
yme 0.273 0.988  1.817 1.237 1.093 0.899 
E03  Hs.485233 NM_001315 MAPK14 
Mitogen-activated protein 
kinase 14 
CSBP1/CS
BP2 0.728 1.054 0.920 1.148    1.158 
E04  Hs.138211 NM_002750 MAPK8 
Mitogen-activated protein 
kinase 8 
JNK/JNK1 
0.770 0.849 0.940 0.937 1.263 1.582 1.480 1.509 
E05  Hs.407995 NM_002415 MIF 
Macrophage migration 
inhibitory factor 
(glycosylation-inhibiting 
factor) 
GIF/GLIF 
0.935 1.197 0.998 1.161 1.557 1.809 1.575 1.626 
E06  Hs.82116 NM_002468 MYD88 
Myeloid differentiation 
primary response gene 
(88) 
MYD88D 
0.769 1.181 1.180 1.335 1.669 1.350 1.085 0.904 
E07  Hs.474781 NM_000631 NCF4 
Neutrophil cytosolic factor 
4, 40kDa 
NCF/P40P
HOX  1.155  1.112 1.249 1.742 1.447 1.784 
E08  Hs.654408 NM_003998 NFKB1 
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 1 
DKFZp686
C01211/E
BP-1 0.896 0.901 0.947 0.902     
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Pos Unigene GeneBank Symbol Description 
Gene 
Name 
Sil Full QD TiO2 Sil Full QD TiO2 
E09  Hs.73090 NM_002502 NFKB2 
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 2 
(p49/p100) 
LYT-
10/LYT10 
0.717 1.292 1.136 1.288 1.470 1.298 1.163 0.802 
E10  Hs.81328 NM_020529 NFKBIA 
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 
inhibitor, alpha 
IKBA/MAD
-3 
1.116 1.034 0.954 0.995 1.176 1.76 2.209 1.356 
E11  Hs.574741 NM_021209 NLRC4 
NLR family, CARD domain 
containing 4 
CARD12/C
LAN 0.366 0.520 0.813 0.526 1.046 1.113 1.113 0.651 
E12  Hs.709191 NM_000625 NOS2 
Nitric oxide synthase 2, 
inducible 
HEP-
NOS/INOS     1.910 2.593 1.993 0.552 
F01  Hs.137583 NM_005091 PGLYRP1 
Peptidoglycan recognition 
protein 1 
PGLYRP/P
GRP         
F02  Hs.282244 NM_052890 PGLYRP2 
Peptidoglycan recognition 
protein 2 
HMFT0141
/PGLYRPL     7.073 11.47 4.892 9.837 
F03  Hs.348266 NM_052891 PGLYRP3 
Peptidoglycan recognition 
protein 3 
PGRP-
Ialpha/PG
RPIA   0.334      
F04  Hs.2164 NM_002704 PPBP 
Pro-platelet basic protein 
(chemokine (C-X-C motif) 
ligand 7) 
B-
TG1/Beta-
TG         
F05  Hs.224698 NM_000312 PROC 
Protein C (inactivator of 
coagulation factors Va and 
VIIIa) 
PC/PROC
1 
        
F06  Hs.709174 NM_000952 PTAFR 
Platelet-activating factor 
receptor 
PAFR 
 1.887       
F07  Hs.19413 NM_005621 S100A12 
S100 calcium binding 
protein A12 
CAAF1/CA
GC         
F08  Hs.525557 NM_000295 
SERPINA
1 
Serpin peptidase inhibitor, 
clade A (alpha-1 
antiproteinase, antitrypsin), 
member 1 
A1A/A1AT 
1.225 1.594 1.016 1.019     
F09  Hs.414795 NM_000602 
SERPINE
1 
Serpin peptidase inhibitor, 
clade E (nexin, 
plasminogen activator 
inhibitor type 1), member 1 
PAI/PAI-1 
0.788 1.092 0.797 1.079 0.769 1.553  1.961 
F10  Hs.253495 NM_003019 SFTPD Surfactant protein D 
COLEC7/P
SP-D 0.410 0.582 0.740 0.506 0.976 1.473 0.883 1.296 
F11  Hs.645227 NM_000660 TGFB1 
Transforming growth factor, 
beta 1 
CED/DPD
1 0.871 1.033 1.008 1.135 146.5 170.3 110.0 404.2 
F12  Hs.654532 NM_003263 TLR1 Toll-like receptor 1 
CD281/DK
FZp547I06
10     0.935 1.548 1.617 1.765 
G01  Hs.120551 NM_030956 TLR10 Toll-like receptor 10 CD290      2.639 0.749 0.799 
G02  Hs.519033 NM_003264 TLR2 Toll-like receptor 2 
CD282/TIL
4         
G03  Hs.657724 NM_003265 TLR3 Toll-like receptor 3 CD283 1.169 2.587 1.795 1.920 0.634 1.213 1.140  
G04  Hs.174312 NM_138554 TLR4 Toll-like receptor 4 
ARMD10/
CD284 1.134 0.852 0.930 0.994 0.744 1.416 1.379 0.837 
G05  Hs.662185 NM_006068 TLR6 Toll-like receptor 6 CD286 1.085 1.841 1.361 0.969 1.089 1.005 0.948 0.872 
G06  Hs.660543 NM_138636 TLR8 Toll-like receptor 8 CD288     1.278 1.866 1.377 1.277 
G07  Hs.87968 NM_017442 TLR9 Toll-like receptor 9 CD289         
G08  Hs.241570 NM_000594 TNF-α 
Tumor necrosis factor (TNF 
superfamily, member 2) 
DIF/TNF-
alpha         
G09  Hs.279594 NM_001065 
TNFRSF1
A 
Tumor necrosis factor 
receptor superfamily, 
member 1A 
CD120a/F
PF 
0.895 1.105 0.902 1.003 0.444 0.535 0.356 0.397 
G10  Hs.368527 NM_019009 TOLLIP Toll interacting protein 
IL-
1RAcPIP 1.155 0.707 1.016 0.753 0.836 1.133 0.860 0.366 
G11  Hs.591983 NM_004620 TRAF6 
TNF receptor-associated 
factor 6 
MGC:3310
/RNF85 1.133 0.773 0.979 0.791 1.389 1.320 1.216 0.645 
G12  Hs.283022 NM_018643 TREM1 
Triggering receptor 
expressed on myeloid cells 
1 
TREM-1 
1.284   3.535 1.377 1.578 1.376 0.923 
 
  
205 
 
 
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
580 630 680 730 780 830 880
R
F
U
 (
@
5
6
0
n
m
 e
x
c
it
ia
ti
o
n
)
Emission wavelength (nm)
resorufin QDs
 
 
A-3. Fluorescence compatibility. Fluorescence spectral emission wavelengths of QDs and 
resorufin, product of resazurin (i.e. the viability marker), when excited at 560 nm. Resazurin 
assay data was collected at 590 nm. 
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Figure A-4. Unencapsulated QD and QDMC fluorescence emission spectra (after 
normalization to peak intensity).  Because no spectral shift to longer wavelength occurs upon 
microencapsulation, the quantum dots are not self-quenching within the microcapsules after 
microencapsulation. The spectra are essentially the same, and there is no evidence of the 
characteristic red-shift that is associated with self-quenching. 
 
 
 
 
 
 
  
207 
VITA 
 
Name: Amelia Antonia Romoser 
 
Address: Interdisciplinary Faculty of Toxicology 
 Department of Veterinary Physiology and Pharmacology 
 College of Veterinary Medicine 
 Texas A&M University 
 4466 TAMU 
 College Station, TX 77843-4466 
 
Email Address: aromoser@cvm.tamu.edu 
Education: B.S., Bioenvironmental Sciences, Texas A&M University, 2008 
 Ph.D., Toxicology, Texas A&M University, 2012 
 
  
 
 
 
 
 
 
 
 
 
 
 
